data_2ka1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.778 0.323 . . . . 1.77 110.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.6699999999999999 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.6599999999999999 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 1.23 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.66000000000000003 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 1.21 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 1.0900000000000001 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 1.28 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.27000000000000002 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 1.1499999999999999 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28000000000000003 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 1.5700000000000001 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 2.1899999999999999 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 1.53 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.5899999999999999 111.192 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 5.0800000000000001 111.194 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.6100000000000001 110.852 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.832 0.349 . . . . 1.98 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 1.49 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.414 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 1.3600000000000001 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.62 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.47999999999999998 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 1.1799999999999999 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 1.1699999999999999 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 1.0800000000000001 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.0800000000000001 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26000000000000001 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 1.1799999999999999 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34000000000000002 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 1.3200000000000001 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 2.4500000000000002 110.841 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 1.55 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.68999999999999995 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 3.0299999999999998 111.157 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.803 0.335 . . . . 1.77 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.6699999999999999 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD11 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.66000000000000003 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1799999999999999 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 1.21 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 1.0900000000000001 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 1.28 110.054 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.27000000000000002 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 1.1499999999999999 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28000000000000003 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 1.5700000000000001 110.663 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.451 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 2.1899999999999999 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 1.53 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55000000000000004 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.5899999999999999 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.451 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 5.0800000000000001 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 110.84 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.843 0.354 . . . . 1.98 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 1.49 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 1.47 111.141 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 1.3600000000000001 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.62 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.47999999999999998 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 1.1799999999999999 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.1699999999999999 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 1.0800000000000001 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26000000000000001 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.1799999999999999 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34000000000000002 112.279 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 1.3200000000000001 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 2.4500000000000002 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 1.55 111.08 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.68999999999999995 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 3.0299999999999998 111.499 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.901 0.381 . . . . 1.77 110.82 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.6699999999999999 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 110.669 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 1.23 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.47999999999999998 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.66000000000000003 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 1.21 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 1.0900000000000001 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 1.28 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.27000000000000002 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 1.1499999999999999 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28000000000000003 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 1.5700000000000001 111.043 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 2.1899999999999999 111.146 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 1.53 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55000000000000004 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.5899999999999999 111.775 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 5.0800000000000001 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.6100000000000001 110.916 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.823 0.344 . . . . 1.98 111.228 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 1.49 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.47 110.794 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.3600000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.447 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.47999999999999998 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.1799999999999999 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 1.1699999999999999 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 1.0800000000000001 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 1.0800000000000001 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26000000000000001 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 1.1799999999999999 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34000000000000002 112.336 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.3200000000000001 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 2.4500000000000002 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 1.55 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.68999999999999995 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 3.0299999999999998 111.38 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 1.77 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.6699999999999999 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.6599999999999999 110.504 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 1.23 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.47999999999999998 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.66000000000000003 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1799999999999999 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.21 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 1.0900000000000001 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 1.28 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.27000000000000002 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 1.1499999999999999 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28000000000000003 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.5700000000000001 110.914 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 2.1899999999999999 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.53 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.5899999999999999 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 5.0800000000000001 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.6100000000000001 110.994 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 1.98 110.459 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 1.49 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 1.47 110.431 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 1.3600000000000001 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.62 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.47999999999999998 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.1799999999999999 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.1699999999999999 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 1.0800000000000001 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 1.0800000000000001 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26000000000000001 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 1.1799999999999999 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34000000000000002 112.262 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 1.3200000000000001 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.41 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 2.4500000000000002 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 1.55 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.68999999999999995 113.683 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 3.0299999999999998 111.004 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.748 0.309 . . . . 1.77 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.6699999999999999 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.6599999999999999 110.925 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 1.23 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.47999999999999998 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.66000000000000003 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 1.1799999999999999 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 1.21 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 1.0900000000000001 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 1.28 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.27000000000000002 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 1.1499999999999999 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.435 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28000000000000003 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 1.5700000000000001 111.164 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 2.1899999999999999 110.798 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 1.53 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55000000000000004 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.5899999999999999 111.439 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 5.0800000000000001 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.6100000000000001 110.764 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 1.98 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.139 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 1.3600000000000001 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.62 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.47999999999999998 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 1.1799999999999999 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.1699999999999999 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 1.0800000000000001 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26000000000000001 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 1.1799999999999999 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34000000000000002 112.233 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.435 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.3200000000000001 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 2.4500000000000002 110.663 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 1.55 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.68999999999999995 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 3.0299999999999998 110.723 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.714 0.292 . . . . 1.77 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.6699999999999999 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.6599999999999999 110.764 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 1.23 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.47999999999999998 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.66000000000000003 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.1799999999999999 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 1.21 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 1.0900000000000001 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 1.28 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.27000000000000002 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 1.1499999999999999 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28000000000000003 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 1.5700000000000001 110.433 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 2.1899999999999999 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 179' ' ' LEU . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55000000000000004 112.885 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.5899999999999999 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 5.0800000000000001 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.6100000000000001 111.081 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.812 0.339 . . . . 1.98 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.402 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 1.47 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.3600000000000001 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.62 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 1.1799999999999999 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.1699999999999999 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 1.0800000000000001 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 1.0800000000000001 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26000000000000001 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 1.1799999999999999 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34000000000000002 112.111 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 1.3200000000000001 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 2.4500000000000002 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.68999999999999995 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 3.0299999999999998 111.132 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.933 0.397 . . . . 1.77 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.6599999999999999 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 1.23 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.43 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.47999999999999998 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 1.1799999999999999 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 1.21 110.656 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 1.0900000000000001 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.28 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.27000000000000002 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 1.1499999999999999 110.222 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28000000000000003 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 1.5700000000000001 110.827 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 2.1899999999999999 110.986 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55000000000000004 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.5899999999999999 111.309 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 5.0800000000000001 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.6100000000000001 110.748 179.471 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 1.98 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 1.49 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.996 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 1.3600000000000001 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.62 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.47999999999999998 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 1.1799999999999999 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 1.1699999999999999 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.421 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 1.0800000000000001 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26000000000000001 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 1.1799999999999999 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34000000000000002 112.361 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 2.4500000000000002 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.026 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.68999999999999995 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 3.0299999999999998 111.934 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.748 0.308 . . . . 1.77 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.413 ' N ' HD11 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.6599999999999999 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 1.23 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.47999999999999998 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.66000000000000003 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 1.1799999999999999 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.21 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 1.0900000000000001 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.27000000000000002 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 1.1499999999999999 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 1.5700000000000001 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 2.1899999999999999 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 1.53 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55000000000000004 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HD3' ' NH1' ' A' ' 186' ' ' ARG . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.5899999999999999 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 5.0800000000000001 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.6100000000000001 110.831 179.695 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.739 0.304 . . . . 1.98 111.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 1.49 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 1.47 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.3600000000000001 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.47999999999999998 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 1.1799999999999999 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 1.1699999999999999 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 1.0800000000000001 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26000000000000001 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 1.1799999999999999 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34000000000000002 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 1.3200000000000001 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.4 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 2.4500000000000002 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 1.55 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.68999999999999995 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 3.0299999999999998 110.982 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.894 0.378 . . . . 1.77 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.6699999999999999 111.407 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.6599999999999999 111.135 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 1.23 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.433 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.47999999999999998 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 1.1799999999999999 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 1.21 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.424 ' HB3' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 1.0900000000000001 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 1.28 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.27000000000000002 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 1.1499999999999999 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28000000000000003 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 1.5700000000000001 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 2.1899999999999999 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 1.53 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55000000000000004 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.5899999999999999 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 5.0800000000000001 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.421 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 110.841 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.839 0.352 . . . . 1.98 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 1.47 111.05 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 1.3600000000000001 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.62 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.47999999999999998 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 1.1799999999999999 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 1.1699999999999999 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 1.0800000000000001 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 1.0800000000000001 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26000000000000001 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 1.1799999999999999 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34000000000000002 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 1.3200000000000001 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 2.4500000000000002 110.691 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.55 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.68999999999999995 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 3.0299999999999998 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.915 0.388 . . . . 1.77 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.6699999999999999 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.6599999999999999 111.148 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.23 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.47999999999999998 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.66000000000000003 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 1.1799999999999999 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 1.21 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 1.0900000000000001 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 1.28 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.27000000000000002 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 1.1499999999999999 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28000000000000003 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 1.5700000000000001 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 2.1899999999999999 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 1.53 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55000000000000004 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.5899999999999999 111.725 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 5.0800000000000001 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.6100000000000001 110.85 179.687 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.843 0.354 . . . . 1.98 110.746 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 1.47 110.643 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.3600000000000001 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.62 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.47999999999999998 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 1.1699999999999999 111.244 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 1.0800000000000001 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 1.0800000000000001 110.313 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 1.1799999999999999 110.519 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34000000000000002 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.436 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 1.3200000000000001 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 1.55 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.68999999999999995 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 3.0299999999999998 111.103 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 1.77 110.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.6699999999999999 110.829 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.6599999999999999 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 1.23 110.717 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.47999999999999998 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.66000000000000003 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 1.1799999999999999 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 1.21 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 1.0900000000000001 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 1.28 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.27000000000000002 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 1.1499999999999999 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28000000000000003 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 1.5700000000000001 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 2.1899999999999999 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 1.53 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55000000000000004 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.5899999999999999 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 5.0800000000000001 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.6100000000000001 110.588 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.796 0.331 . . . . 1.98 110.727 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 1.49 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 1.47 110.865 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 1.3600000000000001 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.62 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.47999999999999998 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 1.1699999999999999 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 1.0800000000000001 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0800000000000001 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26000000000000001 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 1.1799999999999999 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34000000000000002 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 1.3200000000000001 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.4500000000000002 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 1.55 110.978 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.68999999999999995 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 3.0299999999999998 111.854 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.659 0.266 . . . . 1.77 111.524 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.6699999999999999 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.6599999999999999 111.162 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 1.23 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.47999999999999998 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.66000000000000003 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 1.1799999999999999 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.21 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.0900000000000001 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 1.28 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.27000000000000002 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 1.1499999999999999 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28000000000000003 112.65 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 1.5700000000000001 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 2.1899999999999999 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 1.53 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55000000000000004 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.5899999999999999 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 5.0800000000000001 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.6100000000000001 111.077 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.781 0.324 . . . . 1.98 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 1.47 111.111 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 1.3600000000000001 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.62 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.47999999999999998 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.1799999999999999 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 1.0800000000000001 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 1.0800000000000001 110.566 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26000000000000001 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 1.1799999999999999 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34000000000000002 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 1.3200000000000001 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 2.4500000000000002 110.629 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 1.55 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.68999999999999995 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 3.0299999999999998 111.022 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 1.77 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.6699999999999999 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.6599999999999999 110.663 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.47999999999999998 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.66000000000000003 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 1.21 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 1.0900000000000001 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 1.28 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.27000000000000002 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 1.1499999999999999 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28000000000000003 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 1.5700000000000001 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 2.1899999999999999 110.212 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 1.53 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55000000000000004 112.752 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.5899999999999999 111.042 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 5.0800000000000001 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.6100000000000001 110.963 179.722 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.889 0.376 . . . . 1.98 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 1.49 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 1.47 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 1.3600000000000001 110.86 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.62 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.47999999999999998 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 1.1799999999999999 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.1699999999999999 110.528 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 1.0800000000000001 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26000000000000001 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 1.1799999999999999 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34000000000000002 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 1.3200000000000001 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 2.4500000000000002 110.913 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 1.55 111.032 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.68999999999999995 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 3.0299999999999998 111.353 -179.673 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.854 0.359 . . . . 1.77 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.6599999999999999 110.734 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.47999999999999998 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.66000000000000003 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 1.1799999999999999 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 1.21 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.0900000000000001 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 1.28 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.27000000000000002 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 1.1499999999999999 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28000000000000003 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 1.5700000000000001 110.837 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 2.1899999999999999 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 1.53 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55000000000000004 112.977 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.5899999999999999 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 5.0800000000000001 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.6100000000000001 110.935 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 1.98 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 1.49 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.47 110.7 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.3600000000000001 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.62 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 1.1799999999999999 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 1.1699999999999999 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 1.0800000000000001 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 1.0800000000000001 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26000000000000001 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.1799999999999999 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34000000000000002 112.338 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 1.3200000000000001 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 2.4500000000000002 111.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 1.55 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.68999999999999995 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 3.0299999999999998 111.44 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.795 0.331 . . . . 1.77 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.6599999999999999 110.613 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.47999999999999998 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.66000000000000003 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.1799999999999999 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.21 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 1.0900000000000001 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 1.28 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.27000000000000002 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 1.1499999999999999 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28000000000000003 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 1.5700000000000001 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 2.1899999999999999 110.672 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 1.53 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55000000000000004 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.5899999999999999 111.283 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 5.0800000000000001 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.6100000000000001 110.99 179.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.902 0.382 . . . . 1.98 110.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 1.49 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 1.47 110.59 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 1.3600000000000001 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.62 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.47999999999999998 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 1.1699999999999999 110.915 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 1.0800000000000001 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.0800000000000001 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26000000000000001 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 1.1799999999999999 110.475 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34000000000000002 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 1.3200000000000001 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 2.4500000000000002 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 1.55 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.68999999999999995 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 3.0299999999999998 111.269 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.94 0.4 . . . . 1.77 110.556 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 110.892 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.6599999999999999 110.646 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 1.23 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.47999999999999998 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.66000000000000003 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 1.1799999999999999 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 1.21 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 1.0900000000000001 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 1.28 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.27000000000000002 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 1.1499999999999999 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28000000000000003 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 1.5700000000000001 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 2.1899999999999999 110.85 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 1.53 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.5899999999999999 111.178 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 5.0800000000000001 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.6100000000000001 111.114 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 1.98 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 1.49 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.434 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 1.47 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 1.3600000000000001 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.62 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.47999999999999998 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 1.1799999999999999 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 1.1699999999999999 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26000000000000001 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 1.1799999999999999 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34000000000000002 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 2.4500000000000002 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.55 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.68999999999999995 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 3.0299999999999998 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 1.77 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.6699999999999999 110.902 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.6599999999999999 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 1.23 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.47999999999999998 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.66000000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 1.1799999999999999 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 1.0900000000000001 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 1.28 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.27000000000000002 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 1.1499999999999999 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28000000000000003 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 1.5700000000000001 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.438 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 2.1899999999999999 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 1.53 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55000000000000004 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.5899999999999999 111.366 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 5.0800000000000001 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.6100000000000001 111.039 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.785 0.326 . . . . 1.98 111.025 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 1.49 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . 0.418 HD11 ' N ' ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.47 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 1.3600000000000001 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.62 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 1.1699999999999999 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.0800000000000001 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 1.0800000000000001 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26000000000000001 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 1.1799999999999999 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34000000000000002 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 1.3200000000000001 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 2.4500000000000002 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 1.55 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.68999999999999995 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 3.0299999999999998 111.38 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.884 0.373 . . . . 1.77 110.951 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.6699999999999999 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.6599999999999999 110.927 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 1.23 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.47999999999999998 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.66000000000000003 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.1799999999999999 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 1.21 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 1.0900000000000001 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.28 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.27000000000000002 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 1.1499999999999999 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28000000000000003 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 1.5700000000000001 111.14 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.1899999999999999 111.136 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 1.53 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55000000000000004 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.5899999999999999 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.406 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 5.0800000000000001 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.6100000000000001 110.742 179.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.733 0.301 . . . . 1.98 111.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 1.49 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 1.47 110.807 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 1.3600000000000001 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.62 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.47999999999999998 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 1.1799999999999999 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.1699999999999999 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0800000000000001 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 1.0800000000000001 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26000000000000001 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34000000000000002 112.118 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 1.3200000000000001 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 2.4500000000000002 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 1.55 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.68999999999999995 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 3.0299999999999998 111.065 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.73 0.3 . . . . 1.77 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.6699999999999999 111.388 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.6599999999999999 110.92 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 1.23 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.47999999999999998 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.66000000000000003 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 1.1799999999999999 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 110.699 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.27000000000000002 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 1.1499999999999999 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28000000000000003 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.5700000000000001 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 2.1899999999999999 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 1.53 111.056 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55000000000000004 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.5899999999999999 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 5.0800000000000001 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.6100000000000001 110.925 179.618 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.861 0.362 . . . . 1.98 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 1.49 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 1.3600000000000001 110.472 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.62 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.47999999999999998 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 1.1799999999999999 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 1.0800000000000001 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 1.0800000000000001 110.019 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26000000000000001 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 1.1799999999999999 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34000000000000002 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 1.3200000000000001 110.834 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 2.4500000000000002 110.784 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 1.55 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.68999999999999995 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 3.0299999999999998 111.383 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.706 0.288 . . . . 1.77 111.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.6699999999999999 111.405 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 1.23 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.47999999999999998 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.66000000000000003 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 1.1799999999999999 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' B' ' 177' ' ' ILE . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 1.0900000000000001 110.373 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 1.28 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.27000000000000002 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 1.1499999999999999 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28000000000000003 111.496 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 1.5700000000000001 110.642 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 2.1899999999999999 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 1.53 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.5899999999999999 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 5.0800000000000001 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.418 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.6100000000000001 111.225 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.697 0.284 . . . . 1.98 111.341 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 1.49 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.47 111.017 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.62 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.47999999999999998 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 1.1799999999999999 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 1.0800000000000001 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 1.0800000000000001 111.013 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26000000000000001 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 1.1799999999999999 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34000000000000002 112.407 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 111.201 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 2.4500000000000002 111.154 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 1.55 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.68999999999999995 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 3.0299999999999998 111.305 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.508 -0.237 . . . . 7.46 112.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.49 153.85 17.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 6.0999999999999996 112.514 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.23 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.805 0.336 . . . . 7.8300000000000001 111.142 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' ALA . 98.2 m-85 -76.75 -49.35 16.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 5.9699999999999998 110.865 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p 50.48 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.949 -0.569 . . . . 4.9100000000000001 111.646 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.61 -59.98 4.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 4.3399999999999999 111.675 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.1 -32.37 46.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 5.46 111.433 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -83.2 -55.76 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.472 -0.331 . . . . 3.6200000000000001 111.251 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.26 -37.34 85.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 3.71 111.486 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.96 -29.71 57.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.725 0.297 . . . . 4.2199999999999998 111.092 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.77 41.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 2.9199999999999999 111.214 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -119.56 -66.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 2.8599999999999999 110.894 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.7 mt -47.41 -57.13 10.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 2.46 111.641 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 21.0 Cg_endo -60.47 -28.45 86.72 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 1.53 112.245 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -65.21 -41.81 94.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 1.77 110.766 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.6699999999999999 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.6599999999999999 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 1.23 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.66000000000000003 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 1.21 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 1.0900000000000001 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 1.28 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.27000000000000002 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 1.1499999999999999 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28000000000000003 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 1.5700000000000001 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 2.1899999999999999 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 1.53 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.5899999999999999 111.192 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 5.0800000000000001 111.194 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -90.21 -40.63 12.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.6100000000000001 110.852 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.135 -0.936 . . . . 3.1600000000000001 111.28 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.418 -0.273 . . . . 8.1799999999999997 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 175.79 31.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.714 -0.755 . . . . 7.3099999999999996 112.431 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.9 mt -71.79 -65.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 8.1799999999999997 110.961 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -77.37 -71.98 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 7.1900000000000004 110.84 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t 59.73 -84.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 6.3200000000000003 111.365 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.02 -57.08 14.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.732 0.301 . . . . 5.2000000000000002 111.533 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -56.18 -61.58 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 5.1100000000000003 111.22 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -47.47 -49.87 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 4.0599999999999996 111.206 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.6 -38.79 91.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 4.0199999999999996 111.085 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -55.67 -22.56 23.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 4.5899999999999999 111.212 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.78 29.61 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 3.3999999999999999 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -125.6 -39.03 2.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 3.0800000000000001 111.128 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.456 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.8 mt -65.35 -56.92 16.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 2.6499999999999999 111.668 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.0 Cg_endo -60.95 -19.73 63.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.201 1.934 . . . . 1.6000000000000001 112.411 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t -68.58 -45.4 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 1.98 110.885 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 1.49 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.414 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 1.47 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 1.3600000000000001 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.62 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.47999999999999998 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 1.1799999999999999 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 1.1699999999999999 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 1.0800000000000001 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.0800000000000001 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26000000000000001 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 1.1799999999999999 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34000000000000002 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 1.3200000000000001 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 2.4500000000000002 110.841 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 1.55 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.68999999999999995 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -23.31 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 3.0299999999999998 111.157 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -73.93 -33.96 64.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 4.3499999999999996 111.125 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.78 -29.56 32.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 2.1299999999999999 110.794 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 2.5600000000000001 111.143 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.53 -0.228 . . . . 7.46 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -164.15 172.52 39.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.758 -0.734 . . . . 6.0999999999999996 112.482 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -71.23 -65.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 7.8300000000000001 110.915 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 94.8 m-85 -76.51 -85.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 5.9699999999999998 110.704 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.3 t 36.09 -90.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.614 0.598 . . . . 4.9100000000000001 112.614 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.11 -58.74 7.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.868 0.366 . . . . 4.3399999999999999 111.69 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.08 -22.15 10.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 5.46 111.526 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.25 -56.47 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 3.6200000000000001 110.814 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.85 -37.23 86.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 3.71 111.119 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HD2' ' HB2' ' A' ' 159' ' ' ALA . 57.4 mtpt -57.83 -23.6 53.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 4.2199999999999998 111.274 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.66 39.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 2.9199999999999999 111.365 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -135.32 -52.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.8599999999999999 110.693 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.9 mt -55.63 -46.72 99.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.46 111.521 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 69.7 Cg_endo -76.1 -30.14 5.93 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.935 1.756 . . . . 1.53 112.012 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 1.77 110.859 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.6699999999999999 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD11 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.47999999999999998 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.66000000000000003 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1799999999999999 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 1.21 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 1.0900000000000001 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 1.28 110.054 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.27000000000000002 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 1.1499999999999999 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28000000000000003 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 1.5700000000000001 110.663 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.451 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 2.1899999999999999 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 1.53 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55000000000000004 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.5899999999999999 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.451 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 5.0800000000000001 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.65 -63.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.6100000000000001 110.84 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.9 . . . . 3.1600000000000001 111.476 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.503 -0.239 . . . . 8.1799999999999997 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.89 170.89 14.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 7.3099999999999996 112.491 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.12 -63.07 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 8.1799999999999997 111.067 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 86.3 m-85 -76.27 -63.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 7.1900000000000004 110.997 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 63.4 m 47.95 -90.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 6.3200000000000003 111.254 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.07 -55.53 31.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 5.2000000000000002 111.214 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -48.95 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.1100000000000003 110.746 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.431 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 46.3 t80 -56.58 -53.93 51.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 4.0599999999999996 111.181 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 mt -61.85 -34.85 76.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 4.0199999999999996 110.742 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -55.54 -26.18 41.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 4.5899999999999999 110.696 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.96 36.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 3.3999999999999999 111.113 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -123.14 -56.2 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 3.0800000000000001 110.768 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.2 mt -62.27 -45.86 90.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 2.6499999999999999 111.665 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 87.2 Cg_endo -79.83 8.18 4.17 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.269 1.979 . . . . 1.6000000000000001 113.139 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m -96.54 -41.86 8.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 1.98 110.861 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 1.49 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 1.47 111.141 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 1.3600000000000001 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.62 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.47999999999999998 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 1.1799999999999999 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.1699999999999999 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 1.0800000000000001 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26000000000000001 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.1799999999999999 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34000000000000002 112.279 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 1.3200000000000001 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 2.4500000000000002 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.418 ' O ' ' CG ' ' B' ' 186' ' ' ARG . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 1.55 111.08 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.68999999999999995 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 3.0299999999999998 111.499 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' B' ' 183' ' ' ILE . 6.6 ptp180 -69.15 -37.64 78.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 4.3499999999999996 111.111 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.28 -44.71 51.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 2.1299999999999999 111.257 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 2.5600000000000001 111.231 -179.825 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.403 -0.279 . . . . 7.46 112.403 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.46 169.07 42.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.741 -0.743 . . . . 6.0999999999999996 112.52 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.84 -63.67 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.73 0.3 . . . . 7.8300000000000001 111.18 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.1 m-85 -77.13 -75.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 5.9699999999999998 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t 46.62 -88.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 4.9100000000000001 112.064 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.98 -55.83 29.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 4.3399999999999999 111.784 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -36.03 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.898 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.527 ' CZ ' ' CD2' ' A' ' 165' ' ' PHE . 90.6 t80 -81.4 -45.09 16.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 3.6200000000000001 111.713 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 68.4 mt -63.09 -41.55 99.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 3.71 111.707 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -56.3 -20.67 19.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.567 -0.288 . . . . 4.2199999999999998 111.437 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.85 34.17 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 2.9199999999999999 111.335 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' CD2' ' CZ ' ' A' ' 161' ' ' PHE . 54.9 t80 -136.74 -56.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 2.8599999999999999 110.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 55.7 mt -57.76 -58.9 15.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 2.46 111.427 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 9.7 Cg_endo -52.09 -23.79 18.22 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.213 1.942 . . . . 1.53 112.183 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -72.25 -41.66 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 1.77 110.82 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.6699999999999999 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 110.669 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 1.23 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.47999999999999998 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.66000000000000003 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.1799999999999999 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 1.21 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 1.0900000000000001 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 1.28 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.27000000000000002 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 1.1499999999999999 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28000000000000003 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 1.5700000000000001 111.043 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 2.1899999999999999 111.146 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 1.53 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55000000000000004 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.5899999999999999 111.775 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 5.0800000000000001 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.72 -58.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.6100000000000001 110.916 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.892 . . . . 3.1600000000000001 110.998 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.435 -0.266 . . . . 8.1799999999999997 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -144.93 -162.1 9.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 7.3099999999999996 112.586 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.6 mt -70.87 -51.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 8.1799999999999997 111.083 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.6 -78.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 7.1900000000000004 110.734 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 62.2 m 67.07 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 6.3200000000000003 111.462 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.37 -59.88 4.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.058 0.392 . . . . 5.2000000000000002 112.058 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.08 -33.18 64.82 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.283 0.475 . . . . 5.1100000000000003 112.283 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' B' ' 165' ' ' PHE . 65.8 t80 -86.95 -45.73 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.767 0.318 . . . . 4.0599999999999996 111.707 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.421 ' CG ' ' O ' ' B' ' 158' ' ' SER . 42.9 mt -61.57 -38.48 87.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 4.0199999999999996 111.474 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -56.67 -20.27 20.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.329 . . . . 4.5899999999999999 111.411 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.15 42.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 3.3999999999999999 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' B' ' 161' ' ' PHE . 53.9 t80 -146.86 -45.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 3.0800000000000001 110.841 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 62.1 mt -64.71 -44.1 72.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.6499999999999999 111.538 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 29.2 Cg_exo -62.2 -39.35 48.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.298 1.999 . . . . 1.6000000000000001 112.441 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -46.28 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 1.98 111.228 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 1.49 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.47 110.794 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.3600000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.447 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.47999999999999998 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.1799999999999999 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 1.1699999999999999 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 1.0800000000000001 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 1.0800000000000001 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26000000000000001 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 1.1799999999999999 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34000000000000002 112.336 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.3200000000000001 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 2.4500000000000002 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 1.55 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.68999999999999995 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -62.46 -38.67 90.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 3.0299999999999998 111.38 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 29.0 mmt180 -60.36 -38.01 82.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 4.3499999999999996 111.108 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.24 -54.89 14.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 2.1299999999999999 110.951 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.283 -0.865 . . . . 2.5600000000000001 111.152 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.457 -0.257 . . . . 7.46 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.19 176.22 43.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 6.0999999999999996 112.33 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.82 0.343 . . . . 7.8300000000000001 110.953 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' ALA . 56.8 m-85 -77.67 -39.8 43.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 5.9699999999999998 111.154 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.2 m 44.38 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 4.9100000000000001 111.655 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -60.2 -51.76 68.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 4.3399999999999999 111.583 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 1.5 mp0 -57.88 -30.09 65.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 5.46 111.705 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -88.65 -50.05 6.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.6200000000000001 111.213 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.26 -42.11 96.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 3.71 111.839 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.44 ' CD ' ' HA ' ' A' ' 160' ' ' GLU . 12.7 ptmm? -57.92 -18.17 21.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.688 -0.233 . . . . 4.2199999999999998 111.348 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 163' ' ' LYS . 31.8 m -126.47 22.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.745 0.307 . . . . 2.9199999999999999 111.095 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -102.5 -64.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 2.8599999999999999 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 87.3 mt -49.6 -43.61 73.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 2.46 111.65 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 22.0 Cg_exo -64.86 -40.96 19.43 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.308 2.005 . . . . 1.53 111.786 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t -57.7 -41.47 81.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 1.77 110.507 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.6699999999999999 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.6599999999999999 110.504 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 1.23 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.47999999999999998 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.66000000000000003 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 1.1799999999999999 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.21 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 1.0900000000000001 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 1.28 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.27000000000000002 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 1.1499999999999999 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28000000000000003 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.5700000000000001 110.914 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 2.1899999999999999 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.53 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.5899999999999999 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 5.0800000000000001 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt -98.02 -57.78 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.6100000000000001 110.994 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.255 -0.878 . . . . 3.1600000000000001 111.11 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.409 -0.277 . . . . 8.1799999999999997 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.2 -163.13 9.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.638 -0.791 . . . . 7.3099999999999996 112.536 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.11 -55.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.886 0.374 . . . . 8.1799999999999997 111.151 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' B' ' 159' ' ' ALA . 70.0 m-85 -76.19 -61.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 7.1900000000000004 110.856 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 57.8 p 46.05 -90.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.974 -0.557 . . . . 6.3200000000000003 111.408 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.76 -53.84 51.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 5.2000000000000002 111.059 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -59.28 -52.36 65.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 5.1100000000000003 111.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 88.7 t80 -48.96 -53.2 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 4.0599999999999996 111.51 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 32.2 mt -60.43 -36.92 79.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.766 0.317 . . . . 4.0199999999999996 110.873 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.74 -28.13 54.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 4.5899999999999999 111.033 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.32 32.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 3.3999999999999999 111.527 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.445 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 30.6 t80 -110.88 -59.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 3.0800000000000001 110.723 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 96.3 mt -49.49 -48.33 75.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.6499999999999999 111.396 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 65.2 Cg_endo -74.85 -28.33 9.54 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.002 1.801 . . . . 1.6000000000000001 112.05 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t -64.25 -42.17 96.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.459 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 1.49 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' B' ' 166' ' ' LEU . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 1.47 110.431 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 1.3600000000000001 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.62 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.47999999999999998 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.1799999999999999 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 1.1699999999999999 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 1.0800000000000001 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 1.0800000000000001 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26000000000000001 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 1.1799999999999999 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34000000000000002 112.262 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 1.3200000000000001 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.524 ' CE2' ' CZ ' ' B' ' 186' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 2.4500000000000002 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 1.55 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.68999999999999995 113.683 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -51.85 -23.92 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 3.0299999999999998 111.004 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.524 ' CZ ' ' CE2' ' B' ' 182' ' ' TYR . 77.6 mtm180 -85.58 -25.69 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 4.3499999999999996 110.881 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.95 -42.51 12.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 2.1299999999999999 110.994 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.139 -0.934 . . . . 2.5600000000000001 111.132 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.601 -0.2 . . . . 7.46 112.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.98 165.1 24.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 6.0999999999999996 112.339 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.81 -64.09 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 7.8300000000000001 111.032 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.58 -74.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 5.9699999999999998 110.566 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.3 t 60.9 -84.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 4.9100000000000001 111.551 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.98 52.03 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 4.3399999999999999 112.123 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.08 -29.96 61.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 5.46 111.734 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -90.01 -45.47 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 3.6200000000000001 111.375 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.19 -34.26 77.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.145 -0.479 . . . . 3.71 111.626 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.02 -23.77 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 4.2199999999999998 111.132 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.64 42.07 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.398 . . . . 2.9199999999999999 111.286 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -131.63 -52.76 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.247 -0.433 . . . . 2.8599999999999999 111.013 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 67.7 mt -54.74 -44.35 99.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 2.46 111.383 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -67.54 -39.02 13.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.327 2.018 . . . . 1.53 112.249 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m -56.37 -42.17 77.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 1.77 111.108 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.6699999999999999 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.6599999999999999 110.925 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 1.23 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.47999999999999998 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.66000000000000003 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 1.1799999999999999 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 1.21 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 1.0900000000000001 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 1.28 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.27000000000000002 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 1.1499999999999999 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.435 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28000000000000003 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 1.5700000000000001 111.164 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 2.1899999999999999 110.798 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 1.53 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55000000000000004 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.5899999999999999 111.439 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 5.0800000000000001 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt -84.97 -28.34 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.6100000000000001 110.764 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.216 -0.897 . . . . 3.1600000000000001 111.097 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.53 -0.228 . . . . 8.1799999999999997 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -103.69 -152.49 23.0 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.652 -0.785 . . . . 7.3099999999999996 112.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.27 -50.42 76.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.177 -0.675 . . . . 8.1799999999999997 109.177 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -67.68 0.68 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.479 -0.782 . . . . 7.1900000000000004 109.422 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 m -168.85 177.39 5.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.334 -0.848 . . . . 6.3200000000000003 110.233 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.8 66.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 5.2000000000000002 110.73 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -55.37 -60.53 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 5.1100000000000003 111.536 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -43.97 -51.48 7.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 4.0599999999999996 111.814 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.9 -46.25 85.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 4.0199999999999996 111.604 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -57.19 -23.31 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.377 . . . . 4.5899999999999999 111.758 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.69 40.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.682 0.277 . . . . 3.3999999999999999 111.237 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -146.71 -45.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 3.0800000000000001 111.28 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.508 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.9 mt -64.39 -43.55 72.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 2.6499999999999999 111.834 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 37.4 Cg_exo -61.14 -37.89 71.33 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.301 2.0 . . . . 1.6000000000000001 112.502 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -58.73 -42.29 88.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.98 111.13 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.139 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 1.3600000000000001 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.62 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.47999999999999998 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 1.1799999999999999 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.1699999999999999 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 1.0800000000000001 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26000000000000001 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 1.1799999999999999 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34000000000000002 112.233 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.435 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 1.3200000000000001 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 2.4500000000000002 110.663 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 1.55 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.68999999999999995 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 11.8 ptp180 -56.35 -34.98 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 3.0299999999999998 110.723 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 50.4 ttp180 -67.23 -25.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.942 -0.572 . . . . 4.3499999999999996 110.885 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.35 -42.76 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 2.1299999999999999 110.89 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -0.795 . . . . 2.5600000000000001 111.287 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.385 -0.286 . . . . 7.46 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.65 179.24 38.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.728 -0.748 . . . . 6.0999999999999996 112.458 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.9 mm -69.15 -31.14 48.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 7.8300000000000001 110.727 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.4 m-85 -76.71 -63.76 1.27 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.875 -0.602 . . . . 5.9699999999999998 110.457 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.8 t 50.77 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.623 . . . . 4.9100000000000001 111.609 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -49.91 -59.54 3.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 4.3399999999999999 111.468 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.407 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 36.6 tt0 -56.73 -19.79 18.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.554 -0.294 . . . . 5.46 111.079 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -85.19 -45.44 12.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 3.6200000000000001 110.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.29 -39.73 95.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.434 -0.348 . . . . 3.71 111.077 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' CD ' ' HA ' ' A' ' 160' ' ' GLU . 17.8 ptpt -56.79 -21.8 31.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 4.2199999999999998 111.33 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.23 34.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 2.9199999999999999 111.16 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -139.59 -45.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 2.8599999999999999 110.885 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.469 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.5 mt -65.73 -47.36 66.17 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 2.46 111.553 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 70.2 Cg_endo -76.59 -10.38 18.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.111 1.874 . . . . 1.53 112.739 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p -81.32 -41.7 21.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.292 . . . . 1.77 110.692 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.6699999999999999 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.6599999999999999 110.764 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 1.23 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.47999999999999998 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.66000000000000003 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.1799999999999999 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 1.21 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 1.0900000000000001 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 1.28 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.27000000000000002 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 1.1499999999999999 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28000000000000003 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 1.5700000000000001 110.433 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 2.1899999999999999 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 179' ' ' LEU . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55000000000000004 112.885 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.5899999999999999 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 5.0800000000000001 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.02 -45.52 8.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.6100000000000001 111.081 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.261 -0.876 . . . . 3.1600000000000001 111.234 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.419 -0.272 . . . . 8.1799999999999997 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.33 -174.82 7.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.685 -0.769 . . . . 7.3099999999999996 112.388 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.6 mt -71.03 -53.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.38 . . . . 8.1799999999999997 111.034 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.0 m-85 -76.38 -64.14 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 7.1900000000000004 110.892 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m 40.92 -92.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.161 -0.472 . . . . 6.3200000000000003 111.562 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -59.32 -54.19 49.67 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.939 0.4 . . . . 5.2000000000000002 111.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.32 -28.61 59.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 5.1100000000000003 111.057 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.33 -54.96 7.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 4.0599999999999996 111.102 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.34 -33.48 73.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.933 0.397 . . . . 4.0199999999999996 110.562 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.96 -29.5 63.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.548 . . . . 4.5899999999999999 110.823 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.22 33.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 3.3999999999999999 111.321 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -135.95 -58.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 3.0800000000000001 110.969 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 80.4 mt -58.34 -43.59 98.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 2.6499999999999999 111.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 11.2 Cg_exo -71.37 -26.98 19.93 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.43 2.086 . . . . 1.6000000000000001 112.213 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -63.17 -44.54 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.98 110.905 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.402 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 1.47 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 1.3600000000000001 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.62 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 1.1799999999999999 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.1699999999999999 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 1.0800000000000001 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 1.0800000000000001 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26000000000000001 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 1.1799999999999999 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34000000000000002 112.111 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 1.3200000000000001 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 2.4500000000000002 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.68999999999999995 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -21.75 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 3.0299999999999998 111.132 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -82.86 -49.59 9.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 4.3499999999999996 110.883 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.27 -32.96 70.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 2.1299999999999999 111.004 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.892 . . . . 2.5600000000000001 111.174 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.503 -0.239 . . . . 7.46 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.16 153.77 24.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.753 . . . . 6.0999999999999996 112.545 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.75 -57.61 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 7.8300000000000001 110.98 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 74.4 m-85 -76.54 -58.09 3.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 5.9699999999999998 110.901 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.8 t 52.95 -86.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 4.9100000000000001 111.267 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -59.18 -58.78 7.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.645 0.259 . . . . 4.3399999999999999 111.54 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.82 -25.69 56.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.433 . . . . 5.46 111.811 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -88.92 -52.06 5.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 3.6200000000000001 111.533 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.83 -36.75 82.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 3.71 111.803 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.4 ' HG3' HG11 ' A' ' 164' ' ' VAL . 18.1 ptpt -56.37 -28.82 60.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 4.2199999999999998 111.212 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG11 ' HG3' ' A' ' 163' ' ' LYS . 13.2 m -116.89 23.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 2.9199999999999999 111.279 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -132.75 -43.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 2.8599999999999999 110.776 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.459 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 79.3 mt -65.25 -57.28 15.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 2.46 111.484 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 25.9 Cg_endo -61.86 -30.99 84.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.99 1.793 . . . . 1.53 112.088 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m -57.13 -41.95 80.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.77 110.931 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.6599999999999999 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 1.23 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.43 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.47999999999999998 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 1.1799999999999999 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 1.21 110.656 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 1.0900000000000001 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 1.28 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.27000000000000002 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 1.1499999999999999 110.222 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28000000000000003 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 1.5700000000000001 110.827 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 2.1899999999999999 110.986 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55000000000000004 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.5899999999999999 111.309 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 5.0800000000000001 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.95 -40.26 92.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.6100000000000001 110.748 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 3.1600000000000001 111.533 179.727 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.526 -0.23 . . . . 8.1799999999999997 112.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -107.37 -179.17 22.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 7.3099999999999996 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.54 -66.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.073 0.463 . . . . 8.1799999999999997 111.012 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' B' ' 159' ' ' ALA . 81.5 m-85 -77.94 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 7.1900000000000004 111.103 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p 44.26 -91.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.13 -0.487 . . . . 6.3200000000000003 111.25 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.68 -53.15 60.87 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.907 0.384 . . . . 5.2000000000000002 110.945 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.26 -19.38 33.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 5.1100000000000003 111.394 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -81.77 -36.37 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 4.0599999999999996 111.319 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -47.1 84.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 4.0199999999999996 111.04 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -55.78 -24.39 35.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 4.5899999999999999 110.933 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.97 31.28 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 3.3999999999999999 110.819 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -137.0 -43.39 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 3.0800000000000001 111.241 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.5 mt -64.99 -43.84 69.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.345 -0.389 . . . . 2.6499999999999999 111.77 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 16.8 Cg_exo -67.26 -39.8 12.39 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.417 2.078 . . . . 1.6000000000000001 112.548 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m -51.23 -41.99 60.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 1.98 111.164 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 1.49 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.996 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 1.3600000000000001 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.62 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.47999999999999998 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 1.1799999999999999 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 1.1699999999999999 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.421 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 1.0800000000000001 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26000000000000001 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 1.1799999999999999 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34000000000000002 112.361 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 2.4500000000000002 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.425 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.026 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.68999999999999995 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -62.5 -39.43 93.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 3.0299999999999998 111.934 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 23.3 ptt180 -68.95 -26.88 65.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.681 0.277 . . . . 4.3499999999999996 111.517 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.33 -29.46 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 2.1299999999999999 111.178 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 2.5600000000000001 111.266 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 7.46 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.13 173.99 26.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 6.0999999999999996 112.403 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.62 -58.97 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 7.8300000000000001 110.94 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -76.79 -84.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 5.9699999999999998 110.908 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t 71.44 -158.03 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.345 -0.389 . . . . 4.9100000000000001 110.78 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.26 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.779 0.323 . . . . 4.3399999999999999 110.973 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -57.14 -30.23 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 5.46 110.502 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -93.22 -30.32 15.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 3.6200000000000001 110.748 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.01 -47.18 84.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 3.71 110.936 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -55.19 -22.78 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 4.2199999999999998 111.105 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.7 m -110.06 31.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 2.9199999999999999 110.855 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -136.4 -62.23 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 2.8599999999999999 111.071 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 47.6 mt -53.96 -58.33 13.92 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 2.46 111.529 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 29.9 Cg_endo -62.93 -18.13 63.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.976 . . . . 1.53 112.501 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -74.65 -41.8 59.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 1.77 110.998 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.413 ' N ' HD11 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.6599999999999999 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 1.23 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.47999999999999998 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.66000000000000003 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 1.1799999999999999 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 1.21 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 1.0900000000000001 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.27000000000000002 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 1.1499999999999999 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 1.5700000000000001 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 2.1899999999999999 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 1.53 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55000000000000004 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.415 ' HD3' ' NH1' ' A' ' 186' ' ' ARG . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.5899999999999999 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 5.0800000000000001 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt -74.76 -27.28 60.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.6100000000000001 110.831 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.41 -0.805 . . . . 3.1600000000000001 111.206 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.478 -0.249 . . . . 8.1799999999999997 112.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.74 -174.42 30.55 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.798 -0.715 . . . . 7.3099999999999996 112.444 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 19.9 mt -70.62 -59.02 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 8.1799999999999997 111.058 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' B' ' 159' ' ' ALA . 68.7 m-85 -76.47 -63.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 7.1900000000000004 110.836 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 74.3 m 55.31 -85.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 6.3200000000000003 111.416 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.51 -55.16 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 5.2000000000000002 111.494 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.05 -46.9 82.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 5.1100000000000003 111.613 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -72.71 -42.01 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 4.0599999999999996 111.548 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' B' ' 158' ' ' SER . 57.3 mt -63.37 -50.0 71.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 4.0199999999999996 111.992 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -56.97 -25.69 58.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.652 0.263 . . . . 4.5899999999999999 111.078 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 20.2 t -104.75 31.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.911 0.386 . . . . 3.3999999999999999 111.076 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -148.18 -49.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 3.0800000000000001 110.921 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 89.2 mt -55.56 -58.58 14.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 2.6499999999999999 111.652 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 4.7 Cg_endo -47.63 -50.03 12.28 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.515 2.143 . . . . 1.6000000000000001 112.85 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p -48.03 -41.85 26.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.501 -0.318 . . . . 1.98 111.265 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 1.49 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 1.47 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.3600000000000001 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.47999999999999998 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 1.1799999999999999 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 1.1699999999999999 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 1.0800000000000001 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26000000000000001 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 1.1799999999999999 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34000000000000002 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 1.3200000000000001 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' B' ' 186' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 2.4500000000000002 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 1.55 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.68999999999999995 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.9 -29.08 69.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 3.0299999999999998 110.982 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 2.4 mmp_? -69.1 -26.51 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 4.3499999999999996 110.806 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 58.5 mt -102.14 -67.5 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 2.1299999999999999 110.737 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.242 -0.885 . . . . 2.5600000000000001 111.393 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.425 -0.27 . . . . 7.46 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.62 175.3 40.44 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 6.0999999999999996 112.42 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.53 -53.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 7.8300000000000001 110.889 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.2 m-85 -76.53 -71.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 5.9699999999999998 110.515 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.0 m 56.17 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 4.9100000000000001 111.675 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.86 -66.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.324 . . . . 4.3399999999999999 111.41 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.424 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 42.5 mt-10 -54.15 -49.63 68.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 5.46 111.318 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -59.81 -48.9 79.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.446 -0.343 . . . . 3.6200000000000001 110.968 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.73 -38.41 90.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 3.71 111.463 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 50.0 mtmt -56.89 -44.26 82.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.629 -0.26 . . . . 4.2199999999999998 111.149 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.62 36.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.471 -0.332 . . . . 2.9199999999999999 111.15 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -142.9 -60.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 2.8599999999999999 111.044 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 65.4 mt -49.98 -59.01 7.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 2.46 111.438 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 18.7 Cg_endo -59.13 -28.08 86.78 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.38 2.053 . . . . 1.53 112.588 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -69.97 -41.62 74.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 1.77 110.973 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.6699999999999999 111.407 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.6599999999999999 111.135 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 1.23 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.433 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.47999999999999998 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 1.1799999999999999 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 1.21 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.424 ' HB3' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 1.0900000000000001 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 1.28 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.27000000000000002 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 1.1499999999999999 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28000000000000003 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 1.5700000000000001 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 2.1899999999999999 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 1.53 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55000000000000004 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.5899999999999999 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 5.0800000000000001 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.421 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt -98.46 -25.78 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 110.841 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.214 -0.898 . . . . 3.1600000000000001 111.134 179.911 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 8.1799999999999997 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.22 -159.36 22.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 7.3099999999999996 112.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . 0.473 HG21 ' CE2' ' B' ' 157' ' ' PHE . 22.0 mt -71.29 -35.97 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.062 0.458 . . . . 8.1799999999999997 110.559 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.473 ' CE2' HG21 ' B' ' 156' ' ' ILE . 88.5 m-85 -157.85 -57.27 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 7.1900000000000004 110.122 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 59.7 m 38.47 -90.75 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.792 -0.64 . . . . 6.3200000000000003 112.366 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.24 -54.92 37.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 5.2000000000000002 111.614 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.76 -44.19 81.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 5.1100000000000003 110.951 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -66.73 -55.86 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 4.0599999999999996 110.767 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 158' ' ' SER . 52.3 mt -62.25 -30.06 70.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 4.0199999999999996 110.598 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 31.1 ttmt -58.34 -24.99 61.43 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.744 -0.662 . . . . 4.5899999999999999 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.88 -22.09 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 3.3999999999999999 111.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -85.98 -43.4 13.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.375 -0.375 . . . . 3.0800000000000001 111.08 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.463 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 55.6 mt -47.69 -60.02 4.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 2.6499999999999999 111.568 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 3.4 Cg_exo -40.43 -29.26 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.692 2.261 . . . . 1.6000000000000001 112.462 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m -77.18 -41.9 39.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 1.98 110.918 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.49 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 1.47 111.05 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 1.3600000000000001 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.62 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.47999999999999998 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 1.1799999999999999 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 1.1699999999999999 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 1.0800000000000001 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 1.0800000000000001 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26000000000000001 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 1.1799999999999999 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34000000000000002 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 1.3200000000000001 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 2.4500000000000002 110.691 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 1.55 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.68999999999999995 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -24.31 65.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 3.0299999999999998 110.86 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -65.96 -38.12 87.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 4.3499999999999996 110.608 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.79 -37.33 86.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 2.1299999999999999 110.65 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.205 -0.902 . . . . 2.5600000000000001 111.236 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.582 -0.207 . . . . 7.46 112.582 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.74 163.84 12.07 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.824 -0.703 . . . . 6.0999999999999996 112.669 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mm -70.57 -55.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 7.8300000000000001 111.023 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 84.1 m-85 -76.25 -69.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 5.9699999999999998 110.881 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t 43.66 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.14 -0.482 . . . . 4.9100000000000001 111.561 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.13 -51.59 69.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.878 0.37 . . . . 4.3399999999999999 111.148 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -54.89 -22.17 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 5.46 111.292 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -96.18 -50.44 4.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 3.6200000000000001 111.15 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.21 -30.19 71.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 3.71 111.086 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -56.1 -44.29 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 4.2199999999999998 110.888 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.34 43.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 2.9199999999999999 111.233 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -142.47 -50.94 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 2.8599999999999999 110.911 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 84.9 mt -57.76 -58.0 21.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 2.46 111.61 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 19.6 Cg_endo -58.61 -34.22 98.71 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.302 2.002 . . . . 1.53 112.653 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m -59.16 -41.79 89.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 1.77 110.939 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.6699999999999999 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.6599999999999999 111.148 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.23 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.47999999999999998 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.66000000000000003 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 1.1799999999999999 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 1.21 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 1.0900000000000001 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 1.28 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.27000000000000002 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 1.1499999999999999 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28000000000000003 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 1.5700000000000001 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 2.1899999999999999 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 1.53 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55000000000000004 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.5899999999999999 111.725 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 5.0800000000000001 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.22 -51.35 64.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.6100000000000001 110.85 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.22 -0.895 . . . . 3.1600000000000001 111.17 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.448 -0.261 . . . . 8.1799999999999997 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.98 -164.87 29.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 7.3099999999999996 112.533 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.2 mt -71.57 -62.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 8.1799999999999997 111.103 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' B' ' 159' ' ' ALA . 95.3 m-85 -76.5 -53.53 7.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 7.1900000000000004 110.937 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 75.4 m 47.31 -90.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.991 -0.55 . . . . 6.3200000000000003 111.168 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.42 -54.54 45.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.947 0.403 . . . . 5.2000000000000002 111.04 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -58.89 -30.74 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.556 . . . . 5.1100000000000003 111.11 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -64.91 -48.92 72.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 4.0599999999999996 111.043 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 13.8 mt -61.77 -35.67 78.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 4.0199999999999996 110.949 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -57.83 -37.67 74.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 4.5899999999999999 111.063 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.55 16.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.419 . . . . 3.3999999999999999 111.699 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 79.4 t80 -107.61 -38.49 5.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 3.0800000000000001 110.719 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 96.2 mt -70.76 -43.67 15.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 2.6499999999999999 111.332 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 19.5 Cg_exo -66.3 -36.58 27.28 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.327 2.018 . . . . 1.6000000000000001 111.951 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p -54.53 -43.57 72.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.98 110.746 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 1.47 110.643 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.3600000000000001 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.62 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.47999999999999998 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 1.1799999999999999 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 1.1699999999999999 111.244 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 1.0800000000000001 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 1.0800000000000001 110.313 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 1.1799999999999999 110.519 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34000000000000002 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.436 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 1.3200000000000001 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 1.55 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.68999999999999995 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -59.35 -26.57 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 3.0299999999999998 111.103 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -91.46 -33.19 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 4.3499999999999996 110.959 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.99 31.95 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 2.1299999999999999 110.761 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.28 -0.866 . . . . 2.5600000000000001 111.209 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.511 -0.236 . . . . 7.46 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 165.08 164.84 21.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.741 . . . . 6.0999999999999996 112.529 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mm -71.63 -47.7 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 7.8300000000000001 111.084 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.8 m-85 -75.96 -73.25 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 5.9699999999999998 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.4 t 43.01 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.226 -0.443 . . . . 4.9100000000000001 111.765 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.24 -56.64 18.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.639 0.257 . . . . 4.3399999999999999 111.638 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.404 ' HA ' ' HE3' ' A' ' 163' ' ' LYS . 43.7 tt0 -56.87 -19.06 15.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.497 -0.319 . . . . 5.46 111.646 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -95.26 -50.51 5.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 3.6200000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.51 -36.43 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 3.71 111.556 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 17.1 ptpt -56.38 -27.87 57.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.522 -0.308 . . . . 4.2199999999999998 111.294 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.35 32.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 2.9199999999999999 111.217 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -148.57 -45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.8599999999999999 110.901 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.9 mt -50.34 -59.36 7.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 2.46 111.438 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.4 Cg_endo -43.17 -44.08 9.9 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.481 2.121 . . . . 1.53 112.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m -58.6 -41.43 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 1.77 110.633 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.6699999999999999 110.829 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.6599999999999999 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 1.23 110.717 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.47999999999999998 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.66000000000000003 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 1.1799999999999999 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 1.21 110.905 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 1.0900000000000001 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 1.28 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.27000000000000002 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 1.1499999999999999 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28000000000000003 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 1.5700000000000001 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 2.1899999999999999 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 1.53 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55000000000000004 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.5899999999999999 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 5.0800000000000001 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -49.33 8.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.6100000000000001 110.588 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.367 -0.825 . . . . 3.1600000000000001 111.228 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.512 -0.235 . . . . 8.1799999999999997 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.94 -171.28 37.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 7.3099999999999996 112.364 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.99 -56.86 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.769 0.319 . . . . 8.1799999999999997 111.28 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.14 -79.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 7.1900000000000004 111.191 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.44 ' O ' ' CB ' ' B' ' 159' ' ' ALA . 69.7 m 61.06 134.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 6.3200000000000003 111.423 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' B' ' 158' ' ' SER . . . 89.81 -63.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.728 -0.669 . . . . 5.2000000000000002 110.692 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.97 -57.51 12.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.802 -0.635 . . . . 5.1100000000000003 110.914 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.37 -38.03 81.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 4.0599999999999996 110.827 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 166' ' ' LEU . 77.4 mt -63.47 -38.65 91.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 4.0199999999999996 111.08 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -56.83 -24.18 49.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.379 . . . . 4.5899999999999999 110.953 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.66 29.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 3.3999999999999999 111.108 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -145.65 -50.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 3.0800000000000001 111.045 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.475 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 63.3 mt -55.4 -46.88 99.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 2.6499999999999999 111.435 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 98.2 Cg_exo -42.85 -52.05 4.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.311 2.008 . . . . 1.6000000000000001 112.297 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -55.95 -43.57 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 1.98 110.727 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 1.49 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 1.47 110.865 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 1.3600000000000001 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.62 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.481 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.47999999999999998 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 1.1799999999999999 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 1.1699999999999999 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 1.0800000000000001 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0800000000000001 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26000000000000001 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 1.1799999999999999 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34000000000000002 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 1.3200000000000001 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.4500000000000002 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.406 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 1.55 110.978 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.68999999999999995 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -63.18 -38.46 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 3.0299999999999998 111.854 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.432 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 7.2 ptm180 -70.78 -29.78 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 4.3499999999999996 111.075 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.1 -35.61 25.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 2.1299999999999999 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.246 -0.883 . . . . 2.5600000000000001 111.064 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.547 -0.221 . . . . 7.46 112.547 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.45 151.74 31.56 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.646 -0.788 . . . . 6.0999999999999996 112.583 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.73 -66.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 7.8300000000000001 110.899 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.8 m-85 -76.86 -74.09 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 5.9699999999999998 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 48.4 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.996 -0.547 . . . . 4.9100000000000001 111.568 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.09 -55.29 36.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.698 0.285 . . . . 4.3399999999999999 111.335 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.81 -27.96 60.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 5.46 111.165 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 51.7 t80 -84.6 -58.25 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 3.6200000000000001 110.973 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.98 -23.62 66.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 3.71 111.064 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -61.19 -47.13 87.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.294 -0.412 . . . . 4.2199999999999998 110.827 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.7 -20.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 2.9199999999999999 111.767 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.459 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 86.6 t80 -65.08 -56.47 12.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 2.8599999999999999 111.226 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.4 mt -50.31 -58.25 10.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.46 112.007 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 24.7 Cg_endo -60.49 -44.94 24.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.29 1.993 . . . . 1.53 112.985 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p -50.67 -41.63 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 1.77 111.524 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.455 HD12 ' CE2' ' A' ' 165' ' ' PHE . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.6699999999999999 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.6599999999999999 111.162 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 1.23 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.47999999999999998 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.66000000000000003 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 1.1799999999999999 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.21 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.0900000000000001 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 1.28 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.27000000000000002 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 1.1499999999999999 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28000000000000003 112.65 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 1.5700000000000001 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 2.1899999999999999 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 1.53 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55000000000000004 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.5899999999999999 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 5.0800000000000001 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt -95.53 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.6100000000000001 111.077 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.277 -0.868 . . . . 3.1600000000000001 111.183 -179.89 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.829 -0.108 . . . . 8.1799999999999997 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 177.89 -159.9 25.95 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.787 -0.721 . . . . 7.3099999999999996 112.373 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.3 mt -70.79 -59.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 8.1799999999999997 110.812 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 96.7 m-85 -76.99 -27.55 54.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 7.1900000000000004 110.855 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.4 m 42.29 -89.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.784 -0.643 . . . . 6.3200000000000003 112.128 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.05 -62.87 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.707 0.289 . . . . 5.2000000000000002 111.74 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -54.53 -21.5 10.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 5.1100000000000003 110.994 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -78.35 -40.33 36.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 4.0599999999999996 110.907 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.412 ' N ' HD23 ' B' ' 162' ' ' LEU . 5.5 mt -63.1 -48.44 78.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.853 0.359 . . . . 4.0199999999999996 110.676 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -27.85 57.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 4.5899999999999999 111.382 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.76 30.85 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 3.3999999999999999 111.087 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -145.94 -54.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 3.0800000000000001 110.882 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 83.2 mt -53.69 -57.38 17.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 2.6499999999999999 111.465 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.3 Cg_endo -58.84 -44.5 35.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 1.6000000000000001 113.009 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -47.85 -41.71 24.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 1.98 111.137 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 1.47 111.111 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 1.3600000000000001 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.62 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.47999999999999998 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.1799999999999999 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 1.1699999999999999 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 1.0800000000000001 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 1.0800000000000001 110.566 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26000000000000001 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 1.1799999999999999 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34000000000000002 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 1.3200000000000001 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 2.4500000000000002 110.629 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 1.55 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.68999999999999995 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -18.95 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 3.0299999999999998 111.022 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -72.17 -40.35 68.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.9 0.381 . . . . 4.3499999999999996 110.712 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.2 -49.52 73.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 2.1299999999999999 110.952 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.235 -0.888 . . . . 2.5600000000000001 111.195 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.422 -0.271 . . . . 7.46 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.94 178.19 42.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.681 -0.771 . . . . 6.0999999999999996 112.659 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.59 -46.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 7.8300000000000001 110.849 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -76.83 -76.73 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.884 -0.598 . . . . 5.9699999999999998 110.621 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.8 m 63.59 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 4.9100000000000001 111.108 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CG ' ' A' ' 163' ' ' LYS . . . -60.47 -61.03 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 4.3399999999999999 111.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -54.0 -31.55 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 5.46 111.409 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.564 ' CE1' ' CD1' ' A' ' 165' ' ' PHE . 52.6 t80 -84.47 -55.18 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 3.6200000000000001 111.104 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.0 -40.0 91.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.195 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 159' ' ' ALA . 53.2 mtpt -56.63 -29.4 62.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 4.2199999999999998 111.278 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.1 m -125.38 26.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.349 . . . . 2.9199999999999999 111.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 161' ' ' PHE . 82.8 t80 -117.81 -37.96 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 2.8599999999999999 110.807 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 94.0 mt -67.77 -45.53 44.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.46 111.399 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 74.4 Cg_exo -47.12 -39.43 26.03 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.117 1.878 . . . . 1.53 112.08 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m -67.58 -41.59 83.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 1.77 110.662 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.479 HD13 ' CE2' ' A' ' 165' ' ' PHE . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.6699999999999999 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.6599999999999999 110.663 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.47999999999999998 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.66000000000000003 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 1.21 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 1.0900000000000001 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 1.28 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.27000000000000002 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 1.1499999999999999 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28000000000000003 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 1.5700000000000001 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 2.1899999999999999 110.212 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 1.53 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55000000000000004 112.752 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.5899999999999999 111.042 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 5.0800000000000001 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 43.4 mt -79.96 -23.66 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.6100000000000001 110.963 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 3.1600000000000001 111.073 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.418 -0.273 . . . . 8.1799999999999997 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.16 -168.89 11.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 7.3099999999999996 112.486 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.05 -60.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.038 0.447 . . . . 8.1799999999999997 111.156 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.444 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 29.6 p90 -75.81 -57.0 4.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 7.1900000000000004 110.865 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 10.4 t 78.51 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.638 . . . . 6.3200000000000003 111.602 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.66 -22.7 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 5.2000000000000002 111.335 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.4 -64.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.992 0.425 . . . . 5.1100000000000003 110.803 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.444 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 10.9 t80 -60.21 -34.11 73.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.973 -0.558 . . . . 4.0599999999999996 110.953 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 67.9 mt -63.36 -36.14 82.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 4.0199999999999996 111.308 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.16 -20.24 25.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.385 . . . . 4.5899999999999999 111.303 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.35 39.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 3.3999999999999999 111.513 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.448 ' CZ ' HD11 ' B' ' 169' ' ' LEU . 85.4 t80 -139.74 -46.49 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 3.0800000000000001 111.177 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.7 mt -71.4 -46.13 13.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 2.6499999999999999 111.644 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 88.1 Cg_exo -41.97 -28.41 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 1.6000000000000001 112.675 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -87.15 -47.91 8.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.376 . . . . 1.98 110.945 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.448 HD11 ' CZ ' ' B' ' 165' ' ' PHE . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 1.49 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 1.47 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 1.3600000000000001 110.86 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.62 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.47999999999999998 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 1.1799999999999999 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 1.1699999999999999 110.528 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 1.0800000000000001 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26000000000000001 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 1.1799999999999999 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34000000000000002 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 1.3200000000000001 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 2.4500000000000002 110.913 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 1.55 111.032 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.68999999999999995 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 6.6 ptp180 -59.65 -35.39 74.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 3.0299999999999998 111.353 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 15.4 ptm180 -79.67 -27.05 40.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.322 . . . . 4.3499999999999996 111.248 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.86 -50.44 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.411 -0.359 . . . . 2.1299999999999999 111.004 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 2.5600000000000001 111.014 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.647 -0.181 . . . . 7.46 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.26 172.85 22.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.656 -0.783 . . . . 6.0999999999999996 112.416 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.93 -63.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.389 . . . . 7.8300000000000001 110.837 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.7 m-85 -76.19 -68.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 5.9699999999999998 110.638 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.9 m 40.45 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.07 -0.514 . . . . 4.9100000000000001 112.096 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.75 -55.75 30.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.796 0.331 . . . . 4.3399999999999999 111.389 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.7 -23.31 28.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.127 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -89.99 -57.23 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 3.6200000000000001 110.978 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 58.2 mt -62.56 -38.79 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 3.71 111.021 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.94 -21.74 32.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 4.2199999999999998 110.984 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.82 32.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 2.9199999999999999 110.77 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.55 -49.03 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 2.8599999999999999 110.777 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 77.6 mt -55.3 -57.93 17.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 2.46 111.586 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 12.3 Cg_endo -56.66 -34.4 95.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.18 1.92 . . . . 1.53 112.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t -57.14 -41.79 79.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.77 110.661 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.6699999999999999 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.6599999999999999 110.734 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 1.23 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.47999999999999998 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.66000000000000003 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 1.1799999999999999 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 1.21 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.0900000000000001 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 1.28 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.27000000000000002 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 1.1499999999999999 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28000000000000003 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 1.5700000000000001 110.837 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 2.1899999999999999 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 1.53 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55000000000000004 112.977 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.5899999999999999 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 5.0800000000000001 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.59 -45.22 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.6100000000000001 110.935 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.288 -0.863 . . . . 3.1600000000000001 111.397 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.459 -0.256 . . . . 8.1799999999999997 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.55 177.66 24.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 7.3099999999999996 112.536 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.35 -64.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 8.1799999999999997 111.193 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.435 ' HA ' ' CB ' ' B' ' 161' ' ' PHE . 21.2 m-85 -79.51 4.67 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 7.1900000000000004 112.214 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.428 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 68.5 m -75.45 -100.34 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.217 -0.302 . . . . 6.3200000000000003 111.115 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.41 72.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.31 0.485 . . . . 5.2000000000000002 112.31 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -53.27 -76.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.388 . . . . 5.1100000000000003 111.527 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' B' ' 157' ' ' PHE . 7.8 t80 -45.32 -48.61 13.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 4.0599999999999996 111.573 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.428 ' CG ' ' O ' ' B' ' 158' ' ' SER . 95.1 mt -62.12 -41.61 98.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 4.0199999999999996 110.981 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -58.63 -34.77 71.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.246 -0.434 . . . . 4.5899999999999999 110.384 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.96 30.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 3.3999999999999999 110.866 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -132.28 -46.21 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 3.0800000000000001 110.773 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.45 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 70.5 mt -58.14 -58.44 18.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 2.6499999999999999 111.316 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 34.8 Cg_endo -64.28 -26.87 63.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.12 1.88 . . . . 1.6000000000000001 112.005 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -63.91 -44.04 94.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 1.98 110.836 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 1.49 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 1.47 110.7 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.3600000000000001 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.62 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.47999999999999998 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 1.1799999999999999 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 1.1699999999999999 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 1.0800000000000001 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 1.0800000000000001 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26000000000000001 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 1.1799999999999999 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34000000000000002 112.338 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 1.3200000000000001 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 2.4500000000000002 111.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 1.55 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.68999999999999995 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -55.28 -20.37 11.06 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 3.0299999999999998 111.44 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.418 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 76.2 mtp180 -87.02 -29.8 21.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.819 0.342 . . . . 4.3499999999999996 111.0 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.04 -34.79 78.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 2.1299999999999999 110.834 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.189 -0.91 . . . . 2.5600000000000001 111.177 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.661 -0.176 . . . . 7.46 112.661 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -137.25 172.76 22.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 6.0999999999999996 112.455 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.484 HG23 ' CD2' ' A' ' 157' ' ' PHE . 15.8 mt -71.44 -29.91 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 7.8300000000000001 110.892 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.484 ' CD2' HG23 ' A' ' 156' ' ' ILE . 51.2 m-85 -156.44 -50.21 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.908 -0.587 . . . . 5.9699999999999998 110.964 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t 49.89 -87.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 4.9100000000000001 111.595 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.18 -64.51 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 4.3399999999999999 111.446 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.402 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 9.3 tp10 -55.3 -22.73 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 5.46 111.454 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -80.54 -53.82 6.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 3.6200000000000001 111.153 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.3 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 3.71 111.556 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 51.5 mtmt -56.49 -28.1 58.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 4.2199999999999998 110.876 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.18 36.74 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 2.9199999999999999 111.005 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -140.98 -51.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 2.8599999999999999 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.461 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.8 mt -52.19 -57.66 14.42 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.449 . . . . 2.46 111.337 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.8 Cg_endo -61.76 -31.02 85.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.124 1.883 . . . . 1.53 112.19 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 1.77 110.748 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.6699999999999999 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.6599999999999999 110.613 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 1.23 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.47999999999999998 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.66000000000000003 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.1799999999999999 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.21 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 1.0900000000000001 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 1.28 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.27000000000000002 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 1.1499999999999999 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28000000000000003 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 1.5700000000000001 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 2.1899999999999999 110.672 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 1.53 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55000000000000004 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.5899999999999999 111.283 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 5.0800000000000001 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.9 mt -75.16 -35.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.6100000000000001 110.99 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.159 -0.924 . . . . 3.1600000000000001 111.195 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.522 -0.231 . . . . 8.1799999999999997 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -156.68 -168.87 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 7.3099999999999996 112.591 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.8 mm -69.57 -60.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.105 0.479 . . . . 8.1799999999999997 111.107 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.1 m-85 -76.39 -65.96 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.761 -0.654 . . . . 7.1900000000000004 110.871 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 68.6 m 41.32 -92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.071 -0.513 . . . . 6.3200000000000003 111.306 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.98 -53.58 56.62 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.366 . . . . 5.2000000000000002 111.012 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.83 -21.13 26.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 5.1100000000000003 111.133 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.57 ' CE2' ' CD1' ' B' ' 165' ' ' PHE . 47.0 t80 -87.02 -30.28 21.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 4.0599999999999996 111.287 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 158' ' ' SER . 12.7 mt -62.69 -36.15 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.946 0.403 . . . . 4.0199999999999996 110.568 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -56.87 -23.5 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 4.5899999999999999 111.007 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.92 38.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 3.3999999999999999 111.24 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . 0.57 ' CD1' ' CE2' ' B' ' 161' ' ' PHE . 72.4 t80 -122.69 -52.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 3.0800000000000001 110.898 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 69.5 mt -55.89 -57.76 19.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 2.6499999999999999 111.501 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 17.5 Cg_endo -57.98 -26.59 75.61 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.133 1.889 . . . . 1.6000000000000001 112.081 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -67.27 -41.88 84.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 1.98 110.515 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 1.49 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 1.47 110.59 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 1.3600000000000001 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.62 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.47999999999999998 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 1.1699999999999999 110.915 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 1.0800000000000001 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 1.0800000000000001 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26000000000000001 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 1.1799999999999999 110.475 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34000000000000002 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 1.3200000000000001 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 2.4500000000000002 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 1.55 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.68999999999999995 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -51.71 -30.51 22.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 3.0299999999999998 111.269 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.443 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 65.7 mtt180 -84.88 -22.86 29.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 4.3499999999999996 111.453 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.2 mt -51.39 -50.43 59.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 2.1299999999999999 110.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.38 -0.819 . . . . 2.5600000000000001 111.283 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.542 -0.223 . . . . 7.46 112.542 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.33 175.27 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.748 -0.739 . . . . 6.0999999999999996 112.491 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.77 -66.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.998 0.428 . . . . 7.8300000000000001 110.886 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 159' ' ' ALA . 24.3 m-85 -78.1 -69.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 5.9699999999999998 111.029 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.6 p 43.55 -91.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.165 -0.47 . . . . 4.9100000000000001 111.485 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -59.87 -51.34 70.11 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.877 0.37 . . . . 4.3399999999999999 111.186 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.39 -21.57 16.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 5.46 111.382 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -97.21 -51.5 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 3.6200000000000001 110.902 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.89 -37.89 88.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 3.71 111.085 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -58.1 -30.58 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 4.2199999999999998 111.287 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.5 46.17 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 2.9199999999999999 111.394 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.464 ' CE2' HD11 ' A' ' 169' ' ' LEU . 77.5 t80 -156.66 -44.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.397 . . . . 2.8599999999999999 110.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 52.3 mt -60.23 -59.75 12.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.46 111.554 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 2.4 Cg_endo -41.33 -29.92 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.552 2.168 . . . . 1.53 112.384 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t -77.02 -41.75 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.77 110.556 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 165' ' ' PHE . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 110.892 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.6599999999999999 110.646 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 1.23 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.47999999999999998 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.66000000000000003 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 1.1799999999999999 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 1.21 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 1.0900000000000001 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 1.28 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.27000000000000002 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 1.1499999999999999 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28000000000000003 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 1.5700000000000001 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 2.1899999999999999 110.85 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 1.53 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55000000000000004 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.5899999999999999 111.178 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 5.0800000000000001 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.37 -50.35 65.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.6100000000000001 111.114 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.272 -0.87 . . . . 3.1600000000000001 111.312 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.438 -0.265 . . . . 8.1799999999999997 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.58 37.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 7.3099999999999996 112.482 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.36 -60.16 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 8.1799999999999997 111.001 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' B' ' 161' ' ' PHE . 69.8 m-85 -77.04 -84.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 7.1900000000000004 110.813 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.6 22.98 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.959 0.409 . . . . 6.3200000000000003 111.509 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' B' ' 163' ' ' LYS . . . -179.67 -62.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.82 -0.627 . . . . 5.2000000000000002 109.784 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 -26.06 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.548 -0.538 . . . . 5.1100000000000003 109.548 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.485 ' HB2' ' CD2' ' B' ' 157' ' ' PHE . 83.0 t80 -96.16 -47.97 5.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.747 -0.66 . . . . 4.0599999999999996 110.286 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.85 -33.09 73.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.998 0.427 . . . . 4.0199999999999996 110.42 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 18.5 ttpp -60.64 -32.03 71.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 4.5899999999999999 110.899 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.22 37.57 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 3.3999999999999999 111.365 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -146.63 -48.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 3.0800000000000001 110.869 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 91.2 mt -55.9 -46.13 99.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 2.6499999999999999 111.139 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.6 Cg_exo -43.01 -40.22 8.45 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.187 1.924 . . . . 1.6000000000000001 112.319 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -70.0 -42.2 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 1.98 110.627 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 1.49 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.434 HD11 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 1.47 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 1.3600000000000001 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.62 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.47999999999999998 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 1.1799999999999999 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 1.1699999999999999 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 1.0800000000000001 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 1.0800000000000001 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26000000000000001 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 1.1799999999999999 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34000000000000002 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 2.4500000000000002 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.55 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.68999999999999995 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -58.53 -20.44 46.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 3.0299999999999998 111.127 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 24.8 mmm180 -79.52 -26.21 41.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.814 0.34 . . . . 4.3499999999999996 110.72 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 94.4 mt -54.1 -45.83 71.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 2.1299999999999999 110.957 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.389 -0.815 . . . . 2.5600000000000001 111.174 179.903 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.452 -0.259 . . . . 7.46 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.7 172.96 14.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 6.0999999999999996 112.495 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.85 -59.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 7.8300000000000001 110.956 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 87.7 m-85 -75.96 -64.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 5.9699999999999998 110.947 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.9 m 51.44 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 4.9100000000000001 111.216 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.75 -61.61 2.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.325 . . . . 4.3399999999999999 111.356 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -29.04 63.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 5.46 111.488 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 70.4 t80 -74.76 -50.38 17.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 3.6200000000000001 111.203 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.83 -36.71 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 3.71 111.206 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -57.1 -23.09 44.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 4.2199999999999998 111.06 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.59 30.62 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 2.9199999999999999 111.002 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.477 ' CZ ' HD13 ' A' ' 169' ' ' LEU . 90.7 t80 -135.14 -60.57 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 2.8599999999999999 110.847 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 74.6 mt -51.25 -43.33 85.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 2.46 111.652 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 17.4 Cg_exo -67.05 -49.95 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.272 1.981 . . . . 1.53 112.228 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t -47.25 -52.1 16.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 1.77 111.124 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.477 HD13 ' CZ ' ' A' ' 165' ' ' PHE . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.6699999999999999 110.902 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.6599999999999999 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 1.23 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.47999999999999998 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.66000000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 1.1799999999999999 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 1.21 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 1.0900000000000001 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 1.28 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.27000000000000002 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 1.1499999999999999 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28000000000000003 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 1.5700000000000001 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.438 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 2.1899999999999999 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 1.53 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55000000000000004 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.5899999999999999 111.366 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.438 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 5.0800000000000001 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.89 -32.2 11.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.6100000000000001 111.039 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.149 -0.929 . . . . 3.1600000000000001 111.127 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.491 -0.244 . . . . 8.1799999999999997 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -106.19 176.31 21.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.668 -0.777 . . . . 7.3099999999999996 112.531 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 mm -70.14 -49.17 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.409 . . . . 8.1799999999999997 111.102 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.436 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 91.7 m-85 -76.45 -64.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 7.1900000000000004 110.843 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.9 m 45.07 -90.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 6.3200000000000003 111.347 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.41 -55.29 36.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.36 . . . . 5.2000000000000002 111.079 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.43 -42.44 82.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 5.1100000000000003 111.396 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 71.1 t80 -55.27 -53.21 58.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 4.0599999999999996 111.267 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.45 -38.87 91.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 4.0199999999999996 111.235 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -56.51 -32.39 65.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 4.5899999999999999 110.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.75 31.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 3.3999999999999999 110.827 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -128.98 -55.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 3.0800000000000001 111.138 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.473 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 69.0 mt -57.84 -45.9 99.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 2.6499999999999999 111.582 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 96.5 Cg_endo -83.66 13.23 2.75 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 1.6000000000000001 112.957 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -103.81 -45.57 4.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 1.98 111.025 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 1.49 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . 0.418 HD11 ' N ' ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.47 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 1.3600000000000001 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.62 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.1799999999999999 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 1.1699999999999999 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.0800000000000001 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 1.0800000000000001 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26000000000000001 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 1.1799999999999999 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34000000000000002 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 1.3200000000000001 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . 0.462 ' CE2' ' HD2' ' B' ' 186' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 2.4500000000000002 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 1.55 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.68999999999999995 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -58.91 -23.04 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 3.0299999999999998 111.38 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . 0.462 ' HD2' ' CE2' ' B' ' 182' ' ' TYR . 71.4 mtp180 -71.56 -38.4 70.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 4.3499999999999996 110.789 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.1 -34.38 76.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 2.1299999999999999 110.54 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.14 -0.934 . . . . 2.5600000000000001 111.164 179.898 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.565 -0.214 . . . . 7.46 112.565 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.39 160.99 26.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 6.0999999999999996 112.302 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.09 -36.62 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 7.8300000000000001 111.188 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' ALA . 64.2 m-85 -76.74 -79.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 5.9699999999999998 111.125 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.5 t 63.7 -76.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.335 . . . . 4.9100000000000001 111.016 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.68 -53.78 54.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 4.3399999999999999 111.684 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -55.04 -44.85 75.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 5.46 111.589 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.91 -48.01 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 3.6200000000000001 111.54 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.62 -30.51 70.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 3.71 111.271 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -57.42 -28.97 63.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 4.2199999999999998 110.919 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.9 37.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 2.9199999999999999 111.224 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -148.02 -50.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 2.8599999999999999 110.777 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 64.6 mt -61.8 -60.36 10.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 2.46 111.501 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.2 Cg_endo -43.96 -43.29 12.41 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.469 2.113 . . . . 1.53 112.437 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -56.38 -43.02 78.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 1.77 110.951 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.6699999999999999 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.6599999999999999 110.927 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 1.23 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.47999999999999998 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.66000000000000003 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 1.1799999999999999 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 1.21 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 1.0900000000000001 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.28 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.27000000000000002 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 1.1499999999999999 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28000000000000003 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 1.5700000000000001 111.14 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 2.1899999999999999 111.136 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 1.53 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55000000000000004 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 186' ' ' ARG . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.5899999999999999 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.406 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 5.0800000000000001 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.71 -46.15 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.6100000000000001 110.742 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.231 -0.89 . . . . 3.1600000000000001 110.997 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.55 -0.22 . . . . 8.1799999999999997 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.84 174.37 52.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 7.3099999999999996 112.48 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mt -69.93 -60.9 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 8.1799999999999997 110.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' B' ' 159' ' ' ALA . 78.1 m-85 -76.38 -65.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 7.1900000000000004 110.876 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p 43.92 -90.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 6.3200000000000003 111.758 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.71 -50.45 72.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 5.2000000000000002 111.232 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.56 -54.23 49.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 5.1100000000000003 111.013 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.72 -50.72 70.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 4.0599999999999996 111.123 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.21 -35.54 79.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 4.0199999999999996 111.236 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -59.52 -24.59 63.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.215 -0.448 . . . . 4.5899999999999999 110.894 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.56 30.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 3.3999999999999999 111.227 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -133.88 -53.76 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.403 . . . . 3.0800000000000001 111.032 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.1 mt -57.44 -44.95 99.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 111.531 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.4 Cg_exo -48.18 -52.14 8.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.176 1.917 . . . . 1.6000000000000001 112.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m -52.56 -42.54 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 1.98 111.119 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 1.49 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 1.47 110.807 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 1.3600000000000001 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.62 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.47999999999999998 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 1.1799999999999999 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 1.1699999999999999 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 1.0800000000000001 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 1.0800000000000001 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26000000000000001 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 1.1799999999999999 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34000000000000002 112.118 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 1.3200000000000001 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 2.4500000000000002 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 1.55 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.68999999999999995 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -62.2 -29.69 70.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 3.0299999999999998 111.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -76.97 -34.29 57.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.258 -0.428 . . . . 4.3499999999999996 111.189 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.0 mt -83.6 -30.05 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 2.1299999999999999 110.989 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 2.5600000000000001 111.266 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.52 -0.232 . . . . 7.46 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.8 152.51 52.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 6.0999999999999996 112.411 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 26.0 mm -72.22 -66.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.439 . . . . 7.8300000000000001 110.986 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.0 m-85 -77.22 -73.91 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 5.9699999999999998 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.4 m 38.46 -90.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.181 -0.463 . . . . 4.9100000000000001 112.233 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -55.7 -56.74 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.737 0.303 . . . . 4.3399999999999999 111.725 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -57.07 -22.56 40.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.41 -0.359 . . . . 5.46 111.574 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -91.44 -48.65 6.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.802 0.334 . . . . 3.6200000000000001 111.535 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 80.5 mt -62.49 -36.39 82.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 3.71 111.645 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.31 -32.06 66.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.713 0.292 . . . . 4.2199999999999998 111.256 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.95 33.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 2.9199999999999999 111.058 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -147.24 -48.28 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 2.8599999999999999 110.962 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 57.6 mt -58.33 -58.67 17.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 2.46 111.622 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 10.9 Cg_endo -54.23 -42.76 64.61 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.385 2.057 . . . . 1.53 112.708 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p -54.95 -41.95 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 1.77 111.086 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.6699999999999999 111.388 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.6599999999999999 110.92 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 1.23 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.47999999999999998 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.66000000000000003 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 1.1799999999999999 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 110.699 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.27000000000000002 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 1.1499999999999999 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28000000000000003 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 1.5700000000000001 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 2.1899999999999999 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 1.53 111.056 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55000000000000004 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.5899999999999999 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 5.0800000000000001 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.71 -29.99 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.6100000000000001 110.925 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.25 -0.881 . . . . 3.1600000000000001 111.266 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.623 -0.191 . . . . 8.1799999999999997 112.623 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.43 -175.62 20.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.825 -0.702 . . . . 7.3099999999999996 112.495 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 14.4 mm -69.27 -59.27 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 8.1799999999999997 111.04 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 30.1 p90 -75.85 -55.76 5.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 7.1900000000000004 110.671 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 12.7 m 73.84 -163.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.691 -0.686 . . . . 6.3200000000000003 111.336 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -53.92 -21.46 7.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 5.2000000000000002 111.278 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.69 -49.85 67.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 5.1100000000000003 110.834 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 8.2 t80 -79.83 -34.58 39.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.592 . . . . 4.0599999999999996 110.573 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.89 -50.93 68.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 4.0199999999999996 111.003 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -57.4 -34.42 68.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 4.5899999999999999 110.594 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 15.1 t -96.41 31.95 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 3.3999999999999999 110.857 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -144.88 -46.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 3.0800000000000001 111.027 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.2 mt -51.62 -58.75 9.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.998 -0.546 . . . . 2.6499999999999999 111.688 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.0 Cg_endo -53.09 -38.11 80.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.407 2.071 . . . . 1.6000000000000001 112.433 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.37 -44.51 65.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.372 -0.376 . . . . 1.98 110.793 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 1.49 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 1.47 110.553 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 1.3600000000000001 110.472 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.62 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.47999999999999998 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 1.1799999999999999 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 1.1699999999999999 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 1.0800000000000001 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 1.0800000000000001 110.019 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26000000000000001 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 1.1799999999999999 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34000000000000002 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 1.3200000000000001 110.834 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 2.4500000000000002 110.784 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 1.55 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.68999999999999995 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -17.95 40.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 3.0299999999999998 111.383 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -89.03 -40.35 13.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.803 0.335 . . . . 4.3499999999999996 111.129 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.86 -58.03 9.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 2.1299999999999999 110.922 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.252 -0.88 . . . . 2.5600000000000001 111.141 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.496 -0.242 . . . . 7.46 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.76 -171.94 24.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 6.0999999999999996 112.447 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.74 -41.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.19 0.519 . . . . 7.8300000000000001 109.758 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -77.7 -52.76 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 5.9699999999999998 110.491 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.9 m -167.77 -62.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 4.9100000000000001 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 179.01 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 4.3399999999999999 110.64 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.403 ' HA ' ' HE2' ' A' ' 163' ' ' LYS . 43.0 mt-10 -55.15 -26.48 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 5.46 110.72 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.45 -37.16 80.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 3.6200000000000001 110.647 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.1 -39.25 94.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 3.71 110.799 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 160' ' ' GLU . 0.8 OUTLIER -54.48 -28.95 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 4.2199999999999998 110.982 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.52 32.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 2.9199999999999999 110.714 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.489 ' CD1' HD11 ' A' ' 169' ' ' LEU . 57.9 t80 -138.01 -65.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 2.8599999999999999 110.53 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.469 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.8 mt -51.55 -51.42 69.75 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 2.46 111.777 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.7 Cg_endo -70.08 -12.6 32.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.954 1.77 . . . . 1.53 112.979 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p -94.84 -52.61 4.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.288 . . . . 1.77 111.18 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.489 HD11 ' CD1' ' A' ' 165' ' ' PHE . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.6699999999999999 111.405 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 1.23 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.47999999999999998 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.66000000000000003 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 1.1799999999999999 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB2' ' CG1' ' B' ' 177' ' ' ILE . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 1.0900000000000001 110.373 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 1.28 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.27000000000000002 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 1.1499999999999999 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28000000000000003 111.496 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 1.5700000000000001 110.642 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 2.1899999999999999 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 1.53 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55000000000000004 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.5899999999999999 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.416 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 5.0800000000000001 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.418 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt -106.44 -14.17 15.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.6100000000000001 111.225 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.322 -0.847 . . . . 3.1600000000000001 111.272 179.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.461 -0.256 . . . . 8.1799999999999997 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.79 -178.75 41.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 7.3099999999999996 112.515 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -69.57 -35.56 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 8.1799999999999997 111.087 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' B' ' 159' ' ' ALA . 68.4 m-85 -76.91 -71.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 7.1900000000000004 110.966 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p 44.6 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.098 -0.501 . . . . 6.3200000000000003 111.419 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.9 -50.63 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.817 0.342 . . . . 5.2000000000000002 111.004 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.78 -60.62 3.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 5.1100000000000003 111.039 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.43 -52.59 16.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 4.0599999999999996 111.183 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.05 -35.78 79.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 4.0199999999999996 110.854 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.84 -26.59 58.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 4.5899999999999999 110.833 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.67 40.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 3.3999999999999999 110.869 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.41 -42.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 3.0800000000000001 111.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.479 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 87.6 mt -56.69 -56.71 29.72 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.364 -0.38 . . . . 2.6499999999999999 111.86 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.1 Cg_endo -60.87 -42.41 38.0 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.363 2.042 . . . . 1.6000000000000001 113.186 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p -47.12 -45.42 22.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.284 . . . . 1.98 111.341 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 1.49 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.47 111.017 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.3600000000000001 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.62 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.47999999999999998 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 1.1799999999999999 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.1699999999999999 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 1.0800000000000001 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 1.0800000000000001 111.013 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26000000000000001 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 1.1799999999999999 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34000000000000002 112.407 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 1.3200000000000001 111.201 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 2.4500000000000002 111.154 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 1.55 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.68999999999999995 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -25.95 67.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 3.0299999999999998 111.305 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -76.77 -36.41 57.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.506 -0.316 . . . . 4.3499999999999996 111.276 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 65.0 mt -66.41 -58.6 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 2.1299999999999999 110.881 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.316 -0.85 . . . . 2.5600000000000001 111.201 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.778 0.323 . . . . 1.39 110.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.12 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.64 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.53 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.42 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.46 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.21 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.47 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.23 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.36 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.9 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 1.44 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.24 111.192 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 4.48 111.194 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.21 110.852 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.832 0.349 . . . . 1.54 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.86 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.74 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.36 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.48 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.38 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.26 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.29 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.34 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 0.67 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 1.56 110.841 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 0.83 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.69 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 2.56 111.157 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.803 0.335 . . . . 1.39 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.07 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.12 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.64 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.42 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.53 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 0.21 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.054 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.23 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.36 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.434 HD13 ' O ' ' B' ' 180' ' ' GLY . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 0.9 110.663 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.46 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 1.44 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.8 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.24 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 4.48 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.21 110.84 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.843 0.354 . . . . 1.54 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 0.93 111.141 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.74 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.4 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.36 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 0.48 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.38 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.26 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.29 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 0.34 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34 112.279 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.67 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 1.56 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.83 111.08 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.69 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 2.56 111.499 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.901 0.381 . . . . 1.39 110.82 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.07 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.12 110.669 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.64 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.42 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.42 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.46 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.21 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.47 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.23 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.36 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.9 111.043 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.42 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 1.44 111.146 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.8 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.24 111.775 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 4.48 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.21 110.916 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.823 0.344 . . . . 1.54 111.228 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.86 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.478 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.794 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.74 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.4 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.36 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.26 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.34 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34 112.336 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.67 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.56 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.83 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.69 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 2.56 111.38 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 1.39 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.07 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.12 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.64 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.42 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.53 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.42 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.46 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.47 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.23 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.36 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.42 HD13 ' O ' ' B' ' 180' ' ' GLY . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.9 110.914 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 1.44 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.8 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.24 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 4.48 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.21 110.994 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 1.54 110.459 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.93 110.431 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.74 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.4 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.38 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.26 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.29 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.34 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34 112.262 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.67 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 1.56 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 0.83 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.69 113.683 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 2.56 111.004 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.748 0.309 . . . . 1.39 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.12 110.925 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.64 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.53 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 0.42 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.46 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.21 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.23 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 0.36 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.461 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG13 ' CA ' ' B' ' 180' ' ' GLY . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.9 111.164 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 1.44 110.798 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.8 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.24 111.439 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 4.48 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.21 110.764 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 1.54 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.86 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.93 111.139 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 0.74 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.4 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 0.48 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.38 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.26 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.29 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.34 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' A' ' 181' ' ' ILE . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34 112.233 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.67 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 1.56 110.663 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 0.83 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.69 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 11.8 ptp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 2.56 110.723 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.714 0.292 . . . . 1.39 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.07 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.12 110.764 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.64 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.42 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.53 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.42 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.46 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 0.21 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 0.47 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.23 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 0.36 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.595 HD13 ' O ' ' B' ' 180' ' ' GLY . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.9 110.433 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 1.44 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 183' ' ' ILE . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.8 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55 112.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.24 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 4.48 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 54.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.21 111.081 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.812 0.339 . . . . 1.54 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 0.86 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.93 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 0.74 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.4 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.36 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.48 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.26 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.34 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34 112.111 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 0.67 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.56 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.83 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.69 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 2.56 111.132 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.933 0.397 . . . . 1.39 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.12 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.42 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.53 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.42 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 179' ' ' LEU . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.46 110.656 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 0.21 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.23 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 175' ' ' LEU . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 0.36 110.222 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.9 110.827 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.986 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.8 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.24 111.309 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 4.48 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 187' ' ' LEU . 10.1 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.21 110.748 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 1.54 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.86 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.411 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.93 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.48 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.38 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 0.26 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.29 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.34 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34 112.361 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.67 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.56 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.83 111.026 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.69 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 2.56 111.934 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.748 0.308 . . . . 1.39 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.07 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.12 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.64 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.53 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.42 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.46 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.47 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.36 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.9 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 1.44 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.8 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.24 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 4.48 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.831 179.695 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.739 0.304 . . . . 1.54 111.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.86 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.93 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.74 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.4 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.36 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 0.48 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.26 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.34 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 0.67 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 1.56 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.83 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.69 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 2.56 110.982 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.894 0.378 . . . . 1.39 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.07 111.407 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 111.135 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.64 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.53 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.42 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.46 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 0.21 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.47 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.23 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.36 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.9 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 1.44 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.8 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.24 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 4.48 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.21 110.841 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.839 0.352 . . . . 1.54 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.86 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.451 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.93 111.05 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 0.74 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.38 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.26 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.34 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.67 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 1.56 110.691 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.83 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.69 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 2.56 110.86 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.915 0.388 . . . . 1.39 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.07 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.12 111.148 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.64 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.42 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.53 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.42 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.46 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.21 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.47 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.23 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 0.36 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.9 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.44 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.8 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.24 111.725 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 4.48 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.21 110.85 179.687 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.843 0.354 . . . . 1.54 110.746 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.86 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.93 110.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.74 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.4 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.36 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.48 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.38 111.244 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.26 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.427 HG13 ' HB1' ' A' ' 176' ' ' ALA . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.29 110.313 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.34 110.519 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.67 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 1.56 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.83 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.69 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 2.56 111.103 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 1.39 110.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.829 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.12 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.64 110.717 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.42 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.53 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.42 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.46 110.905 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 0.21 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.47 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.23 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 0.36 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.9 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 1.44 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 0.8 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.24 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 4.48 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.21 110.588 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.796 0.331 . . . . 1.54 110.727 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.86 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.93 110.865 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.74 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.4 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.36 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.38 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.26 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.34 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 0.67 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 1.56 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 0.83 110.978 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.69 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 2.56 111.854 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.659 0.266 . . . . 1.39 111.524 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.07 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.12 111.162 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.64 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.42 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.53 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.42 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.46 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.21 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.23 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.36 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' B' ' 177' ' ' ILE . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28 112.65 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.9 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 1.44 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.8 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.24 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 4.48 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.21 111.077 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.781 0.324 . . . . 1.54 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.86 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.458 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.93 111.111 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.74 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.4 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.26 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 180' ' ' GLY . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.566 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 0.34 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.67 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 1.56 110.629 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 0.83 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.69 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 2.56 111.022 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 1.39 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.12 110.663 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.64 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.42 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.53 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.42 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.46 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 0.21 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 0.47 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.23 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 0.36 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.9 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 1.44 110.212 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.8 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55 112.752 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.24 111.042 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 4.48 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 43.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.21 110.963 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.889 0.376 . . . . 1.54 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.86 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 0.93 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 0.74 110.86 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.4 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.515 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.36 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 0.48 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.38 110.528 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.26 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.29 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 0.34 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 0.67 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 1.56 110.913 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.83 111.032 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.69 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.6 ptp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 2.56 111.353 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.854 0.359 . . . . 1.39 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.07 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.12 110.734 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.42 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.53 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.42 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.46 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.21 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.47 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.23 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.36 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 180' ' ' GLY . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.9 110.837 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 1.44 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55 112.977 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.24 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 4.48 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 18.1 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.21 110.935 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 1.54 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.86 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.47 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.93 110.7 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.74 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.36 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.48 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.38 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.26 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 0.34 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34 112.338 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.67 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 1.56 111.164 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.83 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 2.56 111.44 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.795 0.331 . . . . 1.39 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.12 110.613 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.64 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.42 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.53 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.42 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.21 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.23 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.36 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.9 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 1.44 110.672 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 0.8 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.24 111.283 -179.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 4.48 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 187' ' ' LEU . 15.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.21 110.99 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.902 0.382 . . . . 1.54 110.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.86 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.93 110.59 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 0.74 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.4 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.48 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.38 110.915 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.26 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.29 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 0.34 110.475 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 0.67 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 1.56 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 0.83 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.69 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 2.56 111.269 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.94 0.4 . . . . 1.39 110.556 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.07 110.892 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.646 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.64 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.42 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.53 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.42 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.46 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.21 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.47 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.23 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 0.36 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.9 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 1.44 110.85 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.24 111.178 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 4.48 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.21 111.114 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 1.54 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.86 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 0.93 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 0.74 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.4 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.36 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.48 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.38 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 0.26 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.29 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.34 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.67 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 1.56 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.83 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.69 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 2.56 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 1.39 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.902 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.64 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.42 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.53 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 0.42 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 0.21 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.47 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.23 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 0.36 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.9 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.44 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.8 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.24 111.366 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 4.48 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.21 111.039 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.785 0.326 . . . . 1.54 111.025 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.86 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.93 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 0.74 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.38 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.26 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.29 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 0.34 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.67 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 1.56 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 0.83 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.69 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 2.56 111.38 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.884 0.373 . . . . 1.39 110.951 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.07 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.12 110.927 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.42 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.53 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.42 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 0.46 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 0.21 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.47 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.23 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 0.36 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.9 111.14 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.136 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.8 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.24 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.404 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 4.48 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.742 179.339 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.733 0.301 . . . . 1.54 111.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.86 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.93 110.807 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.74 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.4 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.36 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.48 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.38 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.26 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 0.29 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 179' ' ' LEU . . . . . 0.456 ' O ' HD12 ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.34 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34 112.118 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.67 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.56 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.456 HD12 ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.83 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.69 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 2.56 111.065 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.73 0.3 . . . . 1.39 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.07 111.388 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.92 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 0.64 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.42 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.53 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.42 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.46 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.21 110.699 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.47 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.23 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.36 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.9 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.44 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.408 HD12 HD11 ' B' ' 181' ' ' ILE . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.8 111.056 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.24 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 4.48 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.21 110.925 179.618 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.861 0.362 . . . . 1.54 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.86 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.93 110.553 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.74 110.472 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.4 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.36 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.48 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.38 110.685 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.26 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.4 HG13 ' HB1' ' A' ' 176' ' ' ALA . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.29 110.019 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 0.34 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.408 HD11 HD12 ' A' ' 183' ' ' ILE . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 0.67 110.834 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 1.56 110.784 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.83 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.69 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 2.56 111.383 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.706 0.288 . . . . 1.39 111.18 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.07 111.405 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.12 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.64 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.42 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.53 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.42 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.46 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 0.21 110.373 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 0.47 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.23 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 0.36 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' B' ' 181' ' ' ILE . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28 111.496 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.9 110.642 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.435 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.8 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.24 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 4.48 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.21 111.225 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.697 0.284 . . . . 1.54 111.341 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.86 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 170' ' ' LEU . . . . . 0.434 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.93 111.017 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.74 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.36 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.48 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.38 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.26 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.29 111.013 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.34 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34 112.407 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.42 HG12 ' HA2' ' A' ' 180' ' ' GLY . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.67 111.201 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.56 111.154 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.69 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 2.56 111.305 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.508 -0.237 . . . . 7.13 112.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.49 153.85 17.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 6.07 112.514 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.23 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.805 0.336 . . . . 7.47 111.142 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' ALA . 98.2 m-85 -76.75 -49.35 16.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 5.44 110.865 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p 50.48 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.949 -0.569 . . . . 4.61 111.646 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.61 -59.98 4.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 4.05 111.675 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.1 -32.37 46.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 5.46 111.433 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -83.2 -55.76 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.472 -0.331 . . . . 3.23 111.251 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.26 -37.34 85.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 3.35 111.486 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.96 -29.71 57.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.725 0.297 . . . . 3.93 111.092 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.77 41.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 2.51 111.214 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -119.56 -66.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.894 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.7 mt -47.41 -57.13 10.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 2.04 111.641 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 21.0 Cg_endo -60.47 -28.45 86.72 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 1.28 112.245 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -65.21 -41.81 94.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 1.39 110.766 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.12 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.64 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.53 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.42 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.46 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.21 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.47 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.23 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.36 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.9 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 1.44 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.24 111.192 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 4.48 111.194 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -90.21 -40.63 12.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.21 110.852 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.135 -0.936 . . . . 2.72 111.28 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.418 -0.273 . . . . 7.87 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 175.79 31.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.714 -0.755 . . . . 6.96 112.431 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.9 mt -71.79 -65.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 7.93 110.961 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -77.37 -71.98 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 6.69 110.84 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 29.9 t 59.73 -84.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 6.01 111.365 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.02 -57.08 14.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.732 0.301 . . . . 4.95 111.533 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -56.18 -61.58 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 5.11 111.22 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -47.47 -49.87 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 3.68 111.206 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 158' ' ' SER . 67.0 mt -62.6 -38.79 91.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 3.64 111.085 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -55.67 -22.56 23.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 4.17 111.212 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.78 29.61 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 2.98 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -125.6 -39.03 2.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 2.32 111.128 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.8 mt -65.35 -56.92 16.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 2.18 111.668 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.0 Cg_endo -60.95 -19.73 63.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.201 1.934 . . . . 1.36 112.411 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t -68.58 -45.4 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 1.54 110.885 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.86 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.74 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.36 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.48 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.38 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.26 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.29 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.34 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 0.67 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 1.56 110.841 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 0.83 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.69 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.1 OUTLIER -60.83 -23.31 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 2.56 111.157 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 18.2 mmm180 -73.93 -33.96 64.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 3.82 111.125 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.78 -29.56 32.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.72 110.794 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 2.17 111.143 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.53 -0.228 . . . . 7.13 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -164.15 172.52 39.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.758 -0.734 . . . . 6.07 112.482 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -71.23 -65.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 7.47 110.915 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 94.8 m-85 -76.51 -85.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 5.44 110.704 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.3 t 36.09 -90.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.614 0.598 . . . . 4.61 112.614 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.11 -58.74 7.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.868 0.366 . . . . 4.05 111.69 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.08 -22.15 10.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 5.46 111.526 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 47.5 t80 -93.25 -56.47 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 3.23 110.814 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.85 -37.23 86.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 3.35 111.119 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 57.4 mtpt -57.83 -23.6 53.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 3.93 111.274 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.66 39.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 2.51 111.365 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 169' ' ' LEU . 59.8 t80 -135.32 -52.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.693 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.9 mt -55.63 -46.72 99.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.04 111.521 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 69.7 Cg_endo -76.1 -30.14 5.93 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.935 1.756 . . . . 1.28 112.012 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 1.39 110.859 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.07 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.12 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.64 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.42 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.53 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 0.21 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.054 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.23 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.36 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.434 HD13 ' O ' ' B' ' 180' ' ' GLY . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 0.9 110.663 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.46 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 1.44 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.8 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.24 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 4.48 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.65 -63.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.21 110.84 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.9 . . . . 2.72 111.476 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.503 -0.239 . . . . 7.87 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.89 170.89 14.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 6.96 112.491 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.12 -63.07 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 7.93 111.067 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.455 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 86.3 m-85 -76.27 -63.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 6.69 110.997 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 63.4 m 47.95 -90.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 6.01 111.254 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.07 -55.53 31.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 4.95 111.214 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -48.95 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.11 110.746 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.455 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 46.3 t80 -56.58 -53.93 51.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 3.68 111.181 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 158' ' ' SER . 35.8 mt -61.85 -34.85 76.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 3.64 110.742 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -55.54 -26.18 41.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 4.17 110.696 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.96 36.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 2.98 111.113 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -123.14 -56.2 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 2.32 110.768 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.2 mt -62.27 -45.86 90.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 2.18 111.665 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 87.2 Cg_endo -79.83 8.18 4.17 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.269 1.979 . . . . 1.36 113.139 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m -96.54 -41.86 8.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 1.54 110.861 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 0.93 111.141 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.74 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.4 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.36 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 0.48 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.38 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.26 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.29 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 0.34 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34 112.279 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.67 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 1.56 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.83 111.08 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.69 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 2.56 111.499 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 6.6 ptp180 -69.15 -37.64 78.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 3.82 111.111 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.28 -44.71 51.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.72 111.257 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 2.17 111.231 -179.825 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.403 -0.279 . . . . 7.13 112.403 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.46 169.07 42.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.741 -0.743 . . . . 6.07 112.52 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.84 -63.67 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.73 0.3 . . . . 7.47 111.18 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.1 m-85 -77.13 -75.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 5.44 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t 46.62 -88.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 4.61 112.064 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.98 -55.83 29.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 4.05 111.784 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -36.03 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.898 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.527 ' CZ ' ' CD2' ' A' ' 165' ' ' PHE . 90.6 t80 -81.4 -45.09 16.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 3.23 111.713 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 68.4 mt -63.09 -41.55 99.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 3.35 111.707 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG3' HG13 ' A' ' 164' ' ' VAL . 18.0 ptpt -56.3 -20.67 19.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.567 -0.288 . . . . 3.93 111.437 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 163' ' ' LYS . 16.0 m -128.85 34.17 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 2.51 111.335 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' CD2' ' CZ ' ' A' ' 161' ' ' PHE . 54.9 t80 -136.74 -56.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 55.7 mt -57.76 -58.9 15.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 2.04 111.427 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 9.7 Cg_endo -52.09 -23.79 18.22 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.213 1.942 . . . . 1.28 112.183 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -72.25 -41.66 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.82 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.07 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.12 110.669 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.64 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.42 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.42 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.46 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.21 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.47 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.23 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.36 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.9 111.043 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.42 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 1.44 111.146 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.8 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.24 111.775 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 4.48 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.72 -58.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.21 110.916 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.892 . . . . 2.72 110.998 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.435 -0.266 . . . . 7.87 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -144.93 -162.1 9.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 6.96 112.586 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.6 mt -70.87 -51.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 7.93 111.083 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.6 -78.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 6.69 110.734 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 62.2 m 67.07 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 6.01 111.462 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.37 -59.88 4.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.058 0.392 . . . . 4.95 112.058 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.08 -33.18 64.82 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.283 0.475 . . . . 5.11 112.283 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' B' ' 165' ' ' PHE . 65.8 t80 -86.95 -45.73 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.767 0.318 . . . . 3.68 111.707 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.421 ' CG ' ' O ' ' B' ' 158' ' ' SER . 42.9 mt -61.57 -38.48 87.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 3.64 111.474 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -56.67 -20.27 20.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.329 . . . . 4.17 111.411 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.15 42.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 2.98 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' B' ' 161' ' ' PHE . 53.9 t80 -146.86 -45.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 2.32 110.841 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 62.1 mt -64.71 -44.1 72.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.18 111.538 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 29.2 Cg_exo -62.2 -39.35 48.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.298 1.999 . . . . 1.36 112.441 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -46.28 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 1.54 111.228 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.86 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.478 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.794 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.74 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.4 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.36 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.26 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.34 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34 112.336 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.67 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.56 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.83 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.69 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -62.46 -38.67 90.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 2.56 111.38 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 29.0 mmt180 -60.36 -38.01 82.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 3.82 111.108 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.24 -54.89 14.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.72 110.951 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.283 -0.865 . . . . 2.17 111.152 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.457 -0.257 . . . . 7.13 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.19 176.22 43.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 6.07 112.33 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.82 0.343 . . . . 7.47 110.953 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' ALA . 56.8 m-85 -77.67 -39.8 43.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 5.44 111.154 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.2 m 44.38 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 4.61 111.655 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -60.2 -51.76 68.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 4.05 111.583 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 1.5 mp0 -57.88 -30.09 65.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 5.46 111.705 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -88.65 -50.05 6.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.23 111.213 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.26 -42.11 96.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 3.35 111.839 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.536 ' HG3' HG13 ' A' ' 164' ' ' VAL . 12.7 ptmm? -57.92 -18.17 21.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.688 -0.233 . . . . 3.93 111.348 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 163' ' ' LYS . 31.8 m -126.47 22.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.745 0.307 . . . . 2.51 111.095 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -102.5 -64.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 2.08 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 87.3 mt -49.6 -43.61 73.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 2.04 111.65 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 22.0 Cg_exo -64.86 -40.96 19.43 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.308 2.005 . . . . 1.28 111.786 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t -57.7 -41.47 81.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 1.39 110.507 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.07 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.12 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.64 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.42 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.53 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.42 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.46 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.47 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.23 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.36 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.42 HD13 ' O ' ' B' ' 180' ' ' GLY . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.9 110.914 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 1.44 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.8 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.24 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 4.48 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt -98.02 -57.78 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.21 110.994 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.255 -0.878 . . . . 2.72 111.11 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.409 -0.277 . . . . 7.87 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.2 -163.13 9.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.638 -0.791 . . . . 6.96 112.536 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.11 -55.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.886 0.374 . . . . 7.93 111.151 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.442 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 70.0 m-85 -76.19 -61.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 6.69 110.856 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.406 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 57.8 p 46.05 -90.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.974 -0.557 . . . . 6.01 111.408 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.76 -53.84 51.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 4.95 111.059 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -59.28 -52.36 65.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 5.11 111.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 88.7 t80 -48.96 -53.2 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 3.68 111.51 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 158' ' ' SER . 32.2 mt -60.43 -36.92 79.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.766 0.317 . . . . 3.64 110.873 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.74 -28.13 54.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 4.17 111.033 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.32 32.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 2.98 111.527 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.445 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 30.6 t80 -110.88 -59.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 2.32 110.723 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 96.3 mt -49.49 -48.33 75.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.18 111.396 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 65.2 Cg_endo -74.85 -28.33 9.54 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.002 1.801 . . . . 1.36 112.05 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t -64.25 -42.17 96.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 1.54 110.459 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' B' ' 167' ' ' PRO . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.93 110.431 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.74 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.4 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.38 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.26 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.29 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.34 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34 112.262 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.67 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.524 ' CE2' ' CZ ' ' B' ' 186' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 1.56 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 0.83 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' GLY . . . . . 0.467 ' O ' HG22 ' B' ' 188' ' ' THR . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.69 113.683 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -51.85 -23.92 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 2.56 111.004 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.524 ' CZ ' ' CE2' ' B' ' 182' ' ' TYR . 77.6 mtm180 -85.58 -25.69 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 3.82 110.881 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.95 -42.51 12.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 1.72 110.994 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.61 HG23 ' OXT' ' B' ' 188' ' ' THR . 7.3 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.139 -0.934 . . . . 2.17 111.132 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.601 -0.2 . . . . 7.13 112.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.98 165.1 24.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 6.07 112.339 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.81 -64.09 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 7.47 111.032 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.58 -74.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 5.44 110.566 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.3 t 60.9 -84.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 4.61 111.551 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.98 52.03 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 4.05 112.123 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.08 -29.96 61.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 5.46 111.734 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -90.01 -45.47 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 3.23 111.375 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.19 -34.26 77.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.145 -0.479 . . . . 3.35 111.626 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.02 -23.77 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 3.93 111.132 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.64 42.07 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.398 . . . . 2.51 111.286 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -131.63 -52.76 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.247 -0.433 . . . . 2.08 111.013 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 67.7 mt -54.74 -44.35 99.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 2.04 111.383 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -67.54 -39.02 13.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.327 2.018 . . . . 1.28 112.249 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m -56.37 -42.17 77.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 1.39 111.108 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.12 110.925 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.64 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.53 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 0.42 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.46 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.21 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.23 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 0.36 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.461 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG13 ' CA ' ' B' ' 180' ' ' GLY . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.9 111.164 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 1.44 110.798 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.8 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.24 111.439 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 4.48 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt -84.97 -28.34 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.21 110.764 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.216 -0.897 . . . . 2.72 111.097 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.53 -0.228 . . . . 7.87 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLY . . . . . 0.402 ' CA ' HD11 ' B' ' 162' ' ' LEU . . . -103.69 -152.49 23.0 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.652 -0.785 . . . . 6.96 112.153 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.27 -50.42 76.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.177 -0.675 . . . . 7.93 109.177 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -67.68 0.68 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.479 -0.782 . . . . 6.69 109.422 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 m -168.85 177.39 5.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.334 -0.848 . . . . 6.01 110.233 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.8 66.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 4.95 110.73 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.403 ' O ' HG22 ' B' ' 164' ' ' VAL . 11.4 mm-40 -55.37 -60.53 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 5.11 111.536 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -43.97 -51.48 7.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 3.68 111.814 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.402 HD11 ' CA ' ' B' ' 155' ' ' GLY . 68.0 mt -63.9 -46.25 85.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 3.64 111.604 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -57.19 -23.31 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.377 . . . . 4.17 111.758 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 160' ' ' GLU . 32.6 m -121.69 40.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.682 0.277 . . . . 2.98 111.237 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -146.71 -45.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 2.32 111.28 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.508 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.9 mt -64.39 -43.55 72.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 2.18 111.834 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 37.4 Cg_exo -61.14 -37.89 71.33 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.301 2.0 . . . . 1.36 112.502 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -58.73 -42.29 88.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.54 111.13 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.86 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.93 111.139 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 0.74 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.4 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 0.48 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.38 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.26 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.29 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.34 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' A' ' 181' ' ' ILE . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34 112.233 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.67 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 1.56 110.663 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 0.83 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.69 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 11.8 ptp180 -56.35 -34.98 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 2.56 110.723 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.43 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 50.4 ttp180 -67.23 -25.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.942 -0.572 . . . . 3.82 110.885 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.35 -42.76 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 1.72 110.89 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -0.795 . . . . 2.17 111.287 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.385 -0.286 . . . . 7.13 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.65 179.24 38.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.728 -0.748 . . . . 6.07 112.458 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.9 mm -69.15 -31.14 48.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 7.47 110.727 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.4 m-85 -76.71 -63.76 1.27 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.875 -0.602 . . . . 5.44 110.457 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 28.8 t 50.77 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.623 . . . . 4.61 111.609 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -49.91 -59.54 3.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 4.05 111.468 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 36.6 tt0 -56.73 -19.79 18.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.554 -0.294 . . . . 5.46 111.079 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -85.19 -45.44 12.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 3.23 110.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 158' ' ' SER . 10.9 mt -63.29 -39.73 95.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.434 -0.348 . . . . 3.35 111.077 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 160' ' ' GLU . 17.8 ptpt -56.79 -21.8 31.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.93 111.33 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.23 34.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 2.51 111.16 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -139.59 -45.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 2.08 110.885 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.5 mt -65.73 -47.36 66.17 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 2.04 111.553 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 70.2 Cg_endo -76.59 -10.38 18.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.111 1.874 . . . . 1.28 112.739 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p -81.32 -41.7 21.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.292 . . . . 1.39 110.692 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.07 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.12 110.764 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.64 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.42 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.53 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.42 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.46 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 0.21 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 0.47 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.23 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 0.36 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.595 HD13 ' O ' ' B' ' 180' ' ' GLY . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.9 110.433 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 1.44 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 183' ' ' ILE . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.8 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55 112.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.24 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 4.48 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 54.0 mt -92.02 -45.52 8.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.21 111.081 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.261 -0.876 . . . . 2.72 111.234 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.419 -0.272 . . . . 7.87 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.33 -174.82 7.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.685 -0.769 . . . . 6.96 112.388 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.6 mt -71.03 -53.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.38 . . . . 7.93 111.034 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.0 m-85 -76.38 -64.14 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 6.69 110.892 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m 40.92 -92.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.161 -0.472 . . . . 6.01 111.562 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -59.32 -54.19 49.67 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.939 0.4 . . . . 4.95 111.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.32 -28.61 59.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 5.11 111.057 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.33 -54.96 7.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 3.68 111.102 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.34 -33.48 73.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.933 0.397 . . . . 3.64 110.562 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.96 -29.5 63.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.548 . . . . 4.17 110.823 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.22 33.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 2.98 111.321 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -135.95 -58.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 2.32 110.969 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 80.4 mt -58.34 -43.59 98.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 2.18 111.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 11.2 Cg_exo -71.37 -26.98 19.93 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.43 2.086 . . . . 1.36 112.213 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -63.17 -44.54 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.905 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 0.86 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.93 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 0.74 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.4 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.36 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.48 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.26 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.34 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34 112.111 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 0.67 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.56 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.83 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.69 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -21.75 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 2.56 111.132 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -82.86 -49.59 9.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 3.82 110.883 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.27 -32.96 70.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 1.72 111.004 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.892 . . . . 2.17 111.174 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.503 -0.239 . . . . 7.13 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.16 153.77 24.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.753 . . . . 6.07 112.545 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.75 -57.61 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 7.47 110.98 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 74.4 m-85 -76.54 -58.09 3.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 5.44 110.901 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.8 t 52.95 -86.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 4.61 111.267 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -59.18 -58.78 7.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.645 0.259 . . . . 4.05 111.54 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.82 -25.69 56.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.433 . . . . 5.46 111.811 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -88.92 -52.06 5.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 3.23 111.533 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 158' ' ' SER . 89.4 mt -61.83 -36.75 82.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 3.35 111.803 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HG3' HG13 ' A' ' 164' ' ' VAL . 18.1 ptpt -56.37 -28.82 60.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 3.93 111.212 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HG3' ' A' ' 163' ' ' LYS . 13.2 m -116.89 23.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 2.51 111.279 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -132.75 -43.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 2.08 110.776 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 79.3 mt -65.25 -57.28 15.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 2.04 111.484 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 25.9 Cg_endo -61.86 -30.99 84.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.99 1.793 . . . . 1.28 112.088 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m -57.13 -41.95 80.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.39 110.931 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.12 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.42 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.53 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.42 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 179' ' ' LEU . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.46 110.656 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 0.21 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.23 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 175' ' ' LEU . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 0.36 110.222 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.9 110.827 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.986 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.8 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.24 111.309 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 4.48 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 187' ' ' LEU . 10.1 mt -60.95 -40.26 92.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.21 110.748 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 2.72 111.533 179.727 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.526 -0.23 . . . . 7.87 112.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -107.37 -179.17 22.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 6.96 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.54 -66.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.073 0.463 . . . . 7.93 111.012 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' B' ' 159' ' ' ALA . 81.5 m-85 -77.94 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 6.69 111.103 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p 44.26 -91.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.13 -0.487 . . . . 6.01 111.25 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.68 -53.15 60.87 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.907 0.384 . . . . 4.95 110.945 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.26 -19.38 33.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 5.11 111.394 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -81.77 -36.37 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 3.68 111.319 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -47.1 84.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 3.64 111.04 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -55.78 -24.39 35.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 4.17 110.933 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.97 31.28 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 2.98 110.819 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -137.0 -43.39 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 2.32 111.241 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.5 mt -64.99 -43.84 69.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.345 -0.389 . . . . 2.18 111.77 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 16.8 Cg_exo -67.26 -39.8 12.39 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.417 2.078 . . . . 1.36 112.548 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m -51.23 -41.99 60.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 1.54 111.164 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.86 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.411 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.93 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.48 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.38 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 0.26 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.29 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.34 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34 112.361 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.67 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.56 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.44 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.83 111.026 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.69 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -62.5 -39.43 93.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 2.56 111.934 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 23.3 ptt180 -68.95 -26.88 65.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.681 0.277 . . . . 3.82 111.517 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.33 -29.46 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 1.72 111.178 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 2.17 111.266 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 7.13 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.13 173.99 26.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 6.07 112.403 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.62 -58.97 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 7.47 110.94 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 158' ' ' SER . 75.9 m-85 -76.79 -84.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 5.44 110.908 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 23.3 t 71.44 -158.03 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.345 -0.389 . . . . 4.61 110.78 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.26 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.779 0.323 . . . . 4.05 110.973 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -57.14 -30.23 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 5.46 110.502 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -93.22 -30.32 15.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 3.23 110.748 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.01 -47.18 84.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 3.35 110.936 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 164' ' ' VAL . 17.4 ptpt -55.19 -22.78 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 3.93 111.105 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' A' ' 163' ' ' LYS . 29.7 m -110.06 31.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 2.51 110.855 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -136.4 -62.23 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 2.08 111.071 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 47.6 mt -53.96 -58.33 13.92 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 2.04 111.529 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 29.9 Cg_endo -62.93 -18.13 63.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.976 . . . . 1.28 112.501 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -74.65 -41.8 59.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 1.39 110.998 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.07 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.12 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.64 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.53 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.42 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.46 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.47 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.36 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.9 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 1.44 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.8 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.24 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 4.48 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt -74.76 -27.28 60.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.831 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.41 -0.805 . . . . 2.72 111.206 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.478 -0.249 . . . . 7.87 112.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.74 -174.42 30.55 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.798 -0.715 . . . . 6.96 112.444 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 19.9 mt -70.62 -59.02 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 7.93 111.058 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' B' ' 159' ' ' ALA . 68.7 m-85 -76.47 -63.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 6.69 110.836 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 74.3 m 55.31 -85.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 6.01 111.416 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.51 -55.16 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 4.95 111.494 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.05 -46.9 82.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 5.11 111.613 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -72.71 -42.01 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 3.68 111.548 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' B' ' 158' ' ' SER . 57.3 mt -63.37 -50.0 71.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 3.64 111.992 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.503 ' HG3' HG23 ' B' ' 164' ' ' VAL . 18.1 ptpt -56.97 -25.69 58.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.652 0.263 . . . . 4.17 111.078 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.603 ' O ' HG12 ' B' ' 164' ' ' VAL . 20.2 t -104.75 31.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.911 0.386 . . . . 2.98 111.076 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -148.18 -49.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 2.32 110.921 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 89.2 mt -55.56 -58.58 14.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 2.18 111.652 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 4.7 Cg_endo -47.63 -50.03 12.28 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.515 2.143 . . . . 1.36 112.85 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p -48.03 -41.85 26.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.501 -0.318 . . . . 1.54 111.265 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.86 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.93 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.74 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.4 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.36 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 0.48 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.26 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.34 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 0.67 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' B' ' 186' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 1.56 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.83 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.69 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.9 -29.08 69.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 2.56 110.982 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 2.4 mmp_? -69.1 -26.51 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 3.82 110.806 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 58.5 mt -102.14 -67.5 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 1.72 110.737 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.242 -0.885 . . . . 2.17 111.393 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.425 -0.27 . . . . 7.13 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.62 175.3 40.44 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 6.07 112.42 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.53 -53.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 7.47 110.889 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.2 m-85 -76.53 -71.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 5.44 110.515 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.0 m 56.17 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 4.61 111.675 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.86 -66.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.324 . . . . 4.05 111.41 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 42.5 mt-10 -54.15 -49.63 68.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 5.46 111.318 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -59.81 -48.9 79.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.446 -0.343 . . . . 3.23 110.968 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 158' ' ' SER . 78.3 mt -62.73 -38.41 90.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 3.35 111.463 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.433 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 50.0 mtmt -56.89 -44.26 82.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.629 -0.26 . . . . 3.93 111.149 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.62 36.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.471 -0.332 . . . . 2.51 111.15 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 169' ' ' LEU . 72.0 t80 -142.9 -60.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 2.08 111.044 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 65.4 mt -49.98 -59.01 7.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 2.04 111.438 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 18.7 Cg_endo -59.13 -28.08 86.78 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.38 2.053 . . . . 1.28 112.588 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -69.97 -41.62 74.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 1.39 110.973 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 165' ' ' PHE . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.07 111.407 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 111.135 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.64 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.53 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.42 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.46 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 0.21 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.47 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.23 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.36 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.9 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 1.44 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.8 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.24 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 4.48 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt -98.46 -25.78 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.21 110.841 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.214 -0.898 . . . . 2.72 111.134 179.911 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 7.87 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.22 -159.36 22.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ILE . . . . . 0.617 HG22 ' CE2' ' B' ' 157' ' ' PHE . 22.0 mt -71.29 -35.97 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.062 0.458 . . . . 7.93 110.559 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE2' HG22 ' B' ' 156' ' ' ILE . 88.5 m-85 -157.85 -57.27 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 6.69 110.122 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 59.7 m 38.47 -90.75 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.792 -0.64 . . . . 6.01 112.366 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.24 -54.92 37.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 4.95 111.614 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.76 -44.19 81.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 5.11 110.951 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 35.4 t80 -66.73 -55.86 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 3.68 110.767 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 158' ' ' SER . 52.3 mt -62.25 -30.06 70.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 3.64 110.598 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 31.1 ttmt -58.34 -24.99 61.43 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.744 -0.662 . . . . 4.17 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.88 -22.09 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.98 111.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -85.98 -43.4 13.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.375 -0.375 . . . . 2.32 111.08 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 55.6 mt -47.69 -60.02 4.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 2.18 111.568 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 3.4 Cg_exo -40.43 -29.26 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.692 2.261 . . . . 1.36 112.462 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m -77.18 -41.9 39.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 1.54 110.918 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.86 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.93 111.05 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 0.74 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.38 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.26 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.34 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.67 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 1.56 110.691 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.83 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.69 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -60.78 -24.31 65.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 2.56 110.86 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -65.96 -38.12 87.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 3.82 110.608 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.79 -37.33 86.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.65 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.403 ' OXT' HG23 ' B' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.205 -0.902 . . . . 2.17 111.236 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.582 -0.207 . . . . 7.13 112.582 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.74 163.84 12.07 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.824 -0.703 . . . . 6.07 112.669 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mm -70.57 -55.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 7.47 111.023 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 84.1 m-85 -76.25 -69.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 5.44 110.881 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t 43.66 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.14 -0.482 . . . . 4.61 111.561 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.13 -51.59 69.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.878 0.37 . . . . 4.05 111.148 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -54.89 -22.17 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 5.46 111.292 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -96.18 -50.44 4.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 3.23 111.15 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.21 -30.19 71.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 3.35 111.086 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -56.1 -44.29 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 3.93 110.888 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.34 43.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 2.51 111.233 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -142.47 -50.94 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 2.08 110.911 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 84.9 mt -57.76 -58.0 21.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 2.04 111.61 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 19.6 Cg_endo -58.61 -34.22 98.71 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.302 2.002 . . . . 1.28 112.653 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m -59.16 -41.79 89.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 1.39 110.939 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.07 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.12 111.148 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.64 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.42 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.53 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.42 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.46 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.21 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.47 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.23 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 0.36 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.9 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.44 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.8 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.24 111.725 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 4.48 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.22 -51.35 64.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.21 110.85 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.408 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.22 -0.895 . . . . 2.72 111.17 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.448 -0.261 . . . . 7.87 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.98 -164.87 29.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 6.96 112.533 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.2 mt -71.57 -62.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 7.93 111.103 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' B' ' 159' ' ' ALA . 95.3 m-85 -76.5 -53.53 7.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 6.69 110.937 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 75.4 m 47.31 -90.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.991 -0.55 . . . . 6.01 111.168 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.42 -54.54 45.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.947 0.403 . . . . 4.95 111.04 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -58.89 -30.74 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.556 . . . . 5.11 111.11 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 38.7 t80 -64.91 -48.92 72.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 3.68 111.043 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.439 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 13.8 mt -61.77 -35.67 78.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 3.64 110.949 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -57.83 -37.67 74.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 4.17 111.063 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.55 16.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.419 . . . . 2.98 111.699 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 79.4 t80 -107.61 -38.49 5.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 2.32 110.719 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 96.2 mt -70.76 -43.67 15.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 2.18 111.332 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 19.5 Cg_exo -66.3 -36.58 27.28 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.327 2.018 . . . . 1.36 111.951 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p -54.53 -43.57 72.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.54 110.746 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.86 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.93 110.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.74 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.4 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.36 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.48 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.38 111.244 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.26 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.427 HG13 ' HB1' ' A' ' 176' ' ' ALA . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.29 110.313 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.34 110.519 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.67 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 1.56 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.83 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.69 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -59.35 -26.57 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 2.56 111.103 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -91.46 -33.19 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 3.82 110.959 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.99 31.95 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 1.72 110.761 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.28 -0.866 . . . . 2.17 111.209 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.511 -0.236 . . . . 7.13 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 165.08 164.84 21.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.741 . . . . 6.07 112.529 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mm -71.63 -47.7 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 7.47 111.084 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.8 m-85 -75.96 -73.25 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 5.44 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.4 t 43.01 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.226 -0.443 . . . . 4.61 111.765 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.24 -56.64 18.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.639 0.257 . . . . 4.05 111.638 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 43.7 tt0 -56.87 -19.06 15.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.497 -0.319 . . . . 5.46 111.646 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -95.26 -50.51 5.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 3.23 111.178 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.51 -36.43 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 3.35 111.556 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 17.1 ptpt -56.38 -27.87 57.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.522 -0.308 . . . . 3.93 111.294 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 163' ' ' LYS . 6.2 m -110.35 32.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 2.51 111.217 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 169' ' ' LEU . 68.8 t80 -148.57 -45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.08 110.901 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.9 mt -50.34 -59.36 7.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 2.04 111.438 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.4 Cg_endo -43.17 -44.08 9.9 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.481 2.121 . . . . 1.28 112.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m -58.6 -41.43 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 1.39 110.633 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 165' ' ' PHE . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.829 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.12 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.64 110.717 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.42 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.53 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.42 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.46 110.905 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 0.21 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.47 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.23 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 0.36 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.9 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 1.44 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 0.8 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.24 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 4.48 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -49.33 8.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.21 110.588 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 188' ' ' THR . 2.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.367 -0.825 . . . . 2.72 111.228 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.512 -0.235 . . . . 7.87 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.94 -171.28 37.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 6.96 112.364 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.99 -56.86 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.769 0.319 . . . . 7.93 111.28 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.14 -79.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 6.69 111.191 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 69.7 m 61.06 134.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 6.01 111.423 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' B' ' 158' ' ' SER . . . 89.81 -63.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.728 -0.669 . . . . 4.95 110.692 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.97 -57.51 12.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.802 -0.635 . . . . 5.11 110.914 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.37 -38.03 81.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 3.68 110.827 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' B' ' 166' ' ' LEU . 77.4 mt -63.47 -38.65 91.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 3.64 111.08 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -56.83 -24.18 49.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.379 . . . . 4.17 110.953 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.66 29.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 2.98 111.108 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -145.65 -50.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 2.32 111.045 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.475 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 63.3 mt -55.4 -46.88 99.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 2.18 111.435 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 98.2 Cg_exo -42.85 -52.05 4.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.311 2.008 . . . . 1.36 112.297 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -55.95 -43.57 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 1.54 110.727 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.86 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.43 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.93 110.865 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.74 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.4 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.36 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.38 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.26 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.34 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 0.67 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 1.56 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 0.83 110.978 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.69 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -63.18 -38.46 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 2.56 111.854 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 7.2 ptm180 -70.78 -29.78 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 3.82 111.075 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.1 -35.61 25.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 1.72 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.246 -0.883 . . . . 2.17 111.064 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.547 -0.221 . . . . 7.13 112.547 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.45 151.74 31.56 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.646 -0.788 . . . . 6.07 112.583 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.73 -66.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 7.47 110.899 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.8 m-85 -76.86 -74.09 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 5.44 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 48.4 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.996 -0.547 . . . . 4.61 111.568 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.09 -55.29 36.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.698 0.285 . . . . 4.05 111.335 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.81 -27.96 60.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 5.46 111.165 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 51.7 t80 -84.6 -58.25 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 3.23 110.973 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.98 -23.62 66.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 3.35 111.064 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -61.19 -47.13 87.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.294 -0.412 . . . . 3.93 110.827 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.7 -20.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 2.51 111.767 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.464 ' CE2' HD11 ' A' ' 169' ' ' LEU . 86.6 t80 -65.08 -56.47 12.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 2.08 111.226 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.4 mt -50.31 -58.25 10.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.04 112.007 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 24.7 Cg_endo -60.49 -44.94 24.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.29 1.993 . . . . 1.28 112.985 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p -50.67 -41.63 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 1.39 111.524 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 165' ' ' PHE . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.07 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.12 111.162 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.64 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.42 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.53 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.42 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.46 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.21 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.23 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.36 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' B' ' 177' ' ' ILE . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28 112.65 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.9 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 1.44 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.8 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.24 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 4.48 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt -95.53 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.21 111.077 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 188' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.277 -0.868 . . . . 2.72 111.183 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.829 -0.108 . . . . 7.87 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 177.89 -159.9 25.95 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.787 -0.721 . . . . 6.96 112.373 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.3 mt -70.79 -59.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 7.93 110.812 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 96.7 m-85 -76.99 -27.55 54.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 6.69 110.855 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 73.4 m 42.29 -89.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.784 -0.643 . . . . 6.01 112.128 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.05 -62.87 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.707 0.289 . . . . 4.95 111.74 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.522 ' O ' HG22 ' B' ' 164' ' ' VAL . 43.6 tt0 -54.53 -21.5 10.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 5.11 110.994 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -78.35 -40.33 36.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 3.68 110.907 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.43 ' N ' HD23 ' B' ' 162' ' ' LEU . 5.5 mt -63.1 -48.44 78.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.853 0.359 . . . . 3.64 110.676 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' B' ' 164' ' ' VAL . 0.2 OUTLIER -56.42 -27.85 57.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 4.17 111.382 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 160' ' ' GLU . 21.9 m -113.76 30.85 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 2.98 111.087 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -145.94 -54.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 2.32 110.882 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 83.2 mt -53.69 -57.38 17.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 2.18 111.465 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.3 Cg_endo -58.84 -44.5 35.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 1.36 113.009 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -47.85 -41.71 24.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 1.54 111.137 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.86 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.458 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.93 111.111 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.74 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.4 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.26 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 180' ' ' GLY . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.566 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 0.34 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.67 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 1.56 110.629 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 0.83 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.69 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.5 -18.95 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 2.56 111.022 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -72.17 -40.35 68.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.9 0.381 . . . . 3.82 110.712 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.2 -49.52 73.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.72 110.952 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.235 -0.888 . . . . 2.17 111.195 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.422 -0.271 . . . . 7.13 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.94 178.19 42.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.681 -0.771 . . . . 6.07 112.659 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.59 -46.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 7.47 110.849 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -76.83 -76.73 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.884 -0.598 . . . . 5.44 110.621 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.8 m 63.59 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 4.61 111.108 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CG ' ' A' ' 163' ' ' LYS . . . -60.47 -61.03 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 4.05 111.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' HG22 ' A' ' 164' ' ' VAL . 3.3 tm-20 -54.0 -31.55 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 5.46 111.409 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.564 ' CE1' ' CD1' ' A' ' 165' ' ' PHE . 52.6 t80 -84.47 -55.18 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 3.23 111.104 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 165' ' ' PHE . 92.7 mt -61.0 -40.0 91.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 3.35 111.195 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 159' ' ' ALA . 53.2 mtpt -56.63 -29.4 62.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 3.93 111.278 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' GLU . 20.1 m -125.38 26.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.349 . . . . 2.51 111.352 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 161' ' ' PHE . 82.8 t80 -117.81 -37.96 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 2.08 110.807 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 94.0 mt -67.77 -45.53 44.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.04 111.399 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 74.4 Cg_exo -47.12 -39.43 26.03 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.117 1.878 . . . . 1.28 112.08 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m -67.58 -41.59 83.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 1.39 110.662 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.489 HD11 ' CE2' ' A' ' 165' ' ' PHE . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.12 110.663 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.64 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.42 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.53 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.42 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.46 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 0.21 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 0.47 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.23 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 0.36 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.9 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 1.44 110.212 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.8 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55 112.752 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.24 111.042 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 4.48 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 43.4 mt -79.96 -23.66 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.21 110.963 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 2.72 111.073 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.418 -0.273 . . . . 7.87 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.16 -168.89 11.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 6.96 112.486 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.05 -60.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.038 0.447 . . . . 7.93 111.156 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 29.6 p90 -75.81 -57.0 4.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 6.69 110.865 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 10.4 t 78.51 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.638 . . . . 6.01 111.602 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.66 -22.7 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 4.95 111.335 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.4 -64.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.992 0.425 . . . . 5.11 110.803 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 10.9 t80 -60.21 -34.11 73.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.973 -0.558 . . . . 3.68 110.953 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 67.9 mt -63.36 -36.14 82.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 3.64 111.308 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.16 -20.24 25.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.385 . . . . 4.17 111.303 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.35 39.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 2.98 111.513 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' B' ' 169' ' ' LEU . 85.4 t80 -139.74 -46.49 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 2.32 111.177 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.7 mt -71.4 -46.13 13.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 2.18 111.644 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 88.1 Cg_exo -41.97 -28.41 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 1.36 112.675 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -87.15 -47.91 8.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.376 . . . . 1.54 110.945 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' B' ' 165' ' ' PHE . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.86 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 0.93 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 0.74 110.86 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.4 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.515 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.36 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 0.48 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.38 110.528 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.26 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.29 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 0.34 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 0.67 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 1.56 110.913 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.83 111.032 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.69 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 6.6 ptp180 -59.65 -35.39 74.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 2.56 111.353 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 15.4 ptm180 -79.67 -27.05 40.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.322 . . . . 3.82 111.248 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.86 -50.44 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.411 -0.359 . . . . 1.72 111.004 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 2.17 111.014 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.647 -0.181 . . . . 7.13 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.26 172.85 22.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.656 -0.783 . . . . 6.07 112.416 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.93 -63.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.389 . . . . 7.47 110.837 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.7 m-85 -76.19 -68.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 5.44 110.638 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.9 m 40.45 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.07 -0.514 . . . . 4.61 112.096 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' ' 163' ' ' LYS . . . -56.75 -55.75 30.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.796 0.331 . . . . 4.05 111.389 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 164' ' ' VAL . 38.4 tt0 -55.7 -23.31 28.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.127 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -89.99 -57.23 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 3.23 110.978 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 58.2 mt -62.56 -38.79 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 3.35 111.021 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.48 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 58.6 mtpt -56.94 -21.74 32.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 3.93 110.984 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 160' ' ' GLU . 30.3 m -127.82 32.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 2.51 110.77 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.55 -49.03 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 2.08 110.777 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 77.6 mt -55.3 -57.93 17.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 2.04 111.586 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 12.3 Cg_endo -56.66 -34.4 95.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.18 1.92 . . . . 1.28 112.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t -57.14 -41.79 79.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.39 110.661 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.07 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.12 110.734 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.42 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.53 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.42 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.46 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.21 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.47 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.23 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.36 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 180' ' ' GLY . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.9 110.837 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 1.44 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55 112.977 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.24 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 4.48 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 18.1 mt -77.59 -45.22 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.21 110.935 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.288 -0.863 . . . . 2.72 111.397 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.459 -0.256 . . . . 7.87 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.55 177.66 24.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 6.96 112.536 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.35 -64.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 7.93 111.193 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.461 ' HA ' ' HB3' ' B' ' 161' ' ' PHE . 21.2 m-85 -79.51 4.67 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 6.69 112.214 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 68.5 m -75.45 -100.34 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.217 -0.302 . . . . 6.01 111.115 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.41 72.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.31 0.485 . . . . 4.95 112.31 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -53.27 -76.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.388 . . . . 5.11 111.527 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' B' ' 157' ' ' PHE . 7.8 t80 -45.32 -48.61 13.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 3.68 111.573 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 158' ' ' SER . 95.1 mt -62.12 -41.61 98.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 3.64 110.981 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -58.63 -34.77 71.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.246 -0.434 . . . . 4.17 110.384 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.96 30.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 2.98 110.866 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -132.28 -46.21 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 2.32 110.773 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.461 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 70.5 mt -58.14 -58.44 18.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 2.18 111.316 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 34.8 Cg_endo -64.28 -26.87 63.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.12 1.88 . . . . 1.36 112.005 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -63.91 -44.04 94.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 1.54 110.836 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.86 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.47 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.93 110.7 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.74 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.36 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.48 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.38 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.26 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 0.34 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34 112.338 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.67 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 1.56 111.164 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.83 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HD3' ' HG3' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -55.28 -20.37 11.06 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 2.56 111.44 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.431 ' HG3' ' HD3' ' B' ' 185' ' ' ARG . 76.2 mtp180 -87.02 -29.8 21.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.819 0.342 . . . . 3.82 111.0 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.04 -34.79 78.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 1.72 110.834 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.189 -0.91 . . . . 2.17 111.177 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.661 -0.176 . . . . 7.13 112.661 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -137.25 172.76 22.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 6.07 112.455 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.51 HG22 ' CD2' ' A' ' 157' ' ' PHE . 15.8 mt -71.44 -29.91 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 7.47 110.892 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.51 ' CD2' HG22 ' A' ' 156' ' ' ILE . 51.2 m-85 -156.44 -50.21 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.908 -0.587 . . . . 5.44 110.964 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t 49.89 -87.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 4.61 111.595 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.18 -64.51 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 4.05 111.446 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 9.3 tp10 -55.3 -22.73 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 5.46 111.454 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -80.54 -53.82 6.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 3.23 111.153 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.3 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 3.35 111.556 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.411 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 51.5 mtmt -56.49 -28.1 58.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 3.93 110.876 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.18 36.74 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 2.51 111.005 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -140.98 -51.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.8 mt -52.19 -57.66 14.42 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.449 . . . . 2.04 111.337 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.8 Cg_endo -61.76 -31.02 85.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.124 1.883 . . . . 1.28 112.19 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 1.39 110.748 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.12 110.613 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.64 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.42 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.53 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.42 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.21 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.23 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.36 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.9 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 1.44 110.672 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 0.8 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.24 111.283 -179.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 4.48 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 187' ' ' LEU . 15.9 mt -75.16 -35.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.21 110.99 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.474 ' OXT' HG23 ' A' ' 188' ' ' THR . 2.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.159 -0.924 . . . . 2.72 111.195 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.522 -0.231 . . . . 7.87 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -156.68 -168.87 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 6.96 112.591 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.8 mm -69.57 -60.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.105 0.479 . . . . 7.93 111.107 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.1 m-85 -76.39 -65.96 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.761 -0.654 . . . . 6.69 110.871 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.42 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 68.6 m 41.32 -92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.071 -0.513 . . . . 6.01 111.306 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.98 -53.58 56.62 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.366 . . . . 4.95 111.012 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.83 -21.13 26.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 5.11 111.133 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.57 ' CE2' ' CD1' ' B' ' 165' ' ' PHE . 47.0 t80 -87.02 -30.28 21.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 3.68 111.287 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 158' ' ' SER . 12.7 mt -62.69 -36.15 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.946 0.403 . . . . 3.64 110.568 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -56.87 -23.5 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 4.17 111.007 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.92 38.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 2.98 111.24 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' PHE . . . . . 0.57 ' CD1' ' CE2' ' B' ' 161' ' ' PHE . 72.4 t80 -122.69 -52.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 2.32 110.898 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 69.5 mt -55.89 -57.76 19.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.501 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 17.5 Cg_endo -57.98 -26.59 75.61 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.133 1.889 . . . . 1.36 112.081 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -67.27 -41.88 84.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 1.54 110.515 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.86 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.93 110.59 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 0.74 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.4 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.48 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.38 110.915 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.26 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.29 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 0.34 110.475 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 0.67 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 1.56 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 0.83 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.69 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -51.71 -30.51 22.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 2.56 111.269 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 65.7 mtt180 -84.88 -22.86 29.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 3.82 111.453 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.2 mt -51.39 -50.43 59.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 1.72 110.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.38 -0.819 . . . . 2.17 111.283 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.542 -0.223 . . . . 7.13 112.542 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.33 175.27 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.748 -0.739 . . . . 6.07 112.491 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.77 -66.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.998 0.428 . . . . 7.47 110.886 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 159' ' ' ALA . 24.3 m-85 -78.1 -69.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 5.44 111.029 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.6 p 43.55 -91.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.165 -0.47 . . . . 4.61 111.485 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 163' ' ' LYS . . . -59.87 -51.34 70.11 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.877 0.37 . . . . 4.05 111.186 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.39 -21.57 16.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 5.46 111.382 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -97.21 -51.5 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 3.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.89 -37.89 88.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 3.35 111.085 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.432 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 59.2 mtpt -58.1 -30.58 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 3.93 111.287 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.5 46.17 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 2.51 111.394 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 169' ' ' LEU . 77.5 t80 -156.66 -44.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.397 . . . . 2.08 110.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 52.3 mt -60.23 -59.75 12.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.04 111.554 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 2.4 Cg_endo -41.33 -29.92 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.552 2.168 . . . . 1.28 112.384 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t -77.02 -41.75 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.39 110.556 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.475 HD11 ' CE2' ' A' ' 165' ' ' PHE . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.07 110.892 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.646 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.64 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.42 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.53 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.42 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.46 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.21 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.47 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.23 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 0.36 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.9 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 1.44 110.85 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.24 111.178 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 4.48 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.37 -50.35 65.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.21 111.114 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.272 -0.87 . . . . 2.72 111.312 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.438 -0.265 . . . . 7.87 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.58 37.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 6.96 112.482 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.36 -60.16 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 7.93 111.001 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' B' ' 161' ' ' PHE . 69.8 m-85 -77.04 -84.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 6.69 110.813 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.6 22.98 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.959 0.409 . . . . 6.01 111.509 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' B' ' 163' ' ' LYS . . . -179.67 -62.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.82 -0.627 . . . . 4.95 109.784 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 -26.06 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.548 -0.538 . . . . 5.11 109.548 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.507 ' HB2' ' CD2' ' B' ' 157' ' ' PHE . 83.0 t80 -96.16 -47.97 5.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.747 -0.66 . . . . 3.68 110.286 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.85 -33.09 73.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.998 0.427 . . . . 3.64 110.42 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 159' ' ' ALA . 18.5 ttpp -60.64 -32.03 71.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 4.17 110.899 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.22 37.57 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 2.98 111.365 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -146.63 -48.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 2.32 110.869 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 91.2 mt -55.9 -46.13 99.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 2.18 111.139 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.6 Cg_exo -43.01 -40.22 8.45 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.187 1.924 . . . . 1.36 112.319 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -70.0 -42.2 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 1.54 110.627 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.86 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.425 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 0.93 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 0.74 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.4 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.36 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.48 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.38 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 0.26 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.29 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.34 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.67 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 1.56 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.83 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.69 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -58.53 -20.44 46.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 2.56 111.127 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 24.8 mmm180 -79.52 -26.21 41.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.814 0.34 . . . . 3.82 110.72 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 94.4 mt -54.1 -45.83 71.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 1.72 110.957 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 188' ' ' THR . 1.8 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.389 -0.815 . . . . 2.17 111.174 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.452 -0.259 . . . . 7.13 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.7 172.96 14.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 6.07 112.495 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.85 -59.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 7.47 110.956 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 161' ' ' PHE . 87.7 m-85 -75.96 -64.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 5.44 110.947 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 58.9 m 51.44 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 4.61 111.216 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.75 -61.61 2.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.325 . . . . 4.05 111.356 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -29.04 63.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 5.46 111.488 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 70.4 t80 -74.76 -50.38 17.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 3.23 111.203 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 158' ' ' SER . 70.8 mt -62.83 -36.71 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 3.35 111.206 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -57.1 -23.09 44.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 3.93 111.06 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.59 30.62 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 2.51 111.002 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 90.7 t80 -135.14 -60.57 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 2.08 110.847 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 74.6 mt -51.25 -43.33 85.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 2.04 111.652 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 17.4 Cg_exo -67.05 -49.95 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.272 1.981 . . . . 1.28 112.228 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t -47.25 -52.1 16.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 1.39 111.124 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.902 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.64 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.42 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.53 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 0.42 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 0.21 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.47 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.23 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 0.36 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.9 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.44 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.8 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.24 111.366 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 4.48 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.89 -32.2 11.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.21 111.039 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.149 -0.929 . . . . 2.72 111.127 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.491 -0.244 . . . . 7.87 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -106.19 176.31 21.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.668 -0.777 . . . . 6.96 112.531 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 mm -70.14 -49.17 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.409 . . . . 7.93 111.102 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 91.7 m-85 -76.45 -64.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 6.69 110.843 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.9 m 45.07 -90.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 6.01 111.347 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.41 -55.29 36.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.36 . . . . 4.95 111.079 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.43 -42.44 82.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 5.11 111.396 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 71.1 t80 -55.27 -53.21 58.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 3.68 111.267 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.45 -38.87 91.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 3.64 111.235 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -56.51 -32.39 65.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 4.17 110.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.75 31.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.98 110.827 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -128.98 -55.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 2.32 111.138 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.473 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 69.0 mt -57.84 -45.9 99.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 2.18 111.582 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 96.5 Cg_endo -83.66 13.23 2.75 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 1.36 112.957 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -103.81 -45.57 4.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 1.54 111.025 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.86 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.93 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 0.74 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.38 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.26 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.29 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 0.34 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.67 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.479 ' CE2' ' HD2' ' B' ' 186' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 1.56 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 0.83 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.69 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -58.91 -23.04 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 2.56 111.38 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.479 ' HD2' ' CE2' ' B' ' 182' ' ' TYR . 71.4 mtp180 -71.56 -38.4 70.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 3.82 110.789 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.1 -34.38 76.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.72 110.54 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.14 -0.934 . . . . 2.17 111.164 179.898 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.565 -0.214 . . . . 7.13 112.565 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.39 160.99 26.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 6.07 112.302 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.09 -36.62 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 7.47 111.188 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' ALA . 64.2 m-85 -76.74 -79.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 5.44 111.125 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.5 t 63.7 -76.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.335 . . . . 4.61 111.016 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.68 -53.78 54.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 4.05 111.684 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -55.04 -44.85 75.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 5.46 111.589 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.91 -48.01 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 3.23 111.54 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.62 -30.51 70.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 3.35 111.271 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -57.42 -28.97 63.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 3.93 110.919 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.9 37.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 2.51 111.224 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -148.02 -50.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 2.08 110.777 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 64.6 mt -61.8 -60.36 10.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 2.04 111.501 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.2 Cg_endo -43.96 -43.29 12.41 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.469 2.113 . . . . 1.28 112.437 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -56.38 -43.02 78.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 1.39 110.951 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.07 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.12 110.927 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.42 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.53 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.42 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 0.46 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 0.21 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.47 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.23 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 0.36 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.9 111.14 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.136 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.8 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.24 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.404 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 4.48 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.71 -46.15 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.742 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.231 -0.89 . . . . 2.72 110.997 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.55 -0.22 . . . . 7.87 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.84 174.37 52.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 6.96 112.48 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mt -69.93 -60.9 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 7.93 110.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' B' ' 159' ' ' ALA . 78.1 m-85 -76.38 -65.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 6.69 110.876 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p 43.92 -90.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 6.01 111.758 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.71 -50.45 72.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 4.95 111.232 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.56 -54.23 49.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.013 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.72 -50.72 70.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 3.68 111.123 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.21 -35.54 79.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 3.64 111.236 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -59.52 -24.59 63.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.215 -0.448 . . . . 4.17 110.894 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.56 30.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 2.98 111.227 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -133.88 -53.76 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.403 . . . . 2.32 111.032 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.1 mt -57.44 -44.95 99.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 2.18 111.531 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.4 Cg_exo -48.18 -52.14 8.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.176 1.917 . . . . 1.36 112.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m -52.56 -42.54 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 1.54 111.119 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.86 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.93 110.807 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.74 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.4 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.36 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.48 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.38 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.26 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 0.29 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' LEU . . . . . 0.456 ' O ' HD12 ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.34 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34 112.118 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.67 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.56 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.456 HD12 ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.83 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.69 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -62.2 -29.69 70.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 2.56 111.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -76.97 -34.29 57.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.258 -0.428 . . . . 3.82 111.189 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.0 mt -83.6 -30.05 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 1.72 110.989 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 2.17 111.266 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.52 -0.232 . . . . 7.13 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.8 152.51 52.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 6.07 112.411 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 26.0 mm -72.22 -66.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.439 . . . . 7.47 110.986 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.0 m-85 -77.22 -73.91 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 5.44 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.407 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.4 m 38.46 -90.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.181 -0.463 . . . . 4.61 112.233 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -55.7 -56.74 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.737 0.303 . . . . 4.05 111.725 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -57.07 -22.56 40.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.41 -0.359 . . . . 5.46 111.574 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 17.6 t80 -91.44 -48.65 6.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.802 0.334 . . . . 3.23 111.535 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 80.5 mt -62.49 -36.39 82.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 3.35 111.645 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.31 -32.06 66.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.713 0.292 . . . . 3.93 111.256 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.95 33.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 2.51 111.058 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 79.1 t80 -147.24 -48.28 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 2.08 110.962 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 57.6 mt -58.33 -58.67 17.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 2.04 111.622 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 10.9 Cg_endo -54.23 -42.76 64.61 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.385 2.057 . . . . 1.28 112.708 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p -54.95 -41.95 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 1.39 111.086 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 165' ' ' PHE . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.07 111.388 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.92 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 0.64 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.42 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.53 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.42 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.46 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.21 110.699 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.47 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.23 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.36 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.9 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.44 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.408 HD12 HD11 ' B' ' 181' ' ' ILE . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.8 111.056 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.24 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 4.48 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.71 -29.99 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.21 110.925 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.429 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.8 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.25 -0.881 . . . . 2.72 111.266 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.623 -0.191 . . . . 7.87 112.623 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.43 -175.62 20.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.825 -0.702 . . . . 6.96 112.495 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 14.4 mm -69.27 -59.27 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 7.93 111.04 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 30.1 p90 -75.85 -55.76 5.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 6.69 110.671 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 12.7 m 73.84 -163.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.691 -0.686 . . . . 6.01 111.336 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' B' ' 162' ' ' LEU . . . -53.92 -21.46 7.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 4.95 111.278 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.69 -49.85 67.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 5.11 110.834 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.44 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 8.2 t80 -79.83 -34.58 39.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.592 . . . . 3.68 110.573 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' B' ' 159' ' ' ALA . 60.3 mt -62.89 -50.93 68.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 3.64 111.003 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.492 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.4 ptpt -57.4 -34.42 68.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 4.17 110.594 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.552 ' O ' HG12 ' B' ' 164' ' ' VAL . 15.1 t -96.41 31.95 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 2.98 110.857 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -144.88 -46.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.32 111.027 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.2 mt -51.62 -58.75 9.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.998 -0.546 . . . . 2.18 111.688 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.0 Cg_endo -53.09 -38.11 80.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.407 2.071 . . . . 1.36 112.433 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.37 -44.51 65.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.372 -0.376 . . . . 1.54 110.793 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.86 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.93 110.553 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.74 110.472 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.4 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.36 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.48 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.38 110.685 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.26 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.4 HG13 ' HB1' ' A' ' 176' ' ' ALA . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.29 110.019 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 0.34 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.408 HD11 HD12 ' A' ' 183' ' ' ILE . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 0.67 110.834 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.418 ' CZ ' ' HD2' ' B' ' 186' ' ' ARG . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 1.56 110.784 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.83 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.69 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -59.82 -17.95 40.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 2.56 111.383 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 186' ' ' ARG . . . . . 0.418 ' HD2' ' CZ ' ' B' ' 182' ' ' TYR . 76.3 mtp85 -89.03 -40.35 13.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.803 0.335 . . . . 3.82 111.129 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.86 -58.03 9.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 1.72 110.922 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.252 -0.88 . . . . 2.17 111.141 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.496 -0.242 . . . . 7.13 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.76 -171.94 24.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 6.07 112.447 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.74 -41.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.19 0.519 . . . . 7.47 109.758 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -77.7 -52.76 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 5.44 110.491 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.9 m -167.77 -62.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 4.61 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 179.01 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 4.05 110.64 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' HA ' ' HE2' ' A' ' 163' ' ' LYS . 43.0 mt-10 -55.15 -26.48 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 5.46 110.72 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.45 -37.16 80.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 3.23 110.647 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.1 -39.25 94.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 3.35 110.799 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 160' ' ' GLU . 0.8 OUTLIER -54.48 -28.95 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 3.93 110.982 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.52 32.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 2.51 110.714 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 169' ' ' LEU . 57.9 t80 -138.01 -65.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 2.08 110.53 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.8 mt -51.55 -51.42 69.75 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 2.04 111.777 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.7 Cg_endo -70.08 -12.6 32.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.954 1.77 . . . . 1.28 112.979 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p -94.84 -52.61 4.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.288 . . . . 1.39 111.18 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 165' ' ' PHE . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.07 111.405 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.12 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 167' ' ' PRO . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.64 110.905 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.42 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.53 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.42 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.46 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 0.21 110.373 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 0.47 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.23 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 0.36 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' B' ' 181' ' ' ILE . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28 111.496 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.9 110.642 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.435 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.8 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.24 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 4.48 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt -106.44 -14.17 15.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.21 111.225 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 188' ' ' THR . 1.9 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.322 -0.847 . . . . 2.72 111.272 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.461 -0.256 . . . . 7.87 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.79 -178.75 41.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 6.96 112.515 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -69.57 -35.56 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 7.93 111.087 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 68.4 m-85 -76.91 -71.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 6.69 110.966 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p 44.6 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.098 -0.501 . . . . 6.01 111.419 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.9 -50.63 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.817 0.342 . . . . 4.95 111.004 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.78 -60.62 3.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 5.11 111.039 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 82.9 t80 -47.43 -52.59 16.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 3.68 111.183 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.05 -35.78 79.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 3.64 110.854 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.84 -26.59 58.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 4.17 110.833 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.67 40.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 2.98 110.869 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.41 -42.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 2.32 111.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 87.6 mt -56.69 -56.71 29.72 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.364 -0.38 . . . . 2.18 111.86 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.1 Cg_endo -60.87 -42.41 38.0 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.363 2.042 . . . . 1.36 113.186 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p -47.12 -45.42 22.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.284 . . . . 1.54 111.341 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.86 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.93 111.017 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.74 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.36 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.48 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.38 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.26 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.29 111.013 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.34 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34 112.407 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.42 HG12 ' HA2' ' A' ' 180' ' ' GLY . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.67 111.201 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.56 111.154 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.69 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.72 -25.95 67.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 2.56 111.305 -179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -76.77 -36.41 57.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.506 -0.316 . . . . 3.82 111.276 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 65.0 mt -66.41 -58.6 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 1.72 110.881 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.316 -0.85 . . . . 2.17 111.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.778 0.323 . . . . 1.39 110.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.12 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.64 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.53 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.42 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.46 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.21 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.47 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.23 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.36 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.9 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 1.44 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.24 111.192 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 4.48 111.194 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.21 110.852 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.832 0.349 . . . . 1.54 110.885 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.86 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.74 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.36 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.48 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.38 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.26 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.29 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.34 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 0.67 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 1.56 110.841 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 0.83 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.69 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 2.56 111.157 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.803 0.335 . . . . 1.39 110.859 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.07 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.12 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.64 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.42 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.53 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 0.21 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.054 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.23 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.36 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.434 HD13 ' O ' ' B' ' 180' ' ' GLY . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 0.9 110.663 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.46 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 1.44 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.8 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.24 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 4.48 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.21 110.84 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.843 0.354 . . . . 1.54 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 0.93 111.141 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.74 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.4 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.36 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 0.48 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.38 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.26 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.29 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 0.34 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34 112.279 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.67 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 1.56 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.83 111.08 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.69 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 2.56 111.499 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.901 0.381 . . . . 1.39 110.82 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.07 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.12 110.669 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.64 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.42 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.42 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.46 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.21 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.47 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.23 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.36 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.9 111.043 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.42 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 1.44 111.146 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.8 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.24 111.775 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 4.48 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.21 110.916 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.823 0.344 . . . . 1.54 111.228 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.86 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.478 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.794 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.74 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.4 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.36 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.26 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.34 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34 112.336 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.67 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.56 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.83 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.69 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 2.56 111.38 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 1.39 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.07 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.12 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.64 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.42 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.53 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.42 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.46 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.47 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.23 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.36 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.42 HD13 ' O ' ' B' ' 180' ' ' GLY . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.9 110.914 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 1.44 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.8 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.24 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 4.48 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.21 110.994 179.846 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 1.54 110.459 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.93 110.431 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.74 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.4 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.38 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.26 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.29 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.34 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34 112.262 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.67 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 1.56 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 0.83 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.69 113.683 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 2.56 111.004 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.748 0.309 . . . . 1.39 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.12 110.925 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.64 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.53 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 0.42 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.46 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.21 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.23 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 0.36 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.461 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.411 HG13 ' CA ' ' B' ' 180' ' ' GLY . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.9 111.164 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 1.44 110.798 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.8 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.24 111.439 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 4.48 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.21 110.764 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.789 0.328 . . . . 1.54 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.86 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.93 111.139 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 0.74 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.4 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 0.48 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.38 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.26 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.29 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.34 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' A' ' 181' ' ' ILE . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34 112.233 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.67 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 1.56 110.663 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 0.83 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.69 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 11.8 ptp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 2.56 110.723 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.714 0.292 . . . . 1.39 110.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.07 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.12 110.764 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.64 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.42 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.53 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.42 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.46 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 0.21 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 0.47 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.23 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 0.36 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.595 HD13 ' O ' ' B' ' 180' ' ' GLY . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.9 110.433 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 1.44 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 183' ' ' ILE . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.8 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55 112.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.24 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 4.48 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 54.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.21 111.081 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.812 0.339 . . . . 1.54 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 0.86 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.93 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 0.74 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.4 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.36 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.48 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.26 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.34 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34 112.111 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 0.67 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.56 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.83 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.69 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 2.56 111.132 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.933 0.397 . . . . 1.39 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.12 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.42 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.53 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.42 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 179' ' ' LEU . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.46 110.656 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 0.21 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.23 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 175' ' ' LEU . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 0.36 110.222 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.9 110.827 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.986 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.8 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.24 111.309 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 4.48 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 187' ' ' LEU . 10.1 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.21 110.748 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 1.54 111.164 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.86 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.411 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.93 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.48 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.38 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 0.26 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.29 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.34 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34 112.361 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.67 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.56 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.83 111.026 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.69 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 2.56 111.934 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.748 0.308 . . . . 1.39 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.07 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.12 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.64 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.53 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.42 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.46 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.47 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.36 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.9 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 1.44 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.8 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.24 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 4.48 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.831 179.695 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.739 0.304 . . . . 1.54 111.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.86 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.93 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.74 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.4 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.36 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 0.48 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.26 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.34 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 0.67 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 1.56 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.83 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.69 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 2.56 110.982 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.894 0.378 . . . . 1.39 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.07 111.407 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 111.135 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.64 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.53 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.42 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.46 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 0.21 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.47 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.23 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.36 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.9 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 1.44 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.8 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.24 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 4.48 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.21 110.841 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.839 0.352 . . . . 1.54 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.86 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.451 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.93 111.05 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 0.74 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.38 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.26 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.34 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.67 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 1.56 110.691 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.83 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.69 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 2.56 110.86 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.915 0.388 . . . . 1.39 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.07 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.12 111.148 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.64 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.42 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.53 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.42 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.46 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.21 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.47 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.23 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 0.36 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.9 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.44 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.8 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.24 111.725 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 4.48 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.21 110.85 179.687 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.843 0.354 . . . . 1.54 110.746 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.86 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.432 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.93 110.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.74 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.4 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.36 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.48 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.38 111.244 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.26 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.427 HG13 ' HB1' ' A' ' 176' ' ' ALA . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.29 110.313 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.34 110.519 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.67 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 1.56 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.83 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.69 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 2.56 111.103 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 1.39 110.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.829 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.12 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.64 110.717 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.42 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.53 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.42 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.46 110.905 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 0.21 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.47 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.23 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 0.36 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.9 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 1.44 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 0.8 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.24 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 4.48 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.21 110.588 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.796 0.331 . . . . 1.54 110.727 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.86 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.93 110.865 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.74 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.4 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.36 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.38 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.26 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.34 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 0.67 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 1.56 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 0.83 110.978 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.69 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 2.56 111.854 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.659 0.266 . . . . 1.39 111.524 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.07 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.12 111.162 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.64 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.42 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.53 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.42 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.46 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.21 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.23 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.36 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' B' ' 177' ' ' ILE . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28 112.65 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.9 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 1.44 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.8 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.24 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 4.48 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.21 111.077 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.781 0.324 . . . . 1.54 111.137 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.86 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.458 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.93 111.111 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.74 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.4 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.26 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 180' ' ' GLY . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.566 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 0.34 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.67 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 1.56 110.629 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 0.83 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.69 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 2.56 111.022 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.848 0.356 . . . . 1.39 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.12 110.663 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.64 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.42 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.53 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.42 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.46 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 0.21 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 0.47 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.23 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 0.36 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.9 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 1.44 110.212 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.8 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55 112.752 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.24 111.042 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 4.48 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 43.4 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.21 110.963 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.889 0.376 . . . . 1.54 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.403 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.86 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 0.93 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 0.74 110.86 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.4 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.515 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.36 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 0.48 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.38 110.528 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.26 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.29 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 0.34 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 0.67 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.408 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 1.56 110.913 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.83 111.032 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.69 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' B' ' 182' ' ' TYR . 6.6 ptp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 2.56 111.353 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.854 0.359 . . . . 1.39 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.07 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.12 110.734 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.42 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.53 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.42 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.46 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.21 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.47 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.23 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.36 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 180' ' ' GLY . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.9 110.837 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 1.44 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55 112.977 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.24 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 4.48 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 18.1 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.21 110.935 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.303 . . . . 1.54 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.86 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.47 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.93 110.7 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.74 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.36 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.48 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.38 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.26 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 0.34 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34 112.338 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.67 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 1.56 111.164 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.83 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 2.56 111.44 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.795 0.331 . . . . 1.39 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.12 110.613 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.64 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.42 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.53 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.42 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.21 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.23 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.36 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.9 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 1.44 110.672 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 0.8 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.24 111.283 -179.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 4.48 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 187' ' ' LEU . 15.9 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.21 110.99 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.902 0.382 . . . . 1.54 110.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.86 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.93 110.59 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 0.74 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.4 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.48 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.38 110.915 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.26 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.29 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 0.34 110.475 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 0.67 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 1.56 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 0.83 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.69 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 2.56 111.269 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.94 0.4 . . . . 1.39 110.556 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.07 110.892 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.646 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.64 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.42 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.53 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.42 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.46 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.21 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.47 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.23 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 0.36 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.9 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 1.44 110.85 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.24 111.178 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 4.48 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.21 111.114 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 1.54 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.86 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 0.93 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 0.74 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.4 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.36 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.48 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.38 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 0.26 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.29 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.34 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.67 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 1.56 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.83 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.69 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 2.56 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 1.39 111.124 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.902 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.64 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.42 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.53 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 0.42 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 0.21 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.47 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.23 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 0.36 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.9 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.44 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.8 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.24 111.366 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 4.48 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.21 111.039 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.785 0.326 . . . . 1.54 111.025 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.86 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.93 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 0.74 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.38 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.26 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.29 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 0.34 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.67 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 1.56 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 0.83 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.69 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 2.56 111.38 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.884 0.373 . . . . 1.39 110.951 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.07 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.12 110.927 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.42 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.53 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.42 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 0.46 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 0.21 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.47 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.23 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 0.36 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.9 111.14 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.136 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.8 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.24 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.404 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 4.48 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.742 179.339 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.733 0.301 . . . . 1.54 111.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.86 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.93 110.807 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.74 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.4 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.36 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.48 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.38 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.26 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 0.29 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . 0.456 ' O ' HD12 ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.34 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34 112.118 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.67 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.56 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.456 HD12 ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.83 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.69 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 2.56 111.065 -179.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.73 0.3 . . . . 1.39 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.07 111.388 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.92 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 0.64 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.42 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.53 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.42 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.46 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.21 110.699 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.47 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.23 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.36 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.9 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.44 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.408 HD12 HD11 ' B' ' 181' ' ' ILE . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.8 111.056 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.24 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 4.48 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.21 110.925 179.618 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.861 0.362 . . . . 1.54 110.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.86 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.446 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.93 110.553 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.74 110.472 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.4 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.36 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.48 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.38 110.685 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.26 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.4 HG13 ' HB1' ' A' ' 176' ' ' ALA . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.29 110.019 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 0.34 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.408 HD11 HD12 ' A' ' 183' ' ' ILE . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 0.67 110.834 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 1.56 110.784 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.83 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.69 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 2.56 111.383 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.706 0.288 . . . . 1.39 111.18 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.07 111.405 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.12 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.64 110.905 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.42 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.53 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.42 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.46 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 0.21 110.373 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 0.47 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.23 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 0.36 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' B' ' 181' ' ' ILE . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28 111.496 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.9 110.642 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.435 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.8 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.24 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 4.48 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.21 111.225 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.697 0.284 . . . . 1.54 111.341 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.86 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' LEU . . . . . 0.434 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.93 111.017 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.74 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.36 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.48 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.38 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.26 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.29 111.013 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.34 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34 112.407 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.42 HG12 ' HA2' ' A' ' 180' ' ' GLY . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.67 111.201 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.56 111.154 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.69 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 2.56 111.305 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.508 -0.237 . . . . 7.13 112.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -105.49 153.85 17.17 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 6.07 112.514 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.23 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.805 0.336 . . . . 7.47 111.142 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 159' ' ' ALA . 98.2 m-85 -76.75 -49.35 16.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 5.44 110.865 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p 50.48 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.949 -0.569 . . . . 4.61 111.646 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.61 -59.98 4.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 4.05 111.675 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -53.1 -32.37 46.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.304 -0.407 . . . . 5.46 111.433 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -83.2 -55.76 4.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.472 -0.331 . . . . 3.23 111.251 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.26 -37.34 85.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 3.35 111.486 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -54.96 -29.71 57.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.725 0.297 . . . . 3.93 111.092 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.77 41.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 2.51 111.214 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -119.56 -66.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.894 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.7 mt -47.41 -57.13 10.33 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 2.04 111.641 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 21.0 Cg_endo -60.47 -28.45 86.72 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 1.28 112.245 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 50.5 m -65.21 -41.81 94.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 1.39 110.766 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.9 mt -55.44 -44.72 76.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.699 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 170' ' ' LEU . 5.5 mp -62.06 -51.36 68.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 1.12 110.698 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.15 -41.68 93.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.64 110.809 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 64.8 m -59.02 -48.85 80.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 37.5 m80 -54.42 -49.9 68.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.53 110.899 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.24 -48.96 77.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.42 110.85 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.19 -43.28 99.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.46 110.943 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.1 -52.28 59.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.21 110.683 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.6 mt -57.15 -41.83 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.045 -0.525 . . . . 0.47 110.373 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.92 -44.01 94.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.625 -0.798 . . . . 0.23 111.852 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 78.6 mt -56.14 -48.08 76.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.36 110.094 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.03 -51.53 45.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.64 -0.791 . . . . 0.28 112.379 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.74 -45.15 98.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.9 110.995 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -52.06 -48.26 64.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 1.44 110.756 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.5 mt -62.36 -47.54 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.119 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.11 51.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.849 -0.691 . . . . 0.55 113.086 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -27.85 65.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.692 0.282 . . . . 2.24 111.192 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -105.05 46.23 0.93 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.392 -0.367 . . . . 4.48 111.194 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.3 mt -90.21 -40.63 12.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.21 110.852 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.135 -0.936 . . . . 2.72 111.28 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.418 -0.273 . . . . 7.87 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.1 175.79 31.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.714 -0.755 . . . . 6.96 112.431 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.9 mt -71.79 -65.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 7.93 110.961 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -77.37 -71.98 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 6.69 110.84 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 29.9 t 59.73 -84.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 6.01 111.365 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.02 -57.08 14.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.732 0.301 . . . . 4.95 111.533 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -56.18 -61.58 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 5.11 111.22 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -47.47 -49.87 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 3.68 111.206 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 158' ' ' SER . 67.0 mt -62.6 -38.79 91.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 3.64 111.085 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -55.67 -22.56 23.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 4.17 111.212 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.78 29.61 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.955 0.407 . . . . 2.98 111.084 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -125.6 -39.03 2.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.113 -0.494 . . . . 2.32 111.128 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 84.8 mt -65.35 -56.92 16.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 2.18 111.668 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.0 Cg_endo -60.95 -19.73 63.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.201 1.934 . . . . 1.36 112.411 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 46.2 t -68.58 -45.4 72.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 1.54 110.885 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.28 -43.72 75.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.86 111.053 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.0 mp -62.16 -50.13 73.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.614 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 98.1 mt -58.96 -41.93 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.74 110.649 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 51.7 m -55.58 -50.49 69.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.819 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -55.38 -48.81 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.36 110.788 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.77 -49.5 76.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.48 110.775 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.01 -42.93 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.38 111.0 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.45 -52.34 59.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.26 111.012 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.2 mt -60.45 -41.71 88.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.29 110.571 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.57 -45.93 89.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.686 -0.768 . . . . 0.26 111.968 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.46 -47.13 85.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 0.34 110.406 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.41 -45.23 66.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.672 -0.775 . . . . 0.34 112.222 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.8 -48.89 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.412 . . . . 0.67 110.698 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 63.2 t80 -51.72 -44.89 63.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 1.56 110.841 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.72 -48.37 88.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.31 -0.404 . . . . 0.83 111.031 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.31 50.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.98 -0.629 . . . . 0.69 113.269 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.1 OUTLIER -60.83 -23.31 65.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.759 0.314 . . . . 2.56 111.157 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 182' ' ' TYR . 18.2 mmm180 -73.93 -33.96 64.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 3.82 111.125 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.78 -29.56 32.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 1.72 110.794 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 2.17 111.143 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.53 -0.228 . . . . 7.13 112.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -164.15 172.52 39.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.758 -0.734 . . . . 6.07 112.482 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.8 mm -71.23 -65.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.983 0.42 . . . . 7.47 110.915 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 94.8 m-85 -76.51 -85.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.947 -0.57 . . . . 5.44 110.704 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.3 t 36.09 -90.06 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.614 0.598 . . . . 4.61 112.614 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.11 -58.74 7.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.868 0.366 . . . . 4.05 111.69 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.08 -22.15 10.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 5.46 111.526 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 47.5 t80 -93.25 -56.47 2.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 3.23 110.814 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.85 -37.23 86.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 3.35 111.119 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 57.4 mtpt -57.83 -23.6 53.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 3.93 111.274 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.66 39.49 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.428 -0.351 . . . . 2.51 111.365 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 169' ' ' LEU . 59.8 t80 -135.32 -52.97 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.693 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.512 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 89.9 mt -55.63 -46.72 99.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.04 111.521 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 69.7 Cg_endo -76.1 -30.14 5.93 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.935 1.756 . . . . 1.28 112.012 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 67.3 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 1.39 110.859 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 69.7 mt -55.11 -52.11 64.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.07 110.747 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.61 -47.85 83.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 1.12 110.738 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.43 -46.34 80.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.64 110.756 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.5 m -57.5 -49.14 77.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.42 110.574 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 40.4 m80 -58.32 -46.09 86.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.53 110.429 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.53 -45.53 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.541 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.11 -45.57 92.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.708 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.62 -52.53 61.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 0.21 110.458 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.407 ' O ' HG12 ' A' ' 181' ' ' ILE . 66.9 mt -60.53 -42.36 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.054 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.6 -46.76 65.52 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.61 -0.805 . . . . 0.23 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.73 -47.37 80.16 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.69 -0.485 . . . . 0.36 109.69 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -46.09 92.1 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.594 -0.812 . . . . 0.28 111.84 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.434 HD13 ' O ' ' B' ' 180' ' ' GLY . 50.2 mm -61.81 -46.41 96.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.963 0.411 . . . . 0.9 110.663 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.46 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 90.2 t80 -52.22 -46.53 65.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 1.44 110.644 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.94 -43.95 98.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.8 110.875 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.66 -47.59 89.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.55 112.584 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -62.58 -22.84 66.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 2.24 111.378 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.46 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 52.8 ptt85 -107.51 36.46 2.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 4.48 111.399 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.65 -63.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 1.21 110.84 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.211 -0.9 . . . . 2.72 111.476 179.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.503 -0.239 . . . . 7.87 112.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.89 170.89 14.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 6.96 112.491 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.12 -63.07 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 7.93 111.067 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.455 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 86.3 m-85 -76.27 -63.56 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 6.69 110.997 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 63.4 m 47.95 -90.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 6.01 111.254 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.07 -55.53 31.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 4.95 111.214 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -48.95 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.11 110.746 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.455 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 46.3 t80 -56.58 -53.93 51.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 3.68 111.181 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 158' ' ' SER . 35.8 mt -61.85 -34.85 76.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 3.64 110.742 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -55.54 -26.18 41.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 4.17 110.696 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.96 36.79 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 2.98 111.113 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -123.14 -56.2 1.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 2.32 110.768 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.2 mt -62.27 -45.86 90.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 2.18 111.665 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 87.2 Cg_endo -79.83 8.18 4.17 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.269 1.979 . . . . 1.36 113.139 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.1 m -96.54 -41.86 8.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 1.54 110.861 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 84.1 mt -61.88 -48.06 82.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.313 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.8 mp -56.28 -51.32 68.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.33 . . . . 0.93 111.141 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.44 -41.74 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.74 111.036 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.5 m -58.52 -46.97 85.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.4 111.109 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 68.0 m80 -58.48 -52.09 67.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.36 111.078 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 74.9 mt -55.13 -51.09 67.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.386 -0.37 . . . . 0.48 110.874 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.38 111.016 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.31 48.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.26 111.109 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -60.79 -44.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.29 110.651 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.51 95.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.181 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 83.4 mt -57.87 -49.76 75.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 0.34 110.466 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.35 -49.97 49.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.34 112.279 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.84 -44.23 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.977 0.418 . . . . 0.67 110.792 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' B' ' 185' ' ' ARG . 58.3 t80 -60.16 -51.06 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 1.56 110.987 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 60.0 mt -61.21 -41.59 90.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.83 111.08 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.62 95.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.844 -0.693 . . . . 0.69 113.041 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 4.9 ptp180 -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.497 0.189 . . . . 2.56 111.499 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 6.6 ptp180 -69.15 -37.64 78.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 3.82 111.111 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.28 -44.71 51.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.72 111.257 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.241 -0.885 . . . . 2.17 111.231 -179.825 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.403 -0.279 . . . . 7.13 112.403 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.46 169.07 42.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.741 -0.743 . . . . 6.07 112.52 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.84 -63.67 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.73 0.3 . . . . 7.47 111.18 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 159' ' ' ALA . 96.1 m-85 -77.13 -75.28 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 5.44 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.2 t 46.62 -88.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 4.61 112.064 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.98 -55.83 29.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 4.05 111.784 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -36.03 70.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.898 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.527 ' CZ ' ' CD2' ' A' ' 165' ' ' PHE . 90.6 t80 -81.4 -45.09 16.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.818 0.342 . . . . 3.23 111.713 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 68.4 mt -63.09 -41.55 99.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 3.35 111.707 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG3' HG13 ' A' ' 164' ' ' VAL . 18.0 ptpt -56.3 -20.67 19.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.567 -0.288 . . . . 3.93 111.437 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 163' ' ' LYS . 16.0 m -128.85 34.17 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 2.51 111.335 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.527 ' CD2' ' CZ ' ' A' ' 161' ' ' PHE . 54.9 t80 -136.74 -56.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 55.7 mt -57.76 -58.9 15.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 2.04 111.427 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 9.7 Cg_endo -52.09 -23.79 18.22 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.213 1.942 . . . . 1.28 112.183 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -72.25 -41.66 66.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.82 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.5 mt -55.77 -41.66 74.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 1.07 110.755 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.2 mp -59.91 -50.38 74.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 1.12 110.669 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.64 110.819 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 44.7 m -58.17 -46.22 86.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.42 111.019 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -60.41 -51.47 69.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.919 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.4 mt -58.03 -49.6 76.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.42 110.83 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.8 mt -57.72 -42.49 83.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.46 110.713 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.18 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.21 110.814 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 56.9 mt -55.7 -44.16 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.47 110.662 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.48 -47.33 84.38 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.677 -0.773 . . . . 0.23 112.027 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -54.4 -47.98 72.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.829 0.347 . . . . 0.36 110.467 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.78 -44.31 80.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.293 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.0 mm -60.03 -48.64 87.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.9 111.043 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.42 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.3 t80 -54.22 -44.67 71.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 1.44 111.146 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.78 -52.36 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.8 111.365 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.72 -51.53 55.2 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.053 -0.594 . . . . 0.55 113.3 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.43 -17.02 17.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.775 0.287 . . . . 2.24 111.775 -179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -113.02 50.5 0.88 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.034 0.445 . . . . 4.48 111.128 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.5 mt -108.72 -58.7 1.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 1.21 110.916 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.228 -0.892 . . . . 2.72 110.998 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.435 -0.266 . . . . 7.87 112.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -144.93 -162.1 9.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.698 -0.763 . . . . 6.96 112.586 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.6 mt -70.87 -51.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 7.93 111.083 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -75.6 -78.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 6.69 110.734 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 62.2 m 67.07 -75.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 6.01 111.462 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.37 -59.88 4.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.058 0.392 . . . . 4.95 112.058 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.08 -33.18 64.82 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.283 0.475 . . . . 5.11 112.283 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' B' ' 165' ' ' PHE . 65.8 t80 -86.95 -45.73 10.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.767 0.318 . . . . 3.68 111.707 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.421 ' CG ' ' O ' ' B' ' 158' ' ' SER . 42.9 mt -61.57 -38.48 87.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 3.64 111.474 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -56.67 -20.27 20.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.329 . . . . 4.17 111.411 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.15 42.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 2.98 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.442 ' CD2' ' CZ ' ' B' ' 161' ' ' PHE . 53.9 t80 -146.86 -45.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 2.32 110.841 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 62.1 mt -64.71 -44.1 72.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 2.18 111.538 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 29.2 Cg_exo -62.2 -39.35 48.95 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.298 1.999 . . . . 1.36 112.441 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.6 t -51.03 -46.28 61.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.424 . . . . 1.54 111.228 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 73.3 mt -55.39 -51.85 65.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.86 111.042 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.478 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -62.02 -49.24 76.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.794 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.58 -42.28 98.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.74 110.889 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.4 m -53.78 -52.2 61.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.4 110.974 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 51.0 m80 -57.97 -51.88 67.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.36 111.068 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.69 -49.18 75.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.963 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.09 -42.64 99.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.38 111.221 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -52.71 52.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.26 110.934 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.28 -42.27 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.638 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.57 -44.35 96.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.107 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.46 -49.13 75.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.34 110.471 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.4 -46.48 80.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.484 -0.865 . . . . 0.34 112.336 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.19 -47.12 93.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.67 111.085 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -53.48 -46.04 69.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.56 110.988 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.75 -49.23 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.83 111.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.31 -52.55 52.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.803 -0.713 . . . . 0.69 113.243 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -62.46 -38.67 90.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.675 0.274 . . . . 2.56 111.38 -179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 29.0 mmt180 -60.36 -38.01 82.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 3.82 111.108 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 97.0 mt -68.24 -54.89 14.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.72 110.951 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.283 -0.865 . . . . 2.17 111.152 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 N-CA-C 112.457 -0.257 . . . . 7.13 112.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.19 176.22 43.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 6.07 112.33 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.82 0.343 . . . . 7.47 110.953 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' ALA . 56.8 m-85 -77.67 -39.8 43.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 5.44 111.154 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 65.2 m 44.38 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.018 -0.537 . . . . 4.61 111.655 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -60.2 -51.76 68.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 4.05 111.583 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 1.5 mp0 -57.88 -30.09 65.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 5.46 111.705 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -88.65 -50.05 6.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.23 111.213 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.26 -42.11 96.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.964 -0.562 . . . . 3.35 111.839 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.536 ' HG3' HG13 ' A' ' 164' ' ' VAL . 12.7 ptmm? -57.92 -18.17 21.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.688 -0.233 . . . . 3.93 111.348 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG13 ' HG3' ' A' ' 163' ' ' LYS . 31.8 m -126.47 22.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.745 0.307 . . . . 2.51 111.095 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -102.5 -64.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 2.08 111.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 87.3 mt -49.6 -43.61 73.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 2.04 111.65 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 22.0 Cg_exo -64.86 -40.96 19.43 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.308 2.005 . . . . 1.28 111.786 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.6 t -57.7 -41.47 81.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 1.39 110.507 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 85.4 mt -51.54 -47.13 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.07 110.698 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -57.57 -46.95 83.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 1.12 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.35 -48.46 79.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.64 110.483 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.0 m -53.18 -46.99 69.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.42 110.826 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 42.4 m80 -56.24 -52.04 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.383 -0.371 . . . . 0.53 110.681 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 70.3 mt -59.07 -49.47 77.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.42 110.625 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.96 -44.94 67.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.46 110.406 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.53 -51.33 67.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.606 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.1 mm -52.03 -45.66 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.47 110.494 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.7 89.29 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.563 -0.827 . . . . 0.23 111.869 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 56.5 mt -55.42 -50.83 68.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.36 110.248 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.3 -45.72 64.54 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.028 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.42 HD13 ' O ' ' B' ' 180' ' ' GLY . 39.3 mm -61.17 -42.03 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 0.9 110.914 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 54.9 t80 -59.88 -46.55 88.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 1.44 110.976 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.1 mt -62.18 -43.42 97.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.8 111.315 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.2 -46.89 93.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.769 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 8.5 ptp180 -62.13 -16.59 53.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.604 0.224 . . . . 2.24 111.604 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -114.83 42.8 2.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.643 0.259 . . . . 4.48 111.176 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 79.0 mt -98.02 -57.78 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.342 . . . . 1.21 110.994 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.255 -0.878 . . . . 2.72 111.11 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.409 -0.277 . . . . 7.87 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.2 -163.13 9.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.638 -0.791 . . . . 6.96 112.536 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.11 -55.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.886 0.374 . . . . 7.93 111.151 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.442 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 70.0 m-85 -76.19 -61.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.066 -0.515 . . . . 6.69 110.856 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.406 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 57.8 p 46.05 -90.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.974 -0.557 . . . . 6.01 111.408 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.76 -53.84 51.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 4.95 111.059 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -59.28 -52.36 65.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 5.11 111.429 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' B' ' 165' ' ' PHE . 88.7 t80 -48.96 -53.2 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 3.68 111.51 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 158' ' ' SER . 32.2 mt -60.43 -36.92 79.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.766 0.317 . . . . 3.64 110.873 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.74 -28.13 54.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 4.17 111.033 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.32 32.46 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 2.98 111.527 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.445 ' CD1' ' CZ ' ' B' ' 161' ' ' PHE . 30.6 t80 -110.88 -59.62 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 2.32 110.723 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 96.3 mt -49.49 -48.33 75.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.18 111.396 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 65.2 Cg_endo -74.85 -28.33 9.54 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.002 1.801 . . . . 1.36 112.05 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 45.7 t -64.25 -42.17 96.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 1.54 110.459 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -54.31 -41.46 69.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' B' ' 167' ' ' PRO . 7.7 mp -56.23 -49.62 73.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.93 110.431 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.74 110.589 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 m -53.21 -50.02 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.4 110.492 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -58.87 -48.76 80.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.484 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.76 -48.49 79.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 110.461 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -58.15 -45.07 88.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.38 110.394 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.72 -51.7 59.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.26 110.576 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 65.3 mt -53.21 -43.87 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.29 110.408 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.99 95.13 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.26 111.625 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 77.1 mt -54.21 -50.69 66.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.34 110.057 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -56.35 -45.94 87.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.592 -0.813 . . . . 0.34 112.262 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.78 -48.93 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.67 111.083 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.524 ' CE2' ' CZ ' ' B' ' 186' ' ' ARG . 87.1 t80 -52.28 -48.51 65.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 1.56 110.853 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.94 -50.51 77.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.09 -0.505 . . . . 0.83 111.607 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . 0.467 ' O ' HG22 ' B' ' 188' ' ' THR . . . -62.23 -52.95 46.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.093 -0.575 . . . . 0.69 113.683 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -51.85 -23.92 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.875 0.338 . . . . 2.56 111.004 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.524 ' CZ ' ' CE2' ' B' ' 182' ' ' TYR . 77.6 mtm180 -85.58 -25.69 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 3.82 110.881 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.95 -42.51 12.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 1.72 110.994 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.61 HG23 ' OXT' ' B' ' 188' ' ' THR . 7.3 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.139 -0.934 . . . . 2.17 111.132 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.601 -0.2 . . . . 7.13 112.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.98 165.1 24.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 6.07 112.339 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.81 -64.09 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.942 0.401 . . . . 7.47 111.032 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.58 -74.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 5.44 110.566 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.3 t 60.9 -84.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 4.61 111.551 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.85 -53.98 52.03 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.123 0.416 . . . . 4.05 112.123 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.08 -29.96 61.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.455 -0.339 . . . . 5.46 111.734 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -90.01 -45.47 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 3.23 111.375 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.19 -34.26 77.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.145 -0.479 . . . . 3.35 111.626 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -57.02 -23.77 48.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 3.93 111.132 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.64 42.07 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.398 . . . . 2.51 111.286 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -131.63 -52.76 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.247 -0.433 . . . . 2.08 111.013 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 67.7 mt -54.74 -44.35 99.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.414 -0.357 . . . . 2.04 111.383 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -67.54 -39.02 13.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.327 2.018 . . . . 1.28 112.249 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.9 m -56.37 -42.17 77.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 1.39 111.108 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 54.0 mt -54.27 -51.43 64.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 111.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.78 -50.04 75.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 1.12 110.925 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.54 -42.16 82.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.64 110.659 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -59.79 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 45.0 m80 -55.43 -51.84 65.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.361 . . . . 0.53 110.767 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.96 -51.84 64.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 0.42 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.2 mt -56.88 -43.7 81.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.46 110.803 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.56 -51.68 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.21 110.716 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.63 -41.74 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.455 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.27 99.39 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.663 -0.78 . . . . 0.23 112.105 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 53.5 mt -55.22 -50.0 70.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.89 0.376 . . . . 0.36 110.645 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.461 ' CA ' HG13 ' B' ' 181' ' ' ILE . . . -56.96 -52.01 53.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.63 -0.795 . . . . 0.28 112.379 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.411 HG13 ' CA ' ' B' ' 180' ' ' GLY . 61.0 mt -62.35 -43.57 98.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 0.9 111.164 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.413 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 67.9 t80 -54.93 -52.39 63.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.318 -0.401 . . . . 1.44 110.798 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.7 mt -63.16 -48.25 88.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.8 111.067 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.26 -52.31 50.48 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.242 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -59.25 -17.83 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.592 0.234 . . . . 2.24 111.439 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -114.01 44.32 1.68 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 4.48 111.306 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.0 mt -84.97 -28.34 25.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.21 110.764 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.216 -0.897 . . . . 2.72 111.097 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.53 -0.228 . . . . 7.87 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . 0.402 ' CA ' HD11 ' B' ' 162' ' ' LEU . . . -103.69 -152.49 23.0 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.652 -0.785 . . . . 6.96 112.153 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.27 -50.42 76.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.177 -0.675 . . . . 7.93 109.177 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -67.68 0.68 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.479 -0.782 . . . . 6.69 109.422 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 m -168.85 177.39 5.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.334 -0.848 . . . . 6.01 110.233 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.8 66.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.401 . . . . 4.95 110.73 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.403 ' O ' HG22 ' B' ' 164' ' ' VAL . 11.4 mm-40 -55.37 -60.53 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.975 -0.557 . . . . 5.11 111.536 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -43.97 -51.48 7.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 3.68 111.814 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.402 HD11 ' CA ' ' B' ' 155' ' ' GLY . 68.0 mt -63.9 -46.25 85.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.372 -0.376 . . . . 3.64 111.604 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -57.19 -23.31 46.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.377 . . . . 4.17 111.758 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 160' ' ' GLU . 32.6 m -121.69 40.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.682 0.277 . . . . 2.98 111.237 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -146.71 -45.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 2.32 111.28 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.508 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.9 mt -64.39 -43.55 72.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 2.18 111.834 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 37.4 Cg_exo -61.14 -37.89 71.33 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.301 2.0 . . . . 1.36 112.502 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.6 m -58.73 -42.29 88.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.54 111.13 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 98.0 mt -52.38 -49.69 63.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.86 111.131 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.2 mp -61.93 -51.97 65.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.93 111.139 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.87 -43.65 86.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.405 . . . . 0.74 110.98 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.3 m -57.44 -48.62 78.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.4 111.023 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -60.08 -51.96 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.941 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 95.6 mt -52.84 -51.94 59.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.416 . . . . 0.48 110.805 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.14 -47.53 84.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.38 110.972 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.02 -52.55 50.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.26 110.865 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.03 -41.82 90.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.29 110.48 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.94 -46.26 94.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.797 -0.716 . . . . 0.26 111.853 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 90.9 mt -54.31 -47.99 71.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.34 110.403 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' A' ' 181' ' ' ILE . . . -56.2 -48.7 72.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.522 -0.847 . . . . 0.34 112.233 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 180' ' ' GLY . 68.2 mt -58.24 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.67 110.904 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' B' ' 185' ' ' ARG . 64.2 t80 -51.34 -46.41 62.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 1.56 110.663 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.19 -50.84 78.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 0.83 110.801 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.49 -52.16 53.43 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.69 112.47 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 11.8 ptp180 -56.35 -34.98 67.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.912 0.387 . . . . 2.56 110.723 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.43 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 50.4 ttp180 -67.23 -25.23 65.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.942 -0.572 . . . . 3.82 110.885 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.35 -42.76 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 1.72 110.89 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.429 -0.795 . . . . 2.17 111.287 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.385 -0.286 . . . . 7.13 112.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.65 179.24 38.6 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.728 -0.748 . . . . 6.07 112.458 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.9 mm -69.15 -31.14 48.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 7.47 110.727 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.4 m-85 -76.71 -63.76 1.27 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.875 -0.602 . . . . 5.44 110.457 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 28.8 t 50.77 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.623 . . . . 4.61 111.609 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -49.91 -59.54 3.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.649 0.261 . . . . 4.05 111.468 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' HA ' ' CD ' ' A' ' 163' ' ' LYS . 36.6 tt0 -56.73 -19.79 18.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.554 -0.294 . . . . 5.46 111.079 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -85.19 -45.44 12.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 3.23 110.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 158' ' ' SER . 10.9 mt -63.29 -39.73 95.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.434 -0.348 . . . . 3.35 111.077 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 160' ' ' GLU . 17.8 ptpt -56.79 -21.8 31.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.93 111.33 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.23 34.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 2.51 111.16 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -139.59 -45.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 2.08 110.885 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 87.5 mt -65.73 -47.36 66.17 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 2.04 111.553 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 70.2 Cg_endo -76.59 -10.38 18.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.111 1.874 . . . . 1.28 112.739 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 85.9 p -81.32 -41.7 21.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.292 . . . . 1.39 110.692 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.2 mt -56.51 -49.19 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 1.07 111.125 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -58.73 -48.4 81.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.424 -0.353 . . . . 1.12 110.764 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.64 110.609 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 57.9 m -53.75 -52.1 61.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.141 -0.481 . . . . 0.42 110.758 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -52.45 -48.01 66.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.53 110.635 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.34 -47.7 84.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.42 110.534 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.19 -43.88 83.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.032 -0.531 . . . . 0.46 110.709 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.85 -52.28 63.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.134 0.493 . . . . 0.21 110.444 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.8 mt -56.44 -41.93 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.884 -0.598 . . . . 0.47 109.979 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.72 -45.82 68.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.23 111.666 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 183' ' ' ILE . 65.7 mt -56.73 -51.51 68.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.422 . . . . 0.36 109.886 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.76 -43.4 60.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.506 -0.854 . . . . 0.28 111.625 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.595 HD13 ' O ' ' B' ' 180' ' ' GLY . 25.1 mm -62.02 -41.79 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.022 0.439 . . . . 0.9 110.433 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.411 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 78.0 t80 -52.29 -49.81 63.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.826 -0.625 . . . . 1.44 110.675 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 183' ' ' ILE . 3.5 mp -62.44 -43.89 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.8 110.489 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.43 -50.8 61.32 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.796 -0.716 . . . . 0.55 112.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 13.7 ptm180 -54.26 -27.92 38.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.624 0.249 . . . . 2.24 111.283 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.48 36.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 4.48 111.028 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 54.0 mt -92.02 -45.52 8.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.257 -0.429 . . . . 1.21 111.081 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.261 -0.876 . . . . 2.72 111.234 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.419 -0.272 . . . . 7.87 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.33 -174.82 7.33 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.685 -0.769 . . . . 6.96 112.388 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 57.6 mt -71.03 -53.56 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.38 . . . . 7.93 111.034 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.0 m-85 -76.38 -64.14 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 6.69 110.892 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 71.3 m 40.92 -92.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.161 -0.472 . . . . 6.01 111.562 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -59.32 -54.19 49.67 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.939 0.4 . . . . 4.95 111.081 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -56.32 -28.61 59.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 5.11 111.057 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -73.33 -54.96 7.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 3.68 111.102 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.34 -33.48 73.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.933 0.397 . . . . 3.64 110.562 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -56.96 -29.5 63.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.993 -0.548 . . . . 4.17 110.823 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.22 33.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 2.98 111.321 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -135.95 -58.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 2.32 110.969 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.5 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 80.4 mt -58.34 -43.59 98.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 2.18 111.699 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 11.2 Cg_exo -71.37 -26.98 19.93 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.43 2.086 . . . . 1.36 112.213 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 50.4 m -63.17 -44.54 95.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.905 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.423 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 95.6 mt -53.92 -48.2 70.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 0.86 111.213 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.469 ' N ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -61.2 -51.56 68.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.93 111.23 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.74 -46.22 81.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.425 -0.352 . . . . 0.74 111.186 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.3 m -55.09 -49.76 70.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.409 . . . . 0.4 111.08 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.423 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 41.7 m80 -55.43 -51.69 66.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.36 111.083 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 55.0 mt -51.84 -51.81 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.48 110.932 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.34 -41.74 97.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.941 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.31 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.26 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -59.86 -43.08 91.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.778 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.79 86.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.26 112.039 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 96.1 mt -57.09 -46.82 82.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.34 110.403 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -52.59 -48.83 54.88 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.558 -0.83 . . . . 0.34 112.111 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 50.3 mt -57.91 -45.19 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.348 . . . . 0.67 111.116 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -54.88 -45.54 74.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.56 110.987 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 73.7 mt -62.64 -52.13 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.83 110.987 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.44 -51.74 54.14 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.69 112.91 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -21.75 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.661 0.267 . . . . 2.56 111.132 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -82.86 -49.59 9.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.802 0.334 . . . . 3.82 110.883 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.27 -32.96 70.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.436 . . . . 1.72 111.004 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.892 . . . . 2.17 111.174 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.503 -0.239 . . . . 7.13 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.16 153.77 24.77 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.753 . . . . 6.07 112.545 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.75 -57.61 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 7.47 110.98 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 159' ' ' ALA . 74.4 m-85 -76.54 -58.09 3.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 5.44 110.901 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.8 t 52.95 -86.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 4.61 111.267 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -59.18 -58.78 7.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.645 0.259 . . . . 4.05 111.54 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.82 -25.69 56.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.246 -0.433 . . . . 5.46 111.811 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -88.92 -52.06 5.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 3.23 111.533 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 158' ' ' SER . 89.4 mt -61.83 -36.75 82.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 3.35 111.803 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HG3' HG13 ' A' ' 164' ' ' VAL . 18.1 ptpt -56.37 -28.82 60.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 3.93 111.212 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HG3' ' A' ' 163' ' ' LYS . 13.2 m -116.89 23.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 2.51 111.279 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -132.75 -43.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 2.08 110.776 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 79.3 mt -65.25 -57.28 15.63 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 2.04 111.484 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 25.9 Cg_endo -61.86 -30.99 84.88 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.99 1.793 . . . . 1.28 112.088 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 53.4 m -57.13 -41.95 80.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 1.39 110.931 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.7 mt -61.67 -46.5 89.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.935 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.3 mp -61.87 -47.91 82.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 1.12 111.074 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.53 -43.66 93.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.64 111.077 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 53.8 m -56.82 -52.09 66.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.42 110.888 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 44.0 m80 -56.49 -50.97 70.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.53 110.984 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.7 mt -56.96 -45.7 82.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.42 110.745 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 179' ' ' LEU . 94.9 mt -61.53 -46.29 90.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.46 110.656 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -52.94 -52.55 57.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.037 0.446 . . . . 0.21 110.885 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.81 -44.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.47 110.369 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.02 -43.57 93.16 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.644 -0.789 . . . . 0.23 111.913 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 175' ' ' LEU . 90.7 mt -56.13 -48.67 75.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.913 0.387 . . . . 0.36 110.222 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -45.13 93.09 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.569 -0.824 . . . . 0.28 112.037 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.4 mm -62.15 -47.17 94.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.9 110.827 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 81.5 t80 -53.63 -48.55 69.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.44 110.986 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.6 mt -62.81 -43.82 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.8 111.475 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.34 -52.63 48.01 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 0.55 113.485 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 3.3 ptp85 -56.75 -31.87 65.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.279 . . . . 2.24 111.309 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -93.29 28.63 2.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.403 -0.362 . . . . 4.48 111.413 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 187' ' ' LEU . 10.1 mt -60.95 -40.26 92.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 1.21 110.748 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 2.72 111.533 179.727 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.526 -0.23 . . . . 7.87 112.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -107.37 -179.17 22.45 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 6.96 112.491 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.54 -66.3 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.073 0.463 . . . . 7.93 111.012 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' B' ' 159' ' ' ALA . 81.5 m-85 -77.94 -59.0 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 6.69 111.103 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p 44.26 -91.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.13 -0.487 . . . . 6.01 111.25 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -60.68 -53.15 60.87 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.907 0.384 . . . . 4.95 110.945 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.26 -19.38 33.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 5.11 111.394 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -81.77 -36.37 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 3.68 111.319 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -47.1 84.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 3.64 111.04 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -55.78 -24.39 35.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 4.17 110.933 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.97 31.28 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 2.98 110.819 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -137.0 -43.39 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 2.32 111.241 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 87.5 mt -64.99 -43.84 69.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.345 -0.389 . . . . 2.18 111.77 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 16.8 Cg_exo -67.26 -39.8 12.39 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.417 2.078 . . . . 1.36 112.548 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.8 m -51.23 -41.99 60.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 1.54 111.164 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -46.7 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.86 111.161 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.411 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -60.03 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.93 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.17 -41.97 69.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.985 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.7 m -58.03 -51.86 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.801 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.7 m80 -52.1 -47.57 65.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.846 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 87.0 mt -58.89 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.11 -0.496 . . . . 0.48 110.849 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 83.1 mt -58.67 -43.12 89.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 0.38 110.885 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -53.71 -52.58 59.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.924 0.392 . . . . 0.26 110.958 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 36.6 mt -56.44 -44.38 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.29 110.544 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.12 -46.18 70.99 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.585 -0.817 . . . . 0.26 111.945 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.1 -47.61 77.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.027 0.441 . . . . 0.34 110.141 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -55.45 -46.21 81.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.693 -0.765 . . . . 0.34 112.361 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.96 -47.64 89.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.67 110.853 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.65 -47.95 66.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.56 110.741 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.44 ' HA ' ' HG2' ' B' ' 186' ' ' ARG . 72.3 mt -59.08 -41.72 84.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.83 111.026 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.23 74.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.784 -0.722 . . . . 0.69 112.85 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 8.1 ptp180 -62.5 -39.43 93.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.934 0.346 . . . . 2.56 111.934 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' B' ' 183' ' ' ILE . 23.3 ptt180 -68.95 -26.88 65.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.681 0.277 . . . . 3.82 111.517 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.33 -29.46 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.852 0.358 . . . . 1.72 111.178 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.246 -0.883 . . . . 2.17 111.266 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 7.13 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.13 173.99 26.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 6.07 112.403 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.62 -58.97 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 7.47 110.94 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 158' ' ' SER . 75.9 m-85 -76.79 -84.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 5.44 110.908 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 23.3 t 71.44 -158.03 0.12 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.345 -0.389 . . . . 4.61 110.78 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.26 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.779 0.323 . . . . 4.05 110.973 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -57.14 -30.23 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 5.46 110.502 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -93.22 -30.32 15.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 3.23 110.748 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.01 -47.18 84.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 3.35 110.936 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG3' HG13 ' A' ' 164' ' ' VAL . 17.4 ptpt -55.19 -22.78 18.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 3.93 111.105 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.415 HG13 ' HG3' ' A' ' 163' ' ' LYS . 29.7 m -110.06 31.91 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 2.51 110.855 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -136.4 -62.23 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.487 . . . . 2.08 111.071 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 47.6 mt -53.96 -58.33 13.92 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 2.04 111.529 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 29.9 Cg_endo -62.93 -18.13 63.4 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.265 1.976 . . . . 1.28 112.501 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.8 m -74.65 -41.8 59.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 1.39 110.998 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.2 mt -58.57 -46.0 87.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.07 111.236 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 170' ' ' LEU . 6.7 mp -61.64 -52.04 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.12 111.124 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 89.8 mt -57.71 -47.28 82.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.64 111.112 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 48.9 m -57.78 -51.95 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.088 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 38.1 m80 -59.82 -51.55 69.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.53 111.138 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 72.7 mt -52.88 -51.68 60.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.894 0.378 . . . . 0.42 110.815 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -58.56 -42.13 87.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.46 110.825 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.98 -52.23 51.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.765 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.17 -41.77 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.256 -0.429 . . . . 0.47 110.384 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.75 -41.67 90.76 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.188 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 61.1 mt -61.84 -51.59 67.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.848 0.356 . . . . 0.36 110.685 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.55 -51.68 36.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.669 -0.777 . . . . 0.28 112.39 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.01 -41.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.9 110.722 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 70.2 t80 -53.51 -42.3 67.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 1.44 110.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.9 mm -62.88 -47.74 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.8 110.559 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.6 -52.49 48.41 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 115.722 -0.672 . . . . 0.55 113.335 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -58.33 -26.11 62.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 2.24 110.853 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.42 ' NH1' ' HD3' ' A' ' 185' ' ' ARG . 83.3 mmt-85 -103.69 38.61 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 4.48 111.016 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 18.9 mt -74.76 -27.28 60.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.831 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.41 -0.805 . . . . 2.72 111.206 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.478 -0.249 . . . . 7.87 112.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -160.74 -174.42 30.55 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.798 -0.715 . . . . 6.96 112.444 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 19.9 mt -70.62 -59.02 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 7.93 111.058 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' B' ' 159' ' ' ALA . 68.7 m-85 -76.47 -63.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 6.69 110.836 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' B' ' 162' ' ' LEU . 74.3 m 55.31 -85.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 6.01 111.416 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.51 -55.16 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 4.95 111.494 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.05 -46.9 82.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 5.11 111.613 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -72.71 -42.01 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.866 0.365 . . . . 3.68 111.548 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' B' ' 158' ' ' SER . 57.3 mt -63.37 -50.0 71.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 3.64 111.992 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.503 ' HG3' HG23 ' B' ' 164' ' ' VAL . 18.1 ptpt -56.97 -25.69 58.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.652 0.263 . . . . 4.17 111.078 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.603 ' O ' HG12 ' B' ' 164' ' ' VAL . 20.2 t -104.75 31.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.911 0.386 . . . . 2.98 111.076 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -148.18 -49.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.311 -0.404 . . . . 2.32 110.921 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 89.2 mt -55.56 -58.58 14.77 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.083 -0.508 . . . . 2.18 111.652 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 4.7 Cg_endo -47.63 -50.03 12.28 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.515 2.143 . . . . 1.36 112.85 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 93.4 p -48.03 -41.85 26.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.501 -0.318 . . . . 1.54 111.265 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.71 -48.66 79.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 0.86 111.062 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.474 HD12 ' N ' ' B' ' 170' ' ' LEU . 6.8 mp -62.34 -42.02 99.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.93 111.027 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.99 -49.55 75.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.74 110.995 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -56.76 -49.96 73.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.4 111.036 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -52.43 -50.63 62.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.36 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.97 -52.01 67.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.366 . . . . 0.48 110.788 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.5 mt -54.95 -42.84 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.944 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.66 -52.36 64.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.26 111.075 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.94 -42.12 85.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29 110.777 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.24 -45.57 92.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.612 -0.804 . . . . 0.26 111.916 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 99.2 mt -56.96 -48.47 78.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.34 110.438 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.17 -46.07 62.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.667 -0.778 . . . . 0.34 112.416 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.93 -50.16 81.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 0.67 110.832 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' B' ' 186' ' ' ARG . 19.2 t80 -51.44 -50.52 59.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 1.56 110.989 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.71 -48.94 85.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.83 111.065 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.24 -52.14 55.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.969 -0.634 . . . . 0.69 113.148 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.9 -29.08 69.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.764 0.282 . . . . 2.56 110.982 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 182' ' ' TYR . 2.4 mmp_? -69.1 -26.51 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.402 -0.363 . . . . 3.82 110.806 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 58.5 mt -102.14 -67.5 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 1.72 110.737 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.242 -0.885 . . . . 2.17 111.393 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.425 -0.27 . . . . 7.13 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.62 175.3 40.44 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 6.07 112.42 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.53 -53.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 7.47 110.889 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 86.2 m-85 -76.53 -71.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 5.44 110.515 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.0 m 56.17 -82.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 4.61 111.675 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -54.86 -66.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.324 . . . . 4.05 111.41 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 42.5 mt-10 -54.15 -49.63 68.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 5.46 111.318 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -59.81 -48.9 79.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.446 -0.343 . . . . 3.23 110.968 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 158' ' ' SER . 78.3 mt -62.73 -38.41 90.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 3.35 111.463 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.433 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 50.0 mtmt -56.89 -44.26 82.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.629 -0.26 . . . . 3.93 111.149 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.62 36.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.471 -0.332 . . . . 2.51 111.15 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' CE2' HD11 ' A' ' 169' ' ' LEU . 72.0 t80 -142.9 -60.66 0.43 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 2.08 111.044 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 65.4 mt -49.98 -59.01 7.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 2.04 111.438 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 18.7 Cg_endo -59.13 -28.08 86.78 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.38 2.053 . . . . 1.28 112.588 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.5 t -69.97 -41.62 74.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 1.39 110.973 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 165' ' ' PHE . 81.5 mt -57.64 -45.94 84.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 1.07 111.407 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.7 mp -56.78 -45.29 82.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 111.135 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.12 -46.09 90.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.64 111.204 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.453 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 40.6 m -62.37 -52.56 63.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.317 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -62.56 -52.24 64.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.364 -0.38 . . . . 0.53 111.272 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 71.5 mt -54.26 -51.62 63.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.42 110.898 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.4 -46.46 89.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.46 110.772 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' B' ' 177' ' ' ILE . . . -51.85 -52.35 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.352 -0.385 . . . . 0.21 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.57 -41.83 86.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.47 110.531 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.43 -42.98 94.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.624 -0.798 . . . . 0.23 112.066 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.27 -49.19 78.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.36 110.477 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.52 -49.46 45.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.28 112.267 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -58.36 -41.84 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.9 110.494 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 81.5 t80 -54.71 -43.57 72.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.932 -0.576 . . . . 1.44 110.662 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 7.5 mm -62.69 -48.84 86.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.8 111.141 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -60.4 -48.37 86.5 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.55 113.011 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 10.9 ptp180 -55.98 -30.9 62.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.24 111.06 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -101.15 44.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 4.48 111.443 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 78.6 mt -98.46 -25.78 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.21 110.841 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.214 -0.898 . . . . 2.72 111.134 179.911 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 7.87 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.22 -159.36 22.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 6.96 112.586 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . 0.617 HG22 ' CE2' ' B' ' 157' ' ' PHE . 22.0 mt -71.29 -35.97 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.062 0.458 . . . . 7.93 110.559 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.617 ' CE2' HG22 ' B' ' 156' ' ' ILE . 88.5 m-85 -157.85 -57.27 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 6.69 110.122 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 59.7 m 38.47 -90.75 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.792 -0.64 . . . . 6.01 112.366 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.24 -54.92 37.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.685 0.278 . . . . 4.95 111.614 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.76 -44.19 81.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 5.11 110.951 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 35.4 t80 -66.73 -55.86 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 3.68 110.767 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 158' ' ' SER . 52.3 mt -62.25 -30.06 70.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 3.64 110.598 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 159' ' ' ALA . 31.1 ttmt -58.34 -24.99 61.43 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.744 -0.662 . . . . 4.17 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.88 -22.09 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 2.98 111.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -85.98 -43.4 13.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.375 -0.375 . . . . 2.32 111.08 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 55.6 mt -47.69 -60.02 4.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 2.18 111.568 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 3.4 Cg_exo -40.43 -29.26 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.692 2.261 . . . . 1.36 112.462 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 61.9 m -77.18 -41.9 39.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 1.54 110.918 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.421 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.6 mt -61.48 -42.0 98.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.86 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -59.71 -51.61 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.93 111.05 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.63 -49.22 71.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.418 . . . . 0.74 110.801 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.4 m -55.33 -51.83 65.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.866 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 42.8 m80 -60.12 -50.73 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.885 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.0 -51.92 60.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.48 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.81 -42.03 92.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.38 110.742 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.2 59.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.26 110.604 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 176' ' ' ALA . 49.1 mt -58.65 -43.24 87.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.517 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.19 -49.61 70.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.771 -0.728 . . . . 0.26 112.269 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 63.5 mt -54.88 -44.21 73.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.819 0.342 . . . . 0.34 110.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.29 -42.99 93.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.627 -0.797 . . . . 0.34 112.19 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.53 -51.13 76.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.67 110.771 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 31.9 t80 -51.56 -50.59 59.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 1.56 110.691 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.77 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.371 -0.377 . . . . 0.83 111.018 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.33 -52.56 48.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.792 -0.718 . . . . 0.69 112.987 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -60.78 -24.31 65.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.801 0.334 . . . . 2.56 110.86 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -65.96 -38.12 87.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 3.82 110.608 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.79 -37.33 86.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.65 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.403 ' OXT' HG23 ' B' ' 188' ' ' THR . 1.6 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.205 -0.902 . . . . 2.17 111.236 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.582 -0.207 . . . . 7.13 112.582 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.74 163.84 12.07 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.824 -0.703 . . . . 6.07 112.669 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mm -70.57 -55.02 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 7.47 111.023 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 84.1 m-85 -76.25 -69.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 5.44 110.881 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.5 t 43.66 -90.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.14 -0.482 . . . . 4.61 111.561 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.13 -51.59 69.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.878 0.37 . . . . 4.05 111.148 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -54.89 -22.17 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 5.46 111.292 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -96.18 -50.44 4.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 3.23 111.15 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.21 -30.19 71.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 3.35 111.086 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -56.1 -44.29 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 3.93 110.888 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.34 43.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 2.51 111.233 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -142.47 -50.94 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 2.08 110.911 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 84.9 mt -57.76 -58.0 21.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 2.04 111.61 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 19.6 Cg_endo -58.61 -34.22 98.71 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.302 2.002 . . . . 1.28 112.653 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.0 m -59.16 -41.79 89.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.401 . . . . 1.39 110.939 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 84.7 mt -61.68 -44.3 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 1.07 111.414 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.6 mp -61.17 -50.54 72.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.457 -0.338 . . . . 1.12 111.148 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 75.6 mt -60.01 -48.18 82.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.64 111.342 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 58.6 m -58.48 -47.81 82.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.42 111.368 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 33.8 m170 -57.94 -52.08 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.447 -0.342 . . . . 0.53 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 80.2 mt -56.1 -50.54 70.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.42 111.079 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.7 mt -60.48 -45.36 94.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.46 111.259 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' B' ' 176' ' ' ALA . . . -51.61 -52.71 45.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.21 111.08 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.35 -42.65 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.016 0.436 . . . . 0.47 110.377 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.19 99.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.619 -0.8 . . . . 0.23 111.959 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.27 -48.11 71.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.972 0.415 . . . . 0.36 110.111 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' HA2' ' CD1' ' B' ' 181' ' ' ILE . . . -58.12 -47.95 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.675 -0.774 . . . . 0.28 112.494 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.09 -47.85 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.9 111.457 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.505 ' CE2' ' NH2' ' A' ' 186' ' ' ARG . 32.1 t80 -52.76 -50.85 62.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 1.44 110.91 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.97 -46.36 96.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.286 -0.415 . . . . 0.8 111.034 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.41 -52.2 50.92 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.083 -0.58 . . . . 0.55 113.532 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.24 -24.23 66.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.725 0.268 . . . . 2.24 111.725 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.505 ' NH2' ' CE2' ' A' ' 182' ' ' TYR . 42.9 mtm180 -104.58 26.93 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.659 0.266 . . . . 4.48 111.48 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 35.6 mt -64.22 -51.35 64.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.463 -0.335 . . . . 1.21 110.85 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.408 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.22 -0.895 . . . . 2.72 111.17 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 112.448 -0.261 . . . . 7.87 112.448 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.98 -164.87 29.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 6.96 112.533 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 32.2 mt -71.57 -62.09 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.867 0.365 . . . . 7.93 111.103 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' B' ' 159' ' ' ALA . 95.3 m-85 -76.5 -53.53 7.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 6.69 110.937 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 75.4 m 47.31 -90.35 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.991 -0.55 . . . . 6.01 111.168 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -58.42 -54.54 45.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.947 0.403 . . . . 4.95 111.04 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -58.89 -30.74 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.556 . . . . 5.11 111.11 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' B' ' 157' ' ' PHE . 38.7 t80 -64.91 -48.92 72.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 3.68 111.043 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.439 ' HA ' ' HB3' ' B' ' 165' ' ' PHE . 13.8 mt -61.77 -35.67 78.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 3.64 110.949 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -57.83 -37.67 74.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.465 . . . . 4.17 111.063 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.55 16.99 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.277 -0.419 . . . . 2.98 111.699 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 162' ' ' LEU . 79.4 t80 -107.61 -38.49 5.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 2.32 110.719 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 96.2 mt -70.76 -43.67 15.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 2.18 111.332 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 19.5 Cg_exo -66.3 -36.58 27.28 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.327 2.018 . . . . 1.36 111.951 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 79.7 p -54.53 -43.57 72.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.54 110.746 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 83.1 mt -53.65 -51.61 62.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.86 110.652 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -58.49 -47.75 83.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.93 110.643 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.51 -42.61 96.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.74 110.718 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -52.71 -50.67 62.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.4 111.037 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -61.7 -52.42 64.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.31 -0.405 . . . . 0.36 111.278 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.6 mt -60.84 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.48 111.264 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 84.4 mt -56.76 -51.02 70.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.38 111.244 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 176' ' ' ALA . . . -51.43 -52.93 41.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.26 110.976 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.427 HG13 ' HB1' ' A' ' 176' ' ' ALA . 43.6 mt -62.3 -45.13 99.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.29 110.313 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.16 -46.46 93.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.06 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 90.1 mt -52.66 -48.5 66.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.903 0.382 . . . . 0.34 110.519 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.65 92.64 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.773 . . . . 0.34 112.493 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.448 ' CD1' ' HA2' ' A' ' 180' ' ' GLY . 50.5 mm -59.48 -42.44 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.67 111.107 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.97 -49.81 74.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 1.56 111.081 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.3 -45.84 97.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.83 111.106 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.22 -50.94 60.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.824 -0.703 . . . . 0.69 112.899 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -59.35 -26.57 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 2.56 111.103 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -91.46 -33.19 15.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 3.82 110.959 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 81.7 mt -110.99 31.95 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 1.72 110.761 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.28 -0.866 . . . . 2.17 111.209 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.511 -0.236 . . . . 7.13 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 165.08 164.84 21.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.743 -0.741 . . . . 6.07 112.529 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.1 mm -71.63 -47.7 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 7.47 111.084 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.8 m-85 -75.96 -73.25 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.953 -0.567 . . . . 5.44 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.4 t 43.01 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.226 -0.443 . . . . 4.61 111.765 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.24 -56.64 18.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.639 0.257 . . . . 4.05 111.638 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 43.7 tt0 -56.87 -19.06 15.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.497 -0.319 . . . . 5.46 111.646 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -95.26 -50.51 5.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 3.23 111.178 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.51 -36.43 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 3.35 111.556 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 17.1 ptpt -56.38 -27.87 57.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.522 -0.308 . . . . 3.93 111.294 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 163' ' ' LYS . 6.2 m -110.35 32.22 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 2.51 111.217 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 169' ' ' LEU . 68.8 t80 -148.57 -45.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.08 110.901 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 73.9 mt -50.34 -59.36 7.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 2.04 111.438 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.4 Cg_endo -43.17 -44.08 9.9 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.481 2.121 . . . . 1.28 112.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 59.1 m -58.6 -41.43 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 1.39 110.633 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 165' ' ' PHE . 35.7 mt -59.85 -43.35 94.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 1.07 110.829 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.0 mp -62.44 -51.21 68.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 1.12 110.681 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 94.7 mt -51.95 -45.31 64.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.64 110.717 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.507 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 46.0 m -60.64 -46.32 90.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.42 110.672 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -62.2 -51.77 66.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.53 110.752 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -55.26 -49.97 70.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.486 . . . . 0.42 110.737 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 171' ' ' LEU . 95.5 mt -58.82 -47.69 83.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.46 110.905 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -52.56 50.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.985 0.421 . . . . 0.21 110.791 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.0 mt -58.18 -42.4 83.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.47 109.923 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.64 -42.02 83.63 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.51 -0.852 . . . . 0.23 111.473 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.6 -52.07 66.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 0.36 109.942 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.61 -44.78 68.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.599 -0.81 . . . . 0.28 112.17 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 51.0 mm -62.15 -48.76 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.9 110.912 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 70.1 t80 -55.6 -51.13 68.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 1.44 110.867 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.89 -41.9 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.295 -0.412 . . . . 0.8 111.055 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.11 -50.1 68.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.55 112.477 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 6.4 ptp180 -62.06 -18.13 59.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.565 0.221 . . . . 2.24 111.397 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.415 ' NE ' ' CE2' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -125.7 53.4 1.57 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.767 0.317 . . . . 4.48 111.109 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -49.33 8.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 1.21 110.588 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 188' ' ' THR . 2.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.367 -0.825 . . . . 2.72 111.228 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.512 -0.235 . . . . 7.87 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.94 -171.28 37.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 6.96 112.364 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 53.5 mt -71.99 -56.86 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.769 0.319 . . . . 7.93 111.28 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.14 -79.25 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.272 -0.422 . . . . 6.69 111.191 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' B' ' 159' ' ' ALA . 69.7 m 61.06 134.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 6.01 111.423 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' B' ' 158' ' ' SER . . . 89.81 -63.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.728 -0.669 . . . . 4.95 110.692 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -58.97 -57.51 12.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.802 -0.635 . . . . 5.11 110.914 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.37 -38.03 81.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 3.68 110.827 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' B' ' 166' ' ' LEU . 77.4 mt -63.47 -38.65 91.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 3.64 111.08 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -56.83 -24.18 49.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.379 . . . . 4.17 110.953 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.66 29.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 2.98 111.108 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -145.65 -50.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 2.32 111.045 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.475 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 63.3 mt -55.4 -46.88 99.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.29 -0.414 . . . . 2.18 111.435 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 98.2 Cg_exo -42.85 -52.05 4.92 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.311 2.008 . . . . 1.36 112.297 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -55.95 -43.57 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 1.54 110.727 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 55.8 mt -57.22 -51.23 70.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.86 111.1 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.43 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -59.92 -46.58 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.93 110.865 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.86 -43.58 98.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.74 110.787 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.8 m -53.59 -46.99 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.044 -0.526 . . . . 0.4 110.894 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 37.9 m80 -61.66 -52.15 65.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.36 110.993 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 73.9 mt -54.61 -51.2 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.933 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.47 -43.34 88.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.38 110.893 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.33 62.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.26 110.923 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 53.1 mt -54.57 -44.78 70.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.748 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.71 -48.23 72.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.805 -0.712 . . . . 0.26 112.439 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 87.8 mt -55.7 -47.92 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.34 110.651 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.06 -45.74 92.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.816 -0.707 . . . . 0.34 112.482 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.02 -51.05 77.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 0.67 111.137 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -52.09 -49.64 63.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 1.56 111.056 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 60.1 mt -62.28 -47.16 94.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.412 . . . . 0.83 110.978 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.77 -52.68 46.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.499 -0.858 . . . . 0.69 112.647 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -63.18 -38.46 91.25 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.854 0.316 . . . . 2.56 111.854 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' B' ' 183' ' ' ILE . 7.2 ptm180 -70.78 -29.78 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.738 0.304 . . . . 3.82 111.075 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 76.0 mt -83.1 -35.61 25.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 1.72 110.829 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.246 -0.883 . . . . 2.17 111.064 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.547 -0.221 . . . . 7.13 112.547 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -58.45 151.74 31.56 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.646 -0.788 . . . . 6.07 112.583 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.73 -66.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 7.47 110.899 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 159' ' ' ALA . 91.8 m-85 -76.86 -74.09 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 5.44 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.9 t 48.4 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.996 -0.547 . . . . 4.61 111.568 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -57.09 -55.29 36.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.698 0.285 . . . . 4.05 111.335 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.81 -27.96 60.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 5.46 111.165 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.459 ' CZ ' ' CD1' ' A' ' 165' ' ' PHE . 51.7 t80 -84.6 -58.25 2.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 3.23 110.973 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.98 -23.62 66.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 3.35 111.064 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -61.19 -47.13 87.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.294 -0.412 . . . . 3.93 110.827 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.7 -20.54 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.372 -0.376 . . . . 2.51 111.767 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.464 ' CE2' HD11 ' A' ' 169' ' ' LEU . 86.6 t80 -65.08 -56.47 12.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.764 0.316 . . . . 2.08 111.226 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 60.4 mt -50.31 -58.25 10.36 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 2.04 112.007 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 24.7 Cg_endo -60.49 -44.94 24.21 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.29 1.993 . . . . 1.28 112.985 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 92.2 p -50.67 -41.63 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 1.39 111.524 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.464 HD11 ' CE2' ' A' ' 165' ' ' PHE . 72.2 mt -60.4 -49.41 77.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 1.07 111.61 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.98 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.547 -0.297 . . . . 1.12 111.162 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 84.8 mt -58.84 -44.57 90.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 0.64 111.096 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -57.15 -48.09 79.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.415 . . . . 0.42 111.19 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 46.0 m80 -61.74 -52.39 64.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.53 111.272 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.15 -52.32 61.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.42 110.993 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.1 mt -56.64 -42.34 78.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.46 110.771 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.19 -52.27 53.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.21 110.807 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.5 mt -56.26 -42.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.47 110.595 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.83 -42.04 96.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.23 112.185 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.4 -51.38 70.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.907 0.384 . . . . 0.36 110.685 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' B' ' 177' ' ' ILE . . . -52.51 -52.26 38.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.824 -0.703 . . . . 0.28 112.65 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 31.7 mt -55.34 -46.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.9 111.252 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -56.66 -45.98 81.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.308 -0.406 . . . . 1.44 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.1 -48.39 88.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.8 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.49 57.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.703 -0.761 . . . . 0.55 112.6 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -62.15 -22.08 65.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.691 0.282 . . . . 2.24 111.085 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -112.87 50.2 0.89 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.441 -0.345 . . . . 4.48 110.961 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 83.9 mt -95.53 -68.47 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.21 111.077 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 188' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.277 -0.868 . . . . 2.72 111.183 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.829 -0.108 . . . . 7.87 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 177.89 -159.9 25.95 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.787 -0.721 . . . . 6.96 112.373 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 54.3 mt -70.79 -59.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 7.93 110.812 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' B' ' 159' ' ' ALA . 96.7 m-85 -76.99 -27.55 54.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 6.69 110.855 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 73.4 m 42.29 -89.9 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.784 -0.643 . . . . 6.01 112.128 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -55.05 -62.87 1.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.707 0.289 . . . . 4.95 111.74 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.522 ' O ' HG22 ' B' ' 164' ' ' VAL . 43.6 tt0 -54.53 -21.5 10.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 5.11 110.994 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -78.35 -40.33 36.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.574 -0.284 . . . . 3.68 110.907 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.43 ' N ' HD23 ' B' ' 162' ' ' LEU . 5.5 mt -63.1 -48.44 78.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.853 0.359 . . . . 3.64 110.676 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' B' ' 164' ' ' VAL . 0.2 OUTLIER -56.42 -27.85 57.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 4.17 111.382 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 160' ' ' GLU . 21.9 m -113.76 30.85 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 2.98 111.087 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -145.94 -54.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 2.32 110.882 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.501 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 83.2 mt -53.69 -57.38 17.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 2.18 111.465 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 19.3 Cg_endo -58.84 -44.5 35.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 1.36 113.009 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -47.85 -41.71 24.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.781 0.324 . . . . 1.54 111.137 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 89.5 mt -62.27 -44.33 96.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.86 111.191 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.458 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.3 mp -62.27 -50.95 69.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.93 111.111 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -51.78 -51.28 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.74 110.907 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 49.1 m -54.88 -52.72 61.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.4 111.047 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 38.7 m80 -62.61 -51.7 66.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.868 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.54 -50.98 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.987 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 80.4 mt -59.51 -44.48 93.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.38 110.733 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.63 -52.24 60.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.26 110.762 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 180' ' ' GLY . 45.1 mt -62.07 -42.02 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.566 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.04 -47.15 89.7 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.26 111.959 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 93.9 mt -56.73 -49.14 76.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.901 0.382 . . . . 0.34 110.414 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.83 -50.54 43.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.34 112.308 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.25 -52.26 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.67 110.743 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 70.3 t80 -51.79 -49.56 62.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 1.56 110.629 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.7 mt -63.15 -49.74 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.137 -0.483 . . . . 0.83 111.054 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.55 -52.56 51.77 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.853 -0.689 . . . . 0.69 112.881 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.5 -18.95 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.689 0.28 . . . . 2.56 111.022 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -72.17 -40.35 68.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.9 0.381 . . . . 3.82 110.712 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.2 -49.52 73.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.72 110.952 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.235 -0.888 . . . . 2.17 111.195 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.422 -0.271 . . . . 7.13 112.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 171.94 178.19 42.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.681 -0.771 . . . . 6.07 112.659 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.1 mm -69.59 -46.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 7.47 110.849 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -76.83 -76.73 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.884 -0.598 . . . . 5.44 110.621 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.8 m 63.59 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.129 -0.487 . . . . 4.61 111.108 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' CG ' ' A' ' 163' ' ' LYS . . . -60.47 -61.03 2.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 4.05 111.485 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' HG22 ' A' ' 164' ' ' VAL . 3.3 tm-20 -54.0 -31.55 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 5.46 111.409 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.564 ' CE1' ' CD1' ' A' ' 165' ' ' PHE . 52.6 t80 -84.47 -55.18 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 3.23 111.104 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 165' ' ' PHE . 92.7 mt -61.0 -40.0 91.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 3.35 111.195 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' O ' ' A' ' 159' ' ' ALA . 53.2 mtpt -56.63 -29.4 62.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 3.93 111.278 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' GLU . 20.1 m -125.38 26.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.349 . . . . 2.51 111.352 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 161' ' ' PHE . 82.8 t80 -117.81 -37.96 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 2.08 110.807 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 94.0 mt -67.77 -45.53 44.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.04 111.399 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 74.4 Cg_exo -47.12 -39.43 26.03 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.117 1.878 . . . . 1.28 112.08 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 49.8 m -67.58 -41.59 83.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 1.39 110.662 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.489 HD11 ' CE2' ' A' ' 165' ' ' PHE . 26.2 mt -56.54 -44.15 80.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -59.78 -50.13 75.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 1.12 110.663 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -52.15 -45.98 65.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.64 110.712 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.515 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 33.7 m -56.34 -50.5 71.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.42 110.549 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 72.8 m80 -59.14 -47.57 84.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.53 110.205 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.3 -49.6 73.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.42 110.303 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -43.99 97.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.46 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.65 64.46 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.453 . . . . 0.21 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 58.8 mt -57.53 -42.82 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.026 -0.534 . . . . 0.47 110.0 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -51.5 -43.59 52.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.659 -0.782 . . . . 0.23 111.53 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.03 -41.91 97.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.686 -0.487 . . . . 0.36 109.686 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.9 -47.42 65.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.28 112.472 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 181' ' ' ILE . 2.1 mp -62.34 -44.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.9 110.359 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 185' ' ' ARG . 60.8 t80 -51.9 -48.47 64.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.063 0.459 . . . . 1.44 110.212 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.53 -46.52 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.843 -0.617 . . . . 0.8 110.945 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -62.16 -45.48 95.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.959 -0.639 . . . . 0.55 112.752 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 14.1 ptm180 -62.03 -22.52 65.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.681 0.277 . . . . 2.24 111.042 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -104.37 34.91 2.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 4.48 111.137 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 43.4 mt -79.96 -23.66 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 1.21 110.963 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.199 -0.905 . . . . 2.72 111.073 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.418 -0.273 . . . . 7.87 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.16 -168.89 11.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 6.96 112.486 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.05 -60.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.038 0.447 . . . . 7.93 111.156 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 29.6 p90 -75.81 -57.0 4.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 6.69 110.865 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' B' ' 157' ' ' PHE . 10.4 t 78.51 -163.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.638 . . . . 6.01 111.602 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.66 -22.7 14.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 4.95 111.335 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -53.4 -64.58 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.992 0.425 . . . . 5.11 110.803 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 10.9 t80 -60.21 -34.11 73.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.973 -0.558 . . . . 3.68 110.953 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 67.9 mt -63.36 -36.14 82.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 3.64 111.308 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.16 -20.24 25.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.385 . . . . 4.17 111.303 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.35 39.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 2.98 111.513 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' B' ' 169' ' ' LEU . 85.4 t80 -139.74 -46.49 0.45 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 2.32 111.177 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.486 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 86.7 mt -71.4 -46.13 13.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 2.18 111.644 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 88.1 Cg_exo -41.97 -28.41 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 1.36 112.675 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -87.15 -47.91 8.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.889 0.376 . . . . 1.54 110.945 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' B' ' 165' ' ' PHE . 92.6 mt -62.16 -50.43 71.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.476 . . . . 0.86 111.368 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 170' ' ' LEU . 3.6 mp -56.94 -52.36 65.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.526 -0.306 . . . . 0.93 111.441 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 78.7 mt -55.1 -45.37 75.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.708 0.29 . . . . 0.74 110.86 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 53.9 m -56.23 -50.32 71.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.355 -0.384 . . . . 0.4 110.983 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.515 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 44.6 m80 -61.8 -52.11 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.36 111.049 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.1 mt -54.31 -52.26 62.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.882 0.372 . . . . 0.48 110.66 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 92.3 mt -56.43 -41.96 77.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.38 110.528 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.31 -50.4 65.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.26 110.635 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.96 -47.49 76.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.29 110.554 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -53.41 -43.65 66.1 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.505 -0.855 . . . . 0.26 112.089 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.36 -50.87 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.755 0.312 . . . . 0.34 110.579 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.18 -45.96 51.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.561 -0.828 . . . . 0.34 112.111 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.64 -45.87 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.971 0.415 . . . . 0.67 110.506 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.408 ' HA ' ' HG2' ' B' ' 185' ' ' ARG . 79.6 t80 -57.7 -44.27 85.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.891 -0.595 . . . . 1.56 110.913 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' B' ' 186' ' ' ARG . 23.3 mm -60.34 -41.75 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.83 111.032 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.73 -49.52 75.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.69 112.861 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 6.6 ptp180 -59.65 -35.39 74.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.675 0.274 . . . . 2.56 111.353 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.431 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 15.4 ptm180 -79.67 -27.05 40.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.493 -0.322 . . . . 3.82 111.248 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 mt -84.86 -50.44 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.411 -0.359 . . . . 1.72 111.004 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 66.0 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 2.17 111.014 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.647 -0.181 . . . . 7.13 112.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 154.26 172.85 22.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.656 -0.783 . . . . 6.07 112.416 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.93 -63.97 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.389 . . . . 7.47 110.837 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.7 m-85 -76.19 -68.11 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 5.44 110.638 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.9 m 40.45 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.07 -0.514 . . . . 4.61 112.096 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' A' ' 163' ' ' LYS . . . -56.75 -55.75 30.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.796 0.331 . . . . 4.05 111.389 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 164' ' ' VAL . 38.4 tt0 -55.7 -23.31 28.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.379 -0.373 . . . . 5.46 111.127 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -89.99 -57.23 2.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 3.23 110.978 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 58.2 mt -62.56 -38.79 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 3.35 111.021 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.48 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 58.6 mtpt -56.94 -21.74 32.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 3.93 110.984 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 160' ' ' GLU . 30.3 m -127.82 32.4 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.905 0.383 . . . . 2.51 110.77 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.55 -49.03 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 2.08 110.777 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.486 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 77.6 mt -55.3 -57.93 17.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 2.04 111.586 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 12.3 Cg_endo -56.66 -34.4 95.75 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.18 1.92 . . . . 1.28 112.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 45.5 t -57.14 -41.79 79.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.292 -0.413 . . . . 1.39 110.661 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 50.8 mt -58.09 -48.62 79.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 1.07 110.819 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -62.26 -47.5 84.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.12 110.734 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.4 mt -53.86 -47.98 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.64 110.962 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.25 -47.59 85.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.42 110.841 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -58.27 -50.54 73.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.53 110.848 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.0 mt -53.08 -51.5 61.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.42 110.702 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.93 -43.17 99.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.46 110.815 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.12 -52.32 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 0.21 110.944 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.15 -41.73 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.47 110.496 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.23 -41.85 87.32 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.668 -0.777 . . . . 0.23 111.819 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.72 -49.89 75.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 0.36 110.246 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.87 -52.18 44.44 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.406 -0.902 . . . . 0.28 112.037 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 180' ' ' GLY . 66.0 mt -62.12 -42.37 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.38 . . . . 0.9 110.837 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 185' ' ' ARG . 46.2 t80 -53.01 -47.63 68.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 1.44 110.681 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 75.1 mt -62.35 -46.67 95.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.8 111.14 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 187' ' ' LEU . . . -61.78 -44.83 97.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.873 -0.68 . . . . 0.55 112.977 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 182' ' ' TYR . 5.5 ptp180 -61.64 -28.02 69.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.709 0.29 . . . . 2.24 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -96.01 37.68 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 4.48 111.053 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 184' ' ' GLY . 18.1 mt -77.59 -45.22 25.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.21 110.935 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.288 -0.863 . . . . 2.72 111.397 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.459 -0.256 . . . . 7.87 112.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.55 177.66 24.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 6.96 112.536 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.35 -64.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 7.93 111.193 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.461 ' HA ' ' HB3' ' B' ' 161' ' ' PHE . 21.2 m-85 -79.51 4.67 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.524 . . . . 6.69 112.214 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 68.5 m -75.45 -100.34 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.217 -0.302 . . . . 6.01 111.115 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.41 72.89 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.31 0.485 . . . . 4.95 112.31 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -53.27 -76.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.388 . . . . 5.11 111.527 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' B' ' 157' ' ' PHE . 7.8 t80 -45.32 -48.61 13.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 3.68 111.573 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 158' ' ' SER . 95.1 mt -62.12 -41.61 98.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.797 0.332 . . . . 3.64 110.981 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -58.63 -34.77 71.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.246 -0.434 . . . . 4.17 110.384 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.96 30.06 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 2.98 110.866 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -132.28 -46.21 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 2.32 110.773 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.461 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 70.5 mt -58.14 -58.44 18.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 2.18 111.316 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 34.8 Cg_endo -64.28 -26.87 63.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.12 1.88 . . . . 1.36 112.005 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -63.91 -44.04 94.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 1.54 110.836 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.417 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 74.3 mt -53.39 -44.46 68.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.86 110.76 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.47 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.1 mp -60.91 -46.38 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.93 110.7 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.37 -43.18 92.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.74 110.659 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 50.2 m -56.23 -47.7 77.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.5 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 58.9 m80 -54.82 -51.95 64.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.36 110.77 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.71 -51.18 68.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.48 110.508 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 92.3 mt -56.65 -42.13 78.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.38 110.595 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.16 66.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.26 110.73 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 56.2 mt -54.4 -43.72 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.677 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.12 70.78 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.548 -0.834 . . . . 0.26 111.908 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.91 -51.45 65.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.832 0.349 . . . . 0.34 110.49 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 181' ' ' ILE . . . -51.13 -45.72 51.43 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.546 -0.835 . . . . 0.34 112.338 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.48 -49.49 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.67 110.563 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.402 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 76.7 t80 -53.4 -44.13 68.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.665 -0.698 . . . . 1.56 111.164 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.89 -49.71 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.83 111.447 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.52 52.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.028 -0.606 . . . . 0.69 113.392 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.431 ' HD3' ' HG3' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -55.28 -20.37 11.06 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.77 -0.253 . . . . 2.56 111.44 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.431 ' HG3' ' HD3' ' B' ' 185' ' ' ARG . 76.2 mtp180 -87.02 -29.8 21.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.819 0.342 . . . . 3.82 111.0 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.04 -34.79 78.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 1.72 110.834 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.189 -0.91 . . . . 2.17 111.177 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.661 -0.176 . . . . 7.13 112.661 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -137.25 172.76 22.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 6.07 112.455 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.51 HG22 ' CD2' ' A' ' 157' ' ' PHE . 15.8 mt -71.44 -29.91 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 7.47 110.892 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.51 ' CD2' HG22 ' A' ' 156' ' ' ILE . 51.2 m-85 -156.44 -50.21 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.908 -0.587 . . . . 5.44 110.964 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.4 t 49.89 -87.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 4.61 111.595 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.18 -64.51 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.706 0.289 . . . . 4.05 111.446 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . 9.3 tp10 -55.3 -22.73 19.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 5.46 111.454 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -80.54 -53.82 6.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.816 0.341 . . . . 3.23 111.153 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.3 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 3.35 111.556 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.411 ' CE ' ' HA ' ' A' ' 160' ' ' GLU . 51.5 mtmt -56.49 -28.1 58.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.765 0.317 . . . . 3.93 110.876 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.18 36.74 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 2.51 111.005 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -140.98 -51.94 0.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 2.08 110.861 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 66.8 mt -52.19 -57.66 14.42 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.449 . . . . 2.04 111.337 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 26.8 Cg_endo -61.76 -31.02 85.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.124 1.883 . . . . 1.28 112.19 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.3 m -59.43 -43.3 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 1.39 110.748 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.425 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 79.5 mt -57.99 -46.97 84.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 1.07 110.924 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -60.57 -50.4 73.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.421 . . . . 1.12 110.613 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.48 -43.8 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.64 110.61 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' B' ' 173' ' ' HIS . 69.8 m -53.32 -49.86 66.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.42 110.909 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.425 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 41.9 m80 -58.79 -49.37 77.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.53 110.763 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.86 -46.23 90.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.42 110.983 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.92 -46.82 87.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.032 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.63 58.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.21 111.3 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.7 mt -60.97 -42.2 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.815 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.43 -45.04 85.08 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.574 -0.822 . . . . 0.23 112.24 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.22 -46.76 87.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.36 110.796 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.58 -52.57 51.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.608 -0.806 . . . . 0.28 112.441 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 50.0 mt -62.52 -43.98 98.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.785 0.326 . . . . 0.9 111.22 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.85 -51.77 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 1.44 110.672 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.72 -47.19 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.484 . . . . 0.8 111.147 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.37 -52.42 49.45 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.052 -0.594 . . . . 0.55 113.497 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.4 -20.11 18.0 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.678 -0.307 . . . . 2.24 111.283 -179.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -110.44 43.52 1.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.73 0.3 . . . . 4.48 111.026 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 187' ' ' LEU . 15.9 mt -75.16 -35.38 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.384 -0.371 . . . . 1.21 110.99 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.474 ' OXT' HG23 ' A' ' 188' ' ' THR . 2.4 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.159 -0.924 . . . . 2.72 111.195 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.522 -0.231 . . . . 7.87 112.522 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -156.68 -168.87 20.01 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 6.96 112.591 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.8 mm -69.57 -60.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.105 0.479 . . . . 7.93 111.107 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' B' ' 159' ' ' ALA . 50.1 m-85 -76.39 -65.96 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.761 -0.654 . . . . 6.69 110.871 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.42 ' O ' ' HG ' ' B' ' 162' ' ' LEU . 68.6 m 41.32 -92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.071 -0.513 . . . . 6.01 111.306 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.98 -53.58 56.62 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.366 . . . . 4.95 111.012 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.83 -21.13 26.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 5.11 111.133 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.57 ' CE2' ' CD1' ' B' ' 165' ' ' PHE . 47.0 t80 -87.02 -30.28 21.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 3.68 111.287 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 158' ' ' SER . 12.7 mt -62.69 -36.15 81.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.946 0.403 . . . . 3.64 110.568 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -56.87 -23.5 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 4.17 111.007 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.92 38.84 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 2.98 111.24 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . 0.57 ' CD1' ' CE2' ' B' ' 161' ' ' PHE . 72.4 t80 -122.69 -52.28 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 2.32 110.898 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 69.5 mt -55.89 -57.76 19.96 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 2.18 111.501 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 17.5 Cg_endo -57.98 -26.59 75.61 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.133 1.889 . . . . 1.36 112.081 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.8 t -67.27 -41.88 84.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 1.54 110.515 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 68.7 mt -52.65 -42.71 64.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.977 -0.556 . . . . 0.86 110.622 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.5 mp -62.23 -52.09 65.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.93 110.59 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.83 89.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.923 -0.58 . . . . 0.74 110.6 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 m -54.46 -47.18 73.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.4 110.868 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' A' ' 172' ' ' SER . 41.2 m80 -60.19 -46.25 90.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.36 110.706 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.38 -50.09 74.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.48 110.652 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 179' ' ' LEU . 87.5 mt -61.79 -42.11 98.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.38 110.915 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.78 -52.0 52.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.26 111.037 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 34.4 mt -59.64 -46.72 92.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.29 110.692 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.87 -45.08 87.1 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.598 -0.81 . . . . 0.26 112.013 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 175' ' ' LEU . 81.9 mt -55.24 -50.85 68.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.899 0.381 . . . . 0.34 110.475 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.74 -45.36 55.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.549 -0.834 . . . . 0.34 112.02 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.08 -52.21 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.968 0.414 . . . . 0.67 110.811 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.433 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 24.6 t80 -59.51 -51.68 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.864 -0.607 . . . . 1.56 111.189 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.77 -49.81 82.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 0.83 111.656 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.69 -52.17 50.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.955 -0.64 . . . . 0.69 113.315 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -51.71 -30.51 22.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.762 0.315 . . . . 2.56 111.269 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' B' ' 185' ' ' ARG . 65.7 mtt180 -84.88 -22.86 29.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 3.82 111.453 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 56.2 mt -51.39 -50.43 59.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 1.72 110.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.38 -0.819 . . . . 2.17 111.283 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.542 -0.223 . . . . 7.13 112.542 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.33 175.27 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.748 -0.739 . . . . 6.07 112.491 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.77 -66.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.998 0.428 . . . . 7.47 110.886 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 159' ' ' ALA . 24.3 m-85 -78.1 -69.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 5.44 111.029 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.6 p 43.55 -91.72 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.165 -0.47 . . . . 4.61 111.485 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 163' ' ' LYS . . . -59.87 -51.34 70.11 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.877 0.37 . . . . 4.05 111.186 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.39 -21.57 16.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 5.46 111.382 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -97.21 -51.5 4.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 3.23 110.902 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.89 -37.89 88.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 3.35 111.085 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.432 ' HD2' ' HB1' ' A' ' 159' ' ' ALA . 59.2 mtpt -58.1 -30.58 66.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 3.93 111.287 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.5 46.17 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 2.51 111.394 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 169' ' ' LEU . 77.5 t80 -156.66 -44.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.397 . . . . 2.08 110.882 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 52.3 mt -60.23 -59.75 12.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 2.04 111.554 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 2.4 Cg_endo -41.33 -29.92 0.73 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.552 2.168 . . . . 1.28 112.384 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.3 t -77.02 -41.75 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.39 110.556 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.475 HD11 ' CE2' ' A' ' 165' ' ' PHE . 61.1 mt -57.26 -41.54 79.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 1.07 110.892 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.3 mp -58.96 -51.91 68.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 1.12 110.646 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.35 -43.63 92.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.64 110.882 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 50.3 m -61.91 -52.77 62.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.345 -0.389 . . . . 0.42 110.923 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -62.91 -52.3 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.53 110.984 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.48 -51.64 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.42 110.963 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.87 -44.58 91.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.46 110.867 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.29 -52.34 63.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.21 110.868 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.4 mt -54.97 -41.58 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.47 110.229 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.93 -41.66 94.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.705 -0.759 . . . . 0.23 111.897 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 mt -58.71 -49.28 78.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.946 0.403 . . . . 0.36 110.357 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.82 -50.98 58.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 0.28 112.345 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.26 -42.84 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.9 111.016 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 50.8 t80 -56.12 -49.28 74.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 1.44 110.85 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.07 -46.72 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.085 -0.507 . . . . 0.8 111.3 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.47 -52.35 49.71 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.957 -0.639 . . . . 0.55 113.288 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -61.66 -23.63 66.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 2.24 111.178 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -99.11 37.36 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 4.48 111.184 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.37 -50.35 65.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.351 . . . . 1.21 111.114 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.272 -0.87 . . . . 2.72 111.312 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.438 -0.265 . . . . 7.87 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.58 37.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 6.96 112.482 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 51.9 mt -70.36 -60.16 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 7.93 111.001 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' B' ' 161' ' ' PHE . 69.8 m-85 -77.04 -84.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 6.69 110.813 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.6 22.98 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.959 0.409 . . . . 6.01 111.509 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' B' ' 163' ' ' LYS . . . -179.67 -62.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.82 -0.627 . . . . 4.95 109.784 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 -26.06 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.548 -0.538 . . . . 5.11 109.548 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.507 ' HB2' ' CD2' ' B' ' 157' ' ' PHE . 83.0 t80 -96.16 -47.97 5.84 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.747 -0.66 . . . . 3.68 110.286 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.85 -33.09 73.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.998 0.427 . . . . 3.64 110.42 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' B' ' 159' ' ' ALA . 18.5 ttpp -60.64 -32.03 71.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 4.17 110.899 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.22 37.57 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 2.98 111.365 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -146.63 -48.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 2.32 110.869 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.478 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 91.2 mt -55.9 -46.13 99.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 2.18 111.139 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 89.6 Cg_exo -43.01 -40.22 8.45 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.187 1.924 . . . . 1.36 112.319 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t -70.0 -42.2 73.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 1.54 110.627 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' O ' ' ND1' ' B' ' 173' ' ' HIS . 69.4 mt -61.09 -51.71 67.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.86 111.336 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.425 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.7 mp -57.5 -50.39 73.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.371 . . . . 0.93 111.216 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.72 -44.22 93.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.426 -0.352 . . . . 0.74 110.995 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 63.6 m -55.04 -51.22 66.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.4 110.88 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . 0.418 ' ND1' ' O ' ' B' ' 169' ' ' LEU . 52.1 m80 -59.62 -49.41 77.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.36 111.023 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 66.7 mt -57.76 -51.52 69.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.48 110.943 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.1 -43.63 78.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.38 110.817 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.79 -52.14 57.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.413 . . . . 0.26 110.892 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.7 mt -57.84 -41.79 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.971 -0.559 . . . . 0.29 110.59 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.667 -0.778 . . . . 0.26 111.985 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 64.3 mt -58.72 -47.74 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.34 110.17 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.95 -46.34 60.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.662 -0.78 . . . . 0.34 112.123 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 71.7 mt -57.59 -52.21 60.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.67 110.753 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -52.01 -48.96 64.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.938 -0.574 . . . . 1.56 110.561 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.81 -45.13 99.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.83 111.182 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -59.26 -52.75 51.39 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.865 -0.683 . . . . 0.69 113.116 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' B' ' 186' ' ' ARG . 0.0 OUTLIER -58.53 -20.44 46.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.711 0.256 . . . . 2.56 111.127 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' B' ' 185' ' ' ARG . 24.8 mmm180 -79.52 -26.21 41.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.814 0.34 . . . . 3.82 110.72 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 94.4 mt -54.1 -45.83 71.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 1.72 110.957 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 188' ' ' THR . 1.8 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.389 -0.815 . . . . 2.17 111.174 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 112.452 -0.259 . . . . 7.13 112.452 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.7 172.96 14.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 6.07 112.495 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.85 -59.57 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 7.47 110.956 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 161' ' ' PHE . 87.7 m-85 -75.96 -64.78 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 5.44 110.947 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 58.9 m 51.44 -87.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 4.61 111.216 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -56.75 -61.61 2.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.325 . . . . 4.05 111.356 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -29.04 63.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 5.46 111.488 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 157' ' ' PHE . 70.4 t80 -74.76 -50.38 17.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 3.23 111.203 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 158' ' ' SER . 70.8 mt -62.83 -36.71 84.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 3.35 111.206 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -57.1 -23.09 44.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 3.93 111.06 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.9 m -115.59 30.62 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 2.51 111.002 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.511 ' CZ ' HD11 ' A' ' 169' ' ' LEU . 90.7 t80 -135.14 -60.57 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.505 . . . . 2.08 110.847 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 74.6 mt -51.25 -43.33 85.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 2.04 111.652 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 17.4 Cg_exo -67.05 -49.95 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.272 1.981 . . . . 1.28 112.228 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.2 t -47.25 -52.1 16.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 1.39 111.124 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.511 HD11 ' CZ ' ' A' ' 165' ' ' PHE . 52.0 mt -60.65 -41.78 95.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.902 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -50.52 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.12 111.343 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.3 mt -56.06 -44.04 78.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.64 110.882 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.9 m -57.78 -51.69 68.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.42 110.957 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -52.81 -50.6 63.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 0.53 110.869 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.07 -48.13 79.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 0.42 110.84 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 84.3 mt -61.78 -47.06 86.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.46 111.029 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -52.53 49.68 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.989 0.423 . . . . 0.21 110.911 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.8 mt -55.55 -41.88 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.092 -0.504 . . . . 0.47 110.356 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.56 -41.94 93.8 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.623 -0.799 . . . . 0.23 111.837 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 mt -58.26 -46.77 85.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.909 0.385 . . . . 0.36 110.227 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.34 -43.83 89.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.56 -0.828 . . . . 0.28 112.224 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 48.2 mm -62.34 -46.7 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.9 111.107 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 186' ' ' ARG . 65.6 t80 -54.33 -48.6 71.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.44 110.657 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.8 mt -62.95 -49.77 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.113 -0.494 . . . . 0.8 111.083 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.54 -52.15 51.04 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.975 -0.631 . . . . 0.55 113.241 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -60.33 -16.83 38.44 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.758 -0.26 . . . . 2.24 111.366 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.459 ' HD3' ' CE2' ' A' ' 182' ' ' TYR . 75.3 mtp85 -111.39 44.68 1.3 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.728 0.299 . . . . 4.48 111.006 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.89 -32.2 11.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 1.21 111.039 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.149 -0.929 . . . . 2.72 111.127 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.491 -0.244 . . . . 7.87 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -106.19 176.31 21.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.668 -0.777 . . . . 6.96 112.531 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 12.1 mm -70.14 -49.17 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.958 0.409 . . . . 7.93 111.102 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.45 ' CB ' ' HB2' ' B' ' 161' ' ' PHE . 91.7 m-85 -76.45 -64.93 1.0 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.935 -0.575 . . . . 6.69 110.843 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.9 m 45.07 -90.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 6.01 111.347 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.41 -55.29 36.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.857 0.36 . . . . 4.95 111.079 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.43 -42.44 82.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 5.11 111.396 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.45 ' HB2' ' CB ' ' B' ' 157' ' ' PHE . 71.1 t80 -55.27 -53.21 58.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.452 -0.34 . . . . 3.68 111.267 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.45 -38.87 91.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.348 -0.387 . . . . 3.64 111.235 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -56.51 -32.39 65.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 4.17 110.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.75 31.2 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 2.98 110.827 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -128.98 -55.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 2.32 111.138 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.473 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 69.0 mt -57.84 -45.9 99.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 2.18 111.582 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 96.5 Cg_endo -83.66 13.23 2.75 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 1.36 112.957 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 44.6 t -103.81 -45.57 4.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 1.54 111.025 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.71 -45.41 94.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.86 111.137 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 170' ' ' LEU . 5.9 mp -60.01 -44.73 94.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.93 110.964 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 92.6 mt -59.35 -47.15 86.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.38 -0.373 . . . . 0.74 110.716 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 48.7 m -53.7 -49.72 67.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.779 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -57.69 -49.06 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.935 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.35 -47.52 83.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.821 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.21 -42.6 99.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.38 110.755 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.7 -52.04 57.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.26 110.668 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.61 -43.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.965 -0.561 . . . . 0.29 110.539 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.37 -43.33 84.79 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.68 -0.771 . . . . 0.26 111.87 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.22 -50.88 72.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 0.34 110.414 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.37 -49.68 50.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.573 -0.822 . . . . 0.34 112.266 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.17 -42.27 94.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.67 110.835 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.479 ' CE2' ' HD2' ' B' ' 186' ' ' ARG . 66.1 t80 -57.62 -45.03 85.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 1.56 110.866 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.68 -42.73 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.301 -0.408 . . . . 0.83 111.007 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.21 -52.3 50.64 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.835 -0.698 . . . . 0.69 113.153 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -58.91 -23.04 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.567 0.223 . . . . 2.56 111.38 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.479 ' HD2' ' CE2' ' B' ' 182' ' ' TYR . 71.4 mtp180 -71.56 -38.4 70.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 3.82 110.789 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.1 -34.38 76.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.72 110.54 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.14 -0.934 . . . . 2.17 111.164 179.898 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.565 -0.214 . . . . 7.13 112.565 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -140.39 160.99 26.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 6.07 112.302 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.09 -36.62 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 7.47 111.188 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' ALA . 64.2 m-85 -76.74 -79.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.011 -0.541 . . . . 5.44 111.125 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.5 t 63.7 -76.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.802 0.335 . . . . 4.61 111.016 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -58.68 -53.78 54.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.297 -0.41 . . . . 4.05 111.684 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -55.04 -44.85 75.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 5.46 111.589 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.91 -48.01 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.459 -0.337 . . . . 3.23 111.54 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.62 -30.51 70.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 3.35 111.271 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -57.42 -28.97 63.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 3.93 110.919 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.9 37.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 2.51 111.224 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -148.02 -50.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 2.08 110.777 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 64.6 mt -61.8 -60.36 10.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 2.04 111.501 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 1.2 Cg_endo -43.96 -43.29 12.41 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.469 2.113 . . . . 1.28 112.437 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 48.3 t -56.38 -43.02 78.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 1.39 110.951 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.42 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 52.6 mt -62.1 -44.92 95.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 1.07 110.986 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.5 mp -58.84 -46.64 87.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 1.12 110.927 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -56.34 -46.13 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.888 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 49.5 m -60.78 -47.84 84.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.42 110.84 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 169' ' ' LEU . 43.9 m80 -55.09 -50.22 69.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.53 110.835 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 97.1 mt -55.99 -48.52 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.42 110.698 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.66 -45.38 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.042 -0.526 . . . . 0.46 111.022 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.4 -52.87 51.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.924 0.393 . . . . 0.21 111.099 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.3 mt -57.56 -42.94 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.47 110.344 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.65 -42.39 84.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.594 -0.812 . . . . 0.23 112.011 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.1 mt -59.08 -50.77 72.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.952 0.405 . . . . 0.36 110.34 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.96 -44.27 61.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.622 -0.799 . . . . 0.28 112.45 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.41 HD13 ' O ' ' B' ' 180' ' ' GLY . 43.4 mm -62.27 -51.23 74.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.9 111.14 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 185' ' ' ARG . 69.1 t80 -52.45 -46.84 66.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.136 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.83 -44.31 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.399 -0.364 . . . . 0.8 111.497 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.95 -51.65 55.65 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.863 -0.684 . . . . 0.55 112.894 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 182' ' ' TYR . 2.1 ptp180 -55.99 -29.78 60.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.24 111.198 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.404 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 74.7 mtp85 -105.73 48.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 4.48 111.36 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.71 -46.15 7.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 1.21 110.742 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.231 -0.89 . . . . 2.72 110.997 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.55 -0.22 . . . . 7.87 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.84 174.37 52.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 6.96 112.48 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 46.1 mt -69.93 -60.9 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 7.93 110.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' B' ' 159' ' ' ALA . 78.1 m-85 -76.38 -65.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 6.69 110.876 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 79.2 p 43.92 -90.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 6.01 111.758 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -56.71 -50.45 72.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 4.95 111.232 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.56 -54.23 49.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 5.11 111.013 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.72 -50.72 70.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 3.68 111.123 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.21 -35.54 79.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 3.64 111.236 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -59.52 -24.59 63.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.215 -0.448 . . . . 4.17 110.894 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.56 30.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.353 -0.385 . . . . 2.98 111.227 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -133.88 -53.76 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.312 -0.403 . . . . 2.32 111.032 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' B' ' 167' ' ' PRO . 78.1 mt -57.44 -44.95 99.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 2.18 111.531 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' B' ' 166' ' ' LEU . 71.4 Cg_exo -48.18 -52.14 8.84 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.176 1.917 . . . . 1.36 112.299 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 49.4 m -52.56 -42.54 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 1.54 111.119 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 73.8 mt -54.54 -51.71 64.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.86 111.114 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 170' ' ' LEU . 7.3 mp -58.02 -47.56 82.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.93 110.807 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.51 -46.13 84.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.74 110.866 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 54.3 m -53.77 -48.01 70.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.4 111.084 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.52 -52.19 66.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.36 111.13 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -54.62 -49.75 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.48 110.978 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.12 -45.93 92.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.38 111.22 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.34 -52.47 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.26 111.386 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 28.2 mt -58.26 -43.87 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.958 0.409 . . . . 0.29 110.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.38 -43.58 93.82 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 0.26 112.056 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . 0.456 ' O ' HD12 ' B' ' 183' ' ' ILE . 86.6 mt -56.33 -51.3 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.34 110.385 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.13 -51.28 36.22 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.408 -0.901 . . . . 0.34 112.118 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.01 -41.44 58.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.67 110.722 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -55.1 -46.93 75.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.56 111.222 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.456 HD12 ' O ' ' B' ' 179' ' ' LEU . 3.2 mp -62.48 -47.84 91.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.83 110.403 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.84 69.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.69 112.687 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -62.2 -29.69 70.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 2.56 111.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -76.97 -34.29 57.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.258 -0.428 . . . . 3.82 111.189 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 75.0 mt -83.6 -30.05 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 1.72 110.989 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.229 -0.891 . . . . 2.17 111.266 -179.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.52 -0.232 . . . . 7.13 112.52 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.8 152.51 52.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.692 -0.766 . . . . 6.07 112.411 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 26.0 mm -72.22 -66.64 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.439 . . . . 7.47 110.986 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ALA . 80.0 m-85 -77.22 -73.91 0.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.725 -0.67 . . . . 5.44 110.908 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.407 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 74.4 m 38.46 -90.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.181 -0.463 . . . . 4.61 112.233 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 157' ' ' PHE . . . -55.7 -56.74 16.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.737 0.303 . . . . 4.05 111.725 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -57.07 -22.56 40.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.41 -0.359 . . . . 5.46 111.574 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 157' ' ' PHE . 17.6 t80 -91.44 -48.65 6.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.802 0.334 . . . . 3.23 111.535 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 166' ' ' LEU . 80.5 mt -62.49 -36.39 82.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.269 -0.423 . . . . 3.35 111.645 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.31 -32.06 66.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.713 0.292 . . . . 3.93 111.256 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 16.1 m -111.95 33.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 2.51 111.058 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 79.1 t80 -147.24 -48.28 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 2.08 110.962 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 57.6 mt -58.33 -58.67 17.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 2.04 111.622 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 10.9 Cg_endo -54.23 -42.76 64.61 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.385 2.057 . . . . 1.28 112.708 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 97.1 p -54.95 -41.95 71.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.376 -0.374 . . . . 1.39 111.086 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 165' ' ' PHE . 62.2 mt -61.67 -45.95 91.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.399 . . . . 1.07 111.388 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 170' ' ' LEU . 7.4 mp -60.94 -52.2 66.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.92 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.6 mt -52.17 -51.22 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.378 . . . . 0.64 110.961 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.1 m -62.36 -52.03 65.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.42 111.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.6 -52.57 64.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.31 -0.404 . . . . 0.53 111.184 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.4 mt -52.68 -50.35 63.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.42 110.79 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.2 mt -60.41 -44.31 95.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.46 110.839 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.4 ' HB1' HG13 ' B' ' 177' ' ' ILE . . . -54.6 -51.95 63.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.21 110.699 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 57.6 mt -54.22 -45.91 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.47 110.373 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -56.6 -42.82 90.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.641 -0.79 . . . . 0.23 111.942 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.03 -51.89 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.877 0.37 . . . . 0.36 110.441 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.36 -46.73 79.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.67 -0.776 . . . . 0.28 112.454 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 47.5 mm -59.82 -43.69 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.9 111.262 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.61 -45.73 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.44 110.965 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.408 HD12 HD11 ' B' ' 181' ' ' ILE . 68.8 mt -59.31 -42.69 88.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.8 111.056 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.6 -51.39 57.92 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.547 -0.835 . . . . 0.55 112.486 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -62.49 -21.26 65.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 2.24 111.22 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.13 41.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.456 -0.338 . . . . 4.48 111.115 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.71 -29.99 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.412 -0.358 . . . . 1.21 110.925 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.429 ' OXT' HG23 ' A' ' 188' ' ' THR . 1.8 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.25 -0.881 . . . . 2.72 111.266 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.623 -0.191 . . . . 7.87 112.623 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -110.43 -175.62 20.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.825 -0.702 . . . . 6.96 112.495 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 14.4 mm -69.27 -59.27 3.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 7.93 111.04 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' B' ' 161' ' ' PHE . 30.1 p90 -75.85 -55.76 5.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 6.69 110.671 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 12.7 m 73.84 -163.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.691 -0.686 . . . . 6.01 111.336 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' B' ' 162' ' ' LEU . . . -53.92 -21.46 7.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.445 -0.343 . . . . 4.95 111.278 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -53.69 -49.85 67.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.031 0.443 . . . . 5.11 110.834 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.44 ' CB ' ' HB2' ' B' ' 157' ' ' PHE . 8.2 t80 -79.83 -34.58 39.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.592 . . . . 3.68 110.573 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' B' ' 159' ' ' ALA . 60.3 mt -62.89 -50.93 68.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 3.64 111.003 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.492 ' HG3' HG23 ' B' ' 164' ' ' VAL . 17.4 ptpt -57.4 -34.42 68.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 4.17 110.594 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.552 ' O ' HG12 ' B' ' 164' ' ' VAL . 15.1 t -96.41 31.95 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.501 . . . . 2.98 110.857 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -144.88 -46.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 2.32 111.027 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 64.2 mt -51.62 -58.75 9.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.998 -0.546 . . . . 2.18 111.688 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 10.0 Cg_endo -53.09 -38.11 80.17 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.407 2.071 . . . . 1.36 112.433 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 47.9 t -52.37 -44.51 65.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.372 -0.376 . . . . 1.54 110.793 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 99.2 mt -55.14 -49.8 70.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.86 110.965 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -58.19 -47.8 82.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.93 110.553 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 88.1 mt -56.28 -45.28 80.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.74 110.472 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 58.0 m -52.19 -47.78 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.4 110.429 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -60.62 -50.92 71.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.36 110.513 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.6 -48.09 82.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.48 110.577 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 171' ' ' LEU . 86.3 mt -57.81 -45.14 86.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.38 110.685 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.43 -52.63 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.984 0.421 . . . . 0.26 110.581 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.4 HG13 ' HB1' ' A' ' 176' ' ' ALA . 38.4 mt -58.38 -42.98 85.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.29 110.019 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.06 -42.76 97.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.751 -0.738 . . . . 0.26 111.667 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 78.3 mt -54.62 -47.84 72.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.931 -0.396 . . . . 0.34 109.931 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.01 -43.36 93.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.652 -0.785 . . . . 0.34 112.027 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.408 HD11 HD12 ' A' ' 183' ' ' ILE . 51.3 mm -56.32 -48.46 79.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.42 . . . . 0.67 110.834 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.418 ' CZ ' ' HD2' ' B' ' 186' ' ' ARG . 85.2 t80 -59.37 -50.22 74.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.881 -0.599 . . . . 1.56 110.784 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.1 -43.36 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.83 111.364 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.7 -52.7 50.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.866 -0.683 . . . . 0.69 113.473 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -59.82 -17.95 40.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.748 0.274 . . . . 2.56 111.383 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . 0.418 ' HD2' ' CZ ' ' B' ' 182' ' ' TYR . 76.3 mtp85 -89.03 -40.35 13.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.803 0.335 . . . . 3.82 111.129 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 90.5 mt -56.86 -58.03 9.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 1.72 110.922 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.252 -0.88 . . . . 2.17 111.141 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.496 -0.242 . . . . 7.13 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.76 -171.94 24.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 6.07 112.447 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.74 -41.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.19 0.519 . . . . 7.47 109.758 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -77.7 -52.76 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 5.44 110.491 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.9 m -167.77 -62.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 4.61 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 179.01 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.6 -0.727 . . . . 4.05 110.64 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' HA ' ' HE2' ' A' ' 163' ' ' LYS . 43.0 mt-10 -55.15 -26.48 38.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 5.46 110.72 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.45 -37.16 80.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.225 -0.443 . . . . 3.23 110.647 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.1 -39.25 94.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 3.35 110.799 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 160' ' ' GLU . 0.8 OUTLIER -54.48 -28.95 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 3.93 110.982 179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 m -111.52 32.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.454 . . . . 2.51 110.714 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 169' ' ' LEU . 57.9 t80 -138.01 -65.46 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 2.08 110.53 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 167' ' ' PRO . 81.8 mt -51.55 -51.42 69.75 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.506 . . . . 2.04 111.777 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 166' ' ' LEU . 56.7 Cg_endo -70.08 -12.6 32.6 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.954 1.77 . . . . 1.28 112.979 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 57.5 p -94.84 -52.61 4.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.288 . . . . 1.39 111.18 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 165' ' ' PHE . 6.2 mp -62.83 -50.93 69.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 1.07 111.405 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 170' ' ' LEU . 1.8 mp -56.8 -52.11 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 1.12 111.243 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 167' ' ' PRO . 57.8 mt -59.53 -43.36 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.64 110.905 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 66.0 m -57.54 -52.24 66.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.42 111.097 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -62.04 -52.03 65.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.53 110.921 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.62 -50.22 70.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.42 110.668 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 mt -58.89 -41.88 88.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.46 110.794 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.91 -52.36 50.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.054 0.454 . . . . 0.21 110.373 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 55.0 mt -56.75 -41.8 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.852 -0.613 . . . . 0.47 109.981 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.27 -41.87 95.17 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.697 -0.763 . . . . 0.23 111.523 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 36.2 mt -55.42 -50.39 69.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.581 -0.526 . . . . 0.36 109.581 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' B' ' 181' ' ' ILE . . . -52.65 -48.04 56.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.342 -0.933 . . . . 0.28 111.496 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 180' ' ' GLY . 45.6 mm -62.54 -44.07 99.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.9 110.642 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.435 ' CE1' ' HD3' ' A' ' 186' ' ' ARG . 41.1 t80 -53.45 -46.95 70.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.64 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.15 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.8 110.995 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 187' ' ' LEU . . . -62.19 -52.08 52.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.853 -0.689 . . . . 0.55 112.502 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' TYR . 11.3 ptp180 -53.41 -31.86 47.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 2.24 110.711 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 182' ' ' TYR . 35.1 mtp180 -92.79 38.31 1.02 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.532 . . . . 4.48 111.261 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 184' ' ' GLY . 60.4 mt -106.44 -14.17 15.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 1.21 111.225 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 188' ' ' THR . 1.9 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.322 -0.847 . . . . 2.72 111.272 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.461 -0.256 . . . . 7.87 112.461 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.79 -178.75 41.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 6.96 112.515 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 mm -69.57 -35.56 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.886 0.374 . . . . 7.93 111.087 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' B' ' 161' ' ' PHE . 68.4 m-85 -76.91 -71.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 6.69 110.966 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.1 p 44.6 -90.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.098 -0.501 . . . . 6.01 111.419 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' B' ' 157' ' ' PHE . . . -57.9 -50.63 72.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.817 0.342 . . . . 4.95 111.004 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.78 -60.62 3.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 5.11 111.039 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' B' ' 157' ' ' PHE . 82.9 t80 -47.43 -52.59 16.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 3.68 111.183 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 58.3 mt -62.05 -35.78 79.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 3.64 110.854 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.84 -26.59 58.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 4.17 110.833 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.67 40.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 2.98 110.869 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.41 -42.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 2.32 111.1 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' B' ' 167' ' ' PRO . 87.6 mt -56.69 -56.71 29.72 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.364 -0.38 . . . . 2.18 111.86 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 166' ' ' LEU . 24.1 Cg_endo -60.87 -42.41 38.0 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.363 2.042 . . . . 1.36 113.186 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 89.9 p -47.12 -45.42 22.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.284 . . . . 1.54 111.341 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.09 -49.99 75.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.385 -0.37 . . . . 0.86 111.128 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 170' ' ' LEU . 7.4 mp -60.44 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.93 111.017 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 91.3 mt -55.75 -42.77 75.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.74 110.946 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.4 m -55.76 -51.26 68.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.902 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -53.8 -51.77 62.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.281 -0.418 . . . . 0.36 111.032 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -52.62 -52.22 56.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.48 110.721 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.84 -41.59 91.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.38 110.813 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.89 54.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.26 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.61 -45.44 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.29 111.013 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.92 73.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.676 -0.773 . . . . 0.26 112.221 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.14 -45.2 94.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.34 110.737 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 181' ' ' ILE . . . -51.78 -52.12 35.84 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.623 -0.799 . . . . 0.34 112.407 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.42 HG12 ' HA2' ' A' ' 180' ' ' GLY . 50.0 mt -59.29 -48.93 85.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.67 111.201 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' TYR . . . . . 0.404 ' O ' ' HG3' ' B' ' 185' ' ' ARG . 48.6 t80 -54.12 -50.22 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 1.56 111.154 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.39 -47.75 91.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.13 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.15 -52.06 52.42 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.828 -0.701 . . . . 0.69 113.184 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' B' ' 182' ' ' TYR . 0.0 OUTLIER -61.72 -25.95 67.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.699 0.285 . . . . 2.56 111.305 -179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -76.77 -36.41 57.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.506 -0.316 . . . . 3.82 111.276 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 65.0 mt -66.41 -58.6 4.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 1.72 110.881 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 188' ' ' THR . 1.5 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.316 -0.85 . . . . 2.17 111.201 -179.906 . . . . . . . . 1 1 . 1 stop_ save_